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ABSTRACT 
The human bacterial pathogen Neisseria meningitidis (Nm) is one of the 
world’s leading causative agents of systemic meningitis, which is characterised by 
inflammation of the meninges and more rarely, septicaemia. The high mortality rate 
and debilitating long term effects found in infants and young adults is due to the 
mounting of a large scale immune response by the host leading to severe 
inflammation and tissue death. The reasons as to how the meningococcus is able to 
breach innate immune barriers to cause this kind of infection, however, is still 
unclear. One important innate immune defence mechanism is the production of 
acute phase proteins such as C-Reactive Protein (CRP), which is known to opsonise 
pathogens such as N. meningitidis and enhance its uptake into human phagocytic 
cells. This investigation has demonstrated the enhanced uptake of CRP opsonised 
Nm into human macrophages and dendritic cells (DCs); two important innate 
immune cells which are some of the first to encounter the bacterium upon its 
dissemination through mucosal epithelium into the blood stream. Not only are 
these cells important phagocytes needed for the clearance of this pathogen, but 
dendritic cells in particular are the crucial link to the adaptive immune system, and 
play an important role in mounting effective, long term immunity to pathogens such 
as Nm.  
The enhanced uptake of CRP opsonised Nm was shown to occur by Fc 
gamma (γ) receptors I and II, which are expressed by both macrophages and 
dendritic cells. This was demonstrated by the blocking of Fcγ receptors with human 
IgG and specific antibodies to either receptor, which significantly reduced CRP 
enhanced uptake. The effect of CRP enhanced uptake of Nm into DC downstream 
immune responses was investigated to assess if CRP exacerbates or abrogates the 
hosts inflammatory response to Nm. Both unopsonised and CRP opsonised Nm 
were able to activate DCs and stimulate the up regulation of co-stimulatory and 
antigen presentation molecules, which is of significant importance in order to 
present processed Nm antigens to T cells and mount effective adaptive immune 
responses. Additionally, unopsonised Nm and CRP opsonised Nm were equally 
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capable of up regulating the secretion of inflammatory cytokines from DCs. This 
suggests that CRP enhanced uptake of Nm by these phagocytic cells may be 
beneficial towards the host as despite the increased uptake of Nm by both cell 
types (potentially for phagocytic clearance), the pro-inflammatory cytokine 
response by DCs is not further exacerbated, thereby limiting inflammatory damage, 
which is known to the be the major contributor to the pathogenesis of 
meningococcal meningitis.  
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INTRODUCTION 
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1.1 Meningococcal meningitis 
Meningococcal meningitis is a bacterial infection that is characterised by 
inflammation of the meninges; the thin protective layer encapsulating the brain and 
spinal cord. If untreated, it is often fatal or can lead to permanent sequelae such as 
deafness, amputation and brain damage.  More rarely, a very severe form of the 
disease can occur in the form of septicaemia (meningococcemia), which is 
characterised by a haemorrhagic rash and circulatory collapse (Tzeng & Stephens 
2000).  
Several species of bacteria are able to cause meningitis, but Neisseria 
meningitidis (Nm) is the only one capable of causing large epidemics as well as 
sporadic disease (Tzeng and Stephens 2000). This gram negative diplococcus is one 
of the pathogenic species of the betaproteobacteria class (Yu & Houry 2007) and 
has only been reported to infect humans and harmlessly colonises the nasopharynx 
of around 5-10% of the population (Greenfield et al. 1971). It can then go on to 
become pathogenic for reasons that have still not been clearly defined, although it 
has been speculated that predisposition to carriage and disease could be linked to 
smoking, drying of the mucosa, trauma due to dust and other respiratory tract 
infections (Tzeng & Stephens 2000). Transmission occurs via inhalation or direct 
contact of nasal or oral secretions containing virulent bacteria, although the exact 
inoculum size needed for transmission is unknown (Peltola 1983).  
To date, 13 serogroups have been identified, 6 of which are pathogenic and 
capable of causing life threatening disease: A, B, C, W135, X and Y (Stephens et al, 
2000). Nm serogroup A is widely reported for causing the interesting 
epidemiological pattern across sub Saharan Africa, the so called “meningitis belt” 
comprising of 15 countries stretching from Guinea in the West to Somalia in the 
East. In this region, serogroup A epidemics occur yearly, beginning at the end of the 
dry season and rapidly falling at the beginning of the rainy season (van Deuren et al. 
2000). Control measures include reducing carriage and transmission by 
chemoprophylaxis, preventing invasive disease and vaccination. Penicillin or other β 
lactam antibiotics are usually given as treatment, but resistance is a continuing 
problem, hence the importance of prevention of pathogenic infection via increasing 
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host resistance (Tzeng and Stephens 2000). Humoral immune mechanisms are vital 
in defence against Nm, as seen in the high meningococcal morbidity rates in infants 
aged 6-24 months, when their protective maternal antibodies disappear 
(Goldschneider 1969). Also, resistance to Nm can be acquired through exposure to 
different diplococci like N. lactamica (Nl)  where previous carriage of Nl induces 
natural immunity to the meningococcus by the cross reaction of antibodies (Gold et 
al. 1978).  
 
1.2 Meningococcal vaccines 
There are currently three types of meningococcal vaccine available; 
polysaccharide, conjugate and outer membrane protein vaccines. Prior to the 
success of these vaccines, initial attempts involved whole cell vaccine trials and 
supernatant-based trials in the early 1900s (Figure 1.1, adapted from Vipond et al. 
2012). Due to the low efficacy and high reactogenicity of these two methods, 
however, polysaccharide based vaccines were then trialled in the 1950s following 
the success of pneumococcal vaccines. These utilised capsular polysaccharides 
derived from the meningococcus to stimulate an immune response (Finland & 
Ruegsegger 1935). Early polysaccharide trials were unfortunately unsuccessful due 
to the low molecular weight polysaccharides used and it was later shown that larger 
polysaccharides were needed for higher levels of immunogenicity (Kabat & Bezer 
1958). Following on from this discovery, the first bivalent (conveys protection 
against both serogroups A and C), trivalent (A, C and W-135) and tetravalent (A, C, 
W-135 and Y) vaccines were available from the 1970s (Vipond et al. 2012).  
Meningococcal conjugate vaccines were trialled in the 1990s once success of 
the Haemophilus influenzae type b (Hib) glycoconjugate vaccine was observed. 
Conjugate vaccines were created by adjoining meningococcal derived 
polysaccharides to carrier proteins such as tetanus toxoids, which will enhance their 
immunogenicity whilst remaining safe in humans (Vipond et al. 2012). The first 
MenC conjugate vaccine was introduced in 1999 which utilised the cross reacting 
material (CRM) 197 carrier protein. CRM197 is a mutant of the diphtheria toxin where 
a single glycine to glutamic acid substitution renders it non-toxic (McNeela 2000). 
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With the success of the MenC conjugate vaccine, attention was turned to other 
serogroups, leading to the release of the MenAfrivac (serogroup A conjugate 
vaccine) across the meningitis belt in Africa in 2010 and the multivalent A, C W-135 
and Y conjugate vaccine across the world (Samba et al. 2011).  
Following on from the success of the polysaccharide vaccines conferring 
protection against serogroups A and C, attempts at creating a polysaccharide 
vaccine against serogroup B began. It was quickly discovered that these had low 
immunogenicity, however (Wyle et al. 1972) and the next obvious step was to 
attempt conjugated vaccines. These, also, were unable to mount effective humoral 
responses (Moreno et al. 1985) and efforts were made to  discover the reason 
behind the poor efficacy. It was found that the poor immunogenicity was due to the 
serogroup B capsule containing a homopolymer of α2→8-linked N-acetylneuraminic 
acid (Bhattacharjee et al. 1975) which is also present in mammalian tissue and 
vaccines containing this structure would risk mounting an autoimmune response 
(Jennings 1997).  
An alternative approach was, therefore, needed and research into the ability 
of outer membrane proteins (OMPs) to elicit immune responses began. Studies 
showed that OMPs were able to induce production of antibodies specific to PorA 
and PorB (Saukkonen et al. 1987), which are major outer membrane proteins that 
act as pores and are also involved in the translocation of pathogenic Neisseria 
species into target cell membranes (Rudel et al. 1996). Due to OMP insolubility, 
however, new vaccines using outer membrane vesicles (OMVs) were trialled 
instead. OMVs are released naturally during Neisseria growth and showed to induce 
stronger immune responses than OMP vaccines (Frasch & Peppler 1982). As a result 
of this work, tailor made, strain specific OMV vaccines were used in Cuba between 
1987 and 1989 (Sierra et al. 1991), Norway (Fredriksen et al. 1991) and New 
Zealand (Sexton et al. 2004). More recently, a Group B meningococcal vaccine 
named Trumenba® was licensed for use in 2014 in the USA composed of two variant 
of recombinant factor H binding proteins ((fHbp)Shirley & Dhillon 2015). These 
binding proteins are expressed on the surface on Neisseria meningitidis and act as 
virulence factors which are responsible for binding to human factor H. This in turn 
down regulates the alternative complement pathway, thereby helping the 
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bacterium to evade host innate immunity (McNeil et al. 2013). Although these 
particular vaccines made in response to epidemics were significantly effective in 
those particular geographical regions, creating a cross protective vaccine against 
serogroup B for worldwide use proved to be difficult for many years.  
A completely different approach was eventually used to create a cross 
protective vaccine against serogroup B meningitis; reverse vaccinology. Rather than 
the traditional method of screening a few potential vaccine candidates at a time, 
reverse vaccinology used screening of the pathogens entire genome for potential 
proteins which were either surface expressed or secreted and that could be easily 
expressed by E.coli. The panel of selected proteins were used to immunise mice and 
any proteins found to be surface expressed went on to be tested for bactericidal 
activity by means of an antigen specific sandwich enzyme linked immunosorbant 
assay (ELISA). Successful proteins that also showed conservation across multiple 
strains of serogroup B were combined to form the vaccine which is now known as 
Bexsero® (Seib et al. 2012). The four active proteins in Bexsero® (previously named 
4CMenB) are fHbp, Neisserial adhesion A (NadA), Neisseria heparin binding antigen 
(NHBA) and Porin A. NadA is involved in the attachment of the bacterium to host 
cells such as monocyte derived macrophages and dendritic cells, which present 
NadA to lymphocytes, making this protein highly immunogenic.  NHBA is able to 
bind to heparin and protect the meningococcus from complement, but more 
importantly, it prompts high levels of serum bactericidal activity. The PorA portion 
of the vaccine is actually the same as that used in the tailor made OMV vaccine for 
the New Zealand outbreak in 2004 mentioned previously.  Although the New 
Zealand vaccine was strain specific, when combined with the other components of 
the vaccine, PorA was found to increase the overall immunogenicity of Bexsero® 
(Bai et al. 2011). This vaccine was created by Novartis, whose global vaccine 
business has now been acquired by Glaxo-Smith Kline and was licensed for 
worldwide use in September 2015.  
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Figure 1.1 Timeline of the development of meningococcal vaccines 
Development of meningococcal vaccines since the 1800s, adapted from (Vipond et al. 2012). 
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1.3 Pathogenesis of Neisseria meningitidis  
 Neisseria meningitidis may be acquired via the inhalation of respiratory 
droplets and in order for the meningococcus to enter the bloodstream and induce 
sepsis and meningitis, it must first travel through the mucus layers of the upper 
respiratory tract via the twitching motility of its pili. Nm achieves this by also 
evading immune clearance by IgA1, the most abundant immunoglobulin present at 
mucosal surfaces, especially in the upper respiratory tract. Normally, IgA1 would 
agglutinate the bacteria present and facilitate mucocilliary clearance. However, Nm 
possesses the IgA1 protease enzyme, and in pathogenic species this is a highly 
active enzyme that cleaves the IgA1 at its hinge region thereby preventing 
agglutination. Not only this, but released Fab fragments are still able to bind to 
meningococcal antigenic epitopes, thus masking Nm from further recognition by 
any intact immunoglobulins (Vitovski et al, 1999).  
Nm pili are filamentous, glycosylated protein structures and further aid the 
attachment to upper respiratory tract non-ciliated mucosal epithelia via CD46 (the 
complement regulatory protein, membrane cofactor protein (MCP)(Källström et al, 
1997) where the bacteria aggregate on the surface as microcolonies (Merz and So 
2000). Nm is also able to enter non-ciliated epithelial cells and then migrate back to 
the apical surface for transmission to new hosts. Once initial attachment is achieved 
via the pili, further attachment is accomplished by the outer membrane proteins 
Opa and Opc creating the conditions for epithelial invasion (Meyer 1999); this 
induces the extension of host cell microvilli or filopodia towards the bacteria and 
results in the engulfment of the meningococcus, where it can survive and grow in 
vacuoles (Pujol, Eugène et al. 1999).  Aside from transcytosis, Nm can cross directly 
if there is damage to the monolayer or via phagocytes using a “Trojan horse” 
mechanism (Virji 2009). Eighteen hours or so after infection, Nm is able to exit the 
epithelia by transcytosis or induction of apoptosis in order to invade the 
subepithelial stromal tissue (Stephens et al, 1983) where it will encounter cells of 
the innate immune system; namely dendritic cells, macrophages and neutrophils 
(Figure 1.2). 
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Figure 1.2 Stages of Neisseria meningitidis pathogenesis 
Neisseria meningitidis (A) may be acquired via the inhalation of respiratory droplets and go 
on to enter non-ciliated epithelial cells and in some cases, migrate back to the apical 
surface for transmission to new hosts. Aside from transcytosis, Nm can cross directly if 
there is damage to the monolayer or via phagocytes using a “Trojan horse” mechanism (B). 
In susceptible individuals, Nm will traverse the extracellular matrix (ECM) where it will 
encounter cells of the innate immune system such as macrophages (C), dendritic cells (D) 
and neutrophils (E). Adapted from (Virji 2009). 
 
1.3.1 The immune response to Neisseria meningitidis 
 Upon invasion of mucosal surfaces, the meningococcus will encounter 
macrophages and immature dendritic cells, both of which are phagocytic and are 
able to present antigenic peptides to T cells to stimulate the adaptive immune 
response. Macrophages and dendritic cells are thus said to be antigen presenting 
cells (APCs). Once Nm disseminates into the bloodstream it will also face 
phagocytosis mainly by neutrophils. These cells are important in the process of 
vascular damage via the release of the pro inflammatory cytokines interleukin (IL) 1 
and tumour necrosis factor alpha (TNF-α) along with reactive oxygen metabolites, 
which leads to further dissemination of Nm (Klein et al, 1996). However, Nm is able 
to evade phagocytosis due to the presence of its Class 1 (PorA) and 3 (PorB) outer 
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membrane proteins (OMP, Figure 1.3). These porins can inhibit the chemoattractant 
nature of neutrophils and the degranulation of their primary and secondary 
granules as well as down regulate the expression of their receptors for antibody 
(FcγRII and III) (Bjerknes et al, 1995). In addition to this, the polysaccharide capsule 
of N. meningitidis and the presence of sialyated lipo-oligosaccharide  (LOS) also 
confer protection against phagocytosis (Klein et al, 1996).  
 
 
Figure 1.3 Surface expressed structures of Neisseria meningitidis 
Surface structures of Neisseria meningitidis that not only aid pathogenesis but also 
act as virulence factors. Lipopolysaccharide (LPS) is a potent mediator of 
inflammation, Neisserial adhesion A (NadA) and factor H binding protein (fHBP) are 
utilised in new vaccines against serogroup B meningitis. Opa and Opc (not shown) 
are proteins involved in epithelial invasion whilst the porins (PorA and PorB) help 
the bacterium evade phagocytosis. Adapted from (Sadarangani & Pollard 2010). 
 
The LOS of the meningococcus is present in the outer membrane and is one 
the most potent mediators of inflammation (Stephens et al, 2000). The toxic moiety 
of LOS is lipid A which binds to the acute phase protein lipo-polysaccharide binding 
protein (LBP) and this complex is then recognised by pathogen recognition 
receptors (PRR) on macrophages, monocytes and neutrophils. These receptors are 
CD14 and toll like receptor 4 (TLR4) and once bound, this generates transmembrane 
signals that activate the nuclear factor kappa-light-chain-enhancer of activated B 
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cell (NF-κB) pathway which stimulates the production of various inflammatory 
mediators (Zughaier et al, 2004). The serogroup B Nm LOS also allows the 
meningococcus to evade host immune defences as its structure mimics that of 
human lacto-N-neotetraose (a glycosphingolipid) which is a constituent of the 
human erythrocyte antigen (Tsai and Civin 1991). The polysialic acid capsule of the 
Serogroup B strain further assists in down regulating host immune responses as it 
too shares structural similarity with host molecules; the neural cell adhesion 
molecule, N-CAM (Finne et al, 1987). 
Further innate protection of disseminated disease is provided by serum 
bactericidal activity by complement mediated cell lysis. In the absence of antibody, 
the mannose binding lectin or alternative complement pathways can be activated 
by the presence of Nm and leads to the formation of the terminal sequence which 
forms the membrane attack complex necessary for bacterial cell lysis (Estabrook et 
al, 1997). However, the presence of Nm sialic acid prevents the deposition of C3b 
on the surface of bacteria and thus inhibits the progression of the alternative 
pathway. Cell surface sialic acid increases the binding affinity (Ka) of surface bound 
C3b for factor (Royer et al. 2013)H and therefore the initiation of the amplification 
loop is decreased, so low levels of C3b are produced and deposited (Jarvis and 
Vedros 1987).  
Once the meningococcus has gained full access to the bloodstream by 
evading innate defence mechanisms, endotoxins are released in the form of blebs 
(vesicular outer membrane structures) which initiate septic shock by inducing high 
level release of the pro inflammatory cytokine TNF-α from monocytes and 
endothelial cells. High levels of endotoxin and cytokines in the plasma is the typical 
characteristic of fulminant meningococcal sepsis (van Deuren et al, 2000). From this 
point, Nm can go on to cause systemic inflammation in the form of arthritis and 
cellulitis. TNFα and IL-1 enhance the permeability of the blood brain barrier, aiding 
Nm invasion of the meninges. Once it invades the sub arachnoid space, it can evade 
humoral and cellular defences, which are absent here and is permitted to 
proliferate uncontrolled (Brandtzaeg et al, 1992). This induces a huge array of pro 
inflammatory cytokine release including TNFα, IL-1, IL-6 and IL-8. The release of 
cytokines promotes neutrophil chemotaxis towards the site of proliferation and the 
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release of neutrophil products further contribute to the clinical presentations of 
meningococcal meningitis (Ramilo et al, 1990). 
 
The importance of early innate defence in meningococcal pathogenesis is 
crucial as Nm specific antibodies will only be produced a week after colonisation. 
This leaves the host dependent upon the elements of the innate response (van 
Deuren et al, 2000). Once the meningococcus has evaded phagocytic and humoral 
immune defence, then its survival and multiplication in the bloodstream can occur. 
From this point, the chances of suffering from sepsis and meningitis are much 
higher as the bacterium is now able to seed the meninges and large joints with 
ease. This illustrates the importance of eliminating the bacterium as early as 
possible.  
 
1.4 C-reactive protein  
 Human C-reactive protein (CRP) is an acute phase protein produced mainly 
by the liver and found in the serum (Hurlimann et al, 1966). It is a member of the 
pentraxin family (Shrive et al, 1996) and has a total mass of around 115KDa 
composed of 5 identical 23KDa subunits (Oliveira et al, 1979). In healthy individuals, 
CRP levels are less than 1mg/L, but during mild inflammation and viral infection, 
levels can rise to 10-40mg/L in 6-8hours. If active inflammation or bacterial 
infection occurs, levels can escalate to 40-200mg/L and can peak at around 
500mg/L during severe bacterial infection and in burns patients (Clyne and 
Olshaker). It is therefore a useful marker of inflammation during disease and in 
response to treatment (Du Clos 2000). 
 The target ligand of CRP is phosphorylcholine (PC), which it binds to in a 
calcium dependant manner (Volanakis and Kaplan 1971). PC is found in various 
bacterial species, often as a component of their LOS, which is the case for 
commensal Neisseria species (Serino and Virji 2000). However, it has been 
confirmed that pathogenic Neisseria species express PC on their type I and type II 
pili instead of their LOS (Weiser et al, 1998). For this study, the pathogenic piliated 
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serogroup  B strain C311 was used as it was previously shown that PC is indeed 
present on the pili and that CRP is able to bind to it in a calcium dependant manner 
(Casey et al, 2008). PC is also a constituent of lecithin and sphingomyelin found in 
eukaryotic cell membranes, but CRP will only bind when the lipid bi-layer is 
disrupted, signifying that CRP only binds to necrotic or damaged cells and once 
bound, it is able to activate complement to allow clearance of these cells or repair 
(Volanakis 1982).  
 CRP has a strong role in innate immunity and has similar functions to human 
IgG in that it is able to activate complement, bind to Fc receptors and opsonise 
pathogens. Unlike IgG however, CRP does not recognise distinct epitopes but rather 
uses pattern recognition to identify altered self and pathogenic molecules. In this 
way it acts like a surveillance molecule and is therefore crucial for early defence, 
inducing signals which go on to activate humoral and adaptive immune responses 
(Du Clos 2000).  
 The precise receptor for CRP has been the subject of extensive research, 
with conflicting and diverse theories when considering its interaction with Fc 
gamma (Fcγ) receptors; one report found that CRP would only bind to U937 cells 
(human monocytic cell line) via Fcγ receptors when preparations were 
contaminated with human IgG, and hence concluded that CRP alone does not 
interact with Fcγ receptors at all (Hundt et al, 2001). Another study suggested that 
CRP does indeed interact with FcγRs, but that it may also have an additional 
receptor to these (Tebo and Mortensen 1990). Despite this, however, the majority 
of research seems to be in favour of Fcγ receptors being the most likely candidates: 
CRP binding to FcγRI has been confirmed in the monocytic cell line U937 (Crowell et 
al, 1991) and in the simian kidney cell line COS-7,  transfected with FcγRI 
complimentary DNA (cDNA) (Marnell et al, 1995). Studies have also shown CRP 
coated erythrocytes binding to FcγRIIa expressing cells (Bharadwaj et al, 1999; 
Bodman-Smith et al, 2004; Manolov et al, 2004). The latter report has proposed 
that this may even be the major receptor for CRP as increased binding was observed 
in the COS-7 cells. Binding has also been observed in the erythroleukemia cell line K-
562 (which expresses FcγRIIa only) and in the human monocytic THP-1 and U937 
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cell lines when FcγRIIa expression was increased and no further binding of CRP was 
reported when the expression of FcγRI was increased.  
 
1.5 Fc gamma receptors 
Fc gamma receptors (FcγR) are a family of extracellular globular proteins 
capable of binding the Fc portion of immunoglobulin G (IgG) (Fridman 1991). They 
are the bridge between the immune cells that express them and monomeric or 
aggregated IgG, immune complexes and opsonised cells or particles (Guilliams et al. 
2014), such as CRP opsonised meningococci. FcγRs are functionally divided into 
activating (FcγRI (CD64), FcγRIIa (CD32a), FcγRIIc (CD32c) and FcγRIII (CD16)) or 
inhibitory (FcγRIIb (CD32b) receptors based on the type of intracytoplasmic 
domains they have (Boruchov et al. 2005). These can either be immunoreceptor 
tyrosine-based activation motifs (ITAMs) which, upon Fc receptor activation, will 
induce a signalling cascade to begin the process of either phagocytosis or antibody 
dependant cellular cytotoxicity (ADCC) or immunoreceptor tyrosine-based 
inhibitory motifs (ITIMs), which will counteract the signal induced by the activating 
FcγRs (Guilliams et al. 2014).  
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Table 1.1 Expression of FcγR expression on cells of the immune system (Adapted from 
Cohen-Solal, Cassard et al. 2004). 
 
  B 
Lymphocytes 
Dendritic 
Cells 
Macrophages 
Monocytes 
NK Cells Neutrophils Mast Cells 
A
ct
iv
at
in
g 
FcγRI  Antigen 
presentation 
by immune 
complexes, 
cytokine 
production 
Phagocytosis, 
ADCC 
 Superoxide 
production, 
ADCC 
 
FcγRIIa    
FcγRIIIa  Cytokine 
production, 
ADCC 
 Serotonin 
release,  
cytokine 
production 
FcγRIIIb     Superoxide 
production, 
ADCC 
 
In
h
ib
it
o
ry
 FcγRIIb Down 
regulation of 
B Cell 
Receptor 
activation 
Down 
regulation of 
FcγR 
activation 
Down 
regulation of 
FcγR 
activation 
 Down 
regulation of 
FcγR 
activation 
Down 
regulation 
of FcγR 
activation 
ADCC: Antibody dependant cellular cytotoxicity 
Within the family of Fcγ receptors, there are both activatory and inhibitory 
receptors, distinguishable by tyrosine based motifs present in the cytoplasmic 
region. FcγRIIa has the immunoreceptor tyrosine based activating motif (ITAM) 
contained in the cytoplasmic region, whereas FcγRI and IIIa associate with the Fcγ 
chain (which contains an ITAM) allowing the stimulation of effector cells in order to 
carry out inflammatory, cytolytic and phagocytic activities. FcγRIIb has the 
immunoreceptor tyrosine based inhibitory motif (ITIM), which negatively regulates 
B cell differentiation and antigen specific proliferation. It also mediates the release 
of mast cell mediators and the internalisation of IgG complexes by macrophages 
(Table 1.1). 
FcγRI (CD64) is also known as the high affinity receptor as it more readily 
binds its ligand, IgG, than that of the lower affinity receptors, FcγRII (CD32) and 
FcγRIII (CD16). FcγRI has 3 immunoglobulin like extracellular domains (D1, D2 and 
D3), whereas the lower affinity receptors express only 2 (D1 and D2), and it is 
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thought that this structural difference accounts for the difference in IgG binding 
affinity (Ravetch and Kinet 1991). FcγRI is able to bind best to two IgG subclasses: 
IgG1 and IgG3 which are the most pro-inflammatory subclasses. The other Fc 
receptors have broader subclass specificity with lower affinity and thus they 
prevent the binding of monomeric antibody in the serum, thereby avoiding non-
specific pro inflammatory responses (Nimmerjahn and Ravetch 2008).  
The role of Fcγ receptors in immune modulation and their interaction with 
IgG has been thoroughly investigated, however, interactions between Fcγ receptors 
and CRP are less well understood. This study investigates the interactions between 
CRP-opsonised Nm and Fcγ receptors to assess CRP- mediated uptake of the 
meningococcus into human phagocytic cells and the importance of this route of 
uptake on downstream immune responses. Overall, a greater understanding of Nm 
pathogenesis might contribute to our ability to control inflammatory responses, 
thereby minimising the morbidity and mortality of Nm infections. 
1.6 Hypothesis  
 The hypothesis of this study is that opsonisation of Neisseria meningitidis by 
CRP enhances meningococcal uptake into human phagocytic cells (THP-1 cells, 
macrophages and dendritic cells), that this CRP-mediated uptake occurs via Fcγ 
receptors and affects the activation of these cells and downstream immune 
responses. 
1.7 Objectives 
 The specific aims of this PhD project are to investigate: 
1.) If CRP opsonisation enhances uptake of N. meningitidis by human 
macrophages and dendritic cells. 
2.) Whether FcγRI and FcγRII expressed by human phagocytic cells are involved 
in CRP-opsonised Nm uptake into these cells 
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3.)  Whether CRP mediated uptake into these cells is due to or specific to a 
particular Fcγ receptor 
4.) The effect of CRP mediated uptake on phagocytic cell activation and 
downstream immune responses by analysis of surface activation markers 
and secreted inflammatory cytokines 
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CHAPTER 2 
GENERAL MATERIALS AND METHODS 
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2.1 Materials  
2.1.1 Bacterial strains 
Piliated serogroup B Neisseria meningitidis (Nm) strain H44/76 containing a 
Green Fluorescent Protein (GFP) expressing plasmid “pEG2” was kindly donated by 
Dr Myron Christodoulides from the University of Southampton. The pEG2 plasmid is 
a shuttle vector containing the red shifted mutant form of the GFP gene (rs-gfp) 
which is under the control of the promoter PorA (Christodoulides et al. 2000). pEG2 
was modified to “pEG2-Ery” by replacing the ampicillin resistance cassette (bla) 
with an erythromycin resistance cassette (ermC) by Peter van der Ley (personal 
communication M Christodoulides). The GFP expressing, pili positive (p+) Nm strain 
C311 was constructed by Rosalyn Casey (University of Surrey) by extracting the GFP 
plasmid pEG2-Ery from the H44/76 strain using a QIAprep miniprep kit (Qiagen, UK) 
and transforming into the C311p+ strain, kindly donated by Professor Mumtaz Virji 
at the University of Bristol. The presence of GFP was confirmed by fluorescence 
microscopy, All bacterial culture stocks were stored in Mueller Hinton Broth (MHB, 
Oxoid, UK) supplemented with 15% (v/v) glycerol at -80°C. 
2.1.2 Bacterial culture media 
MHB was prepared from powdered stocks as per the manufacturer’s 
instructions and autoclaved prior to use. Colombia blood agar (CBA, Oxoid, UK) was 
prepared from powdered stocks as per the manufacturer’s instructions, autoclaved 
and prior to use was supplemented with 5% (v/v) defibrinated horse blood (Tissue 
Culture Systems Biosciences, UK). The selection of GFP expressing C311 colonies 
was achieved with the addition of 20µg/ml of erythromycin (Sigma Aldrich, UK). 
2.1.3 Buffering solutions  
All chemicals were purchased from Sigma Aldrich (UK) unless otherwise stated and 
solutions prepared were autoclaved wherever possible before use.  
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Tris-buffered saline (TBS, 10x) 
0.1M Tris base (Calbiochem, UK) containing 1.5M sodium chloride (Fisher Scientific, 
UK) was adjusted to pH8.0 using 0.1M hydrogen chloride (HCl). 
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) resolving 
buffer (4x) 
1.5M Tris base was adjusted to pH8.8 using 0.1M HCl.  
SDS-PAGE stacking buffer (4x) 
0.5M Tris base was adjusted to pH6.8 using 0.1M HCl.  
12.5% SDS-PAGE resolving gel 
Acrylamide/bis-acrylamide, 40% (v/v) solution was used at a final concentration of 
12.5% (v/v) with 1X SDS-PAGE resolving buffer and 0.1% (v/v) sodium dodecyl 
sulphate (SDS). The solution was polymerised with 0.1% (v/v) ammonium 
persulphate (APS) and 0.1% (v/v) tetramethylethylenediamine (TEMED).  
6% SDS-PAGE stacking gel 
Acrylamide/bis-acrylamide, 40% (v/v) solution was used at a final concentration of 
6% (v/v) containing 1X SDS-PAGE stacking buffer and 0.1% SDS (v/v). The solution 
was polymerised with 0.1% (v/v) APS and 0.1% (v/v) TEMED.  
SDS-PAGE running buffer (10x) 
A stock solution of 1.92M of glycine (Fisher Scientific, UK) containing 0.25M of Tris 
Base and 1% (v/v) SDS was prepared with distilled water and diluted 1 in 10 before 
use. 
CD14+ cell isolation buffer 
Phosphate buffered saline (PBS, Life Technologies Ltd, UK) was prepared from a 10x 
sterile solution and supplemented with 0.5% (v/v) bovine serum albumin (BSA) and 
2mM ethylenediaminetetraacetic acid (EDTA, Life Technologies, UK). 
Tris base, acetic acid and EDTA (TAE) Buffer (10x) 
0.4M Tris Base was made up in 0.2M of glacial acetic acid (Fisher Scientific, UK) 
containing 10mM EDTA and the pH was adjusted to 8.2. 
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Western blotting transfer buffer (1x) 
192mM of glycine containing 25mM Tris Base was made up in 20% methanol. 
0.1M citrate buffer pH3.5 
81mM citric acid was made up in 26mM sodium citrate (both Fisher Scientific, UK) 
and made up to 1 litre with distilled water with the pH adjusted to 3.5 using either 
1M HCl or sodium hydroxide (NaOH, Fisher Scientific, UK) as required. 
0.1M citrate buffer pH5.0 
40mM citric acid was made up in 63mM sodium citrate and made up to 1 litre with 
distilled water and the pH adjusted to 5 using either 1M HCl or sodium hydroxide as 
required. 
0.1M acetate buffer pH5.0 
36mM acetic acid was made up in 64mM sodium acetate (both Fisher Scientific, UK)   
and made up to 1 litre with distilled water and the pH adjusted to 5 using either 1M 
HCl or sodium hydroxide as required. 
Elution buffer 
100mM glycine was dissolved in distilled water and adjusted to pH 2.7 using HCl. 
Fluorescence activated cell sorting (FACS) buffer 
Phosphate buffered saline (PBS) was made up using tablets and supplemented with 
2% (v/v) bovine serum albumin (BSA) and 0.02% (v/v) sodium azide. 10% (v/v) 
normal human serum (NHS) was added immediately before use.  
 
2.2 Methods 
2.2.1 Culture of C311P+ Neisseria meningitidis and growth curve 
experiments 
 Frozen C311p+ bacteria stored at -80°C were sub cultured onto Columbia 
blood agar (CBA, Oxoid, UK) plates with 5% (v/v) defibrinated horse blood (Tissue 
Culture Systems, UK) and 20µg/ml erythromycin (Sigma-Aldrich, UK) to select for 
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mutant strains containing the GFP plasmid, pEG-Ery and incubated overnight. All 
colonies were collected and used to inoculate warm MHB in small tissue culture 
flasks to a known optical density (OD) at 595nm (0.1 for growth curve experiments 
and 0.02 for general culture). These ODs were selected based on earlier 
experiments which showed that when Neisseria meningitidis strain C311 was grown 
for 4 hours from a starting optical density of 0.02 at 595nm, serially diluted in PBS 
and plated out overnight on CBA, cultures had a final density of 1x109CFU/ml at an 
OD of 1. Cultures were shaken at 125rpm for 4 hours at 35°C.  
 For growth curve experiments, 900µl aliquots were taken every 2 hours for 8 
hours to measure the OD at 595nm and a further 100µl was taken to serially dilute 
in MHB to allow enumeration of colonies formed in 20µl drops plated in triplicate 
onto CBA plates.     
For general culture, the bacterial cultures were transferred to 50ml 
centrifuge tubes after shaking, and were spun at 1000xg for 15mins. The OD at 
595nm was measured and the bacteria were fixed overnight in 4% (w/v) 
paraformaldehyde (PFA, Thermo Scientific, UK). Fixed cultures were then washed 
twice in PBS before use in assays.   
2.2.2 Isolation of peripheral blood mononuclear cells (PBMCs) for culture 
of macrophages and dendritic cells  
2.2.2.1 Density gradient separation of PBMCs from whole blood 
 Peripheral blood mononuclear cells (PBMCs) were isolated either from 
leucocyte cones purchased from the National Health Service Blood and Transplant 
(NHSBT) special health authority or from whole blood collected in EDTA (10.8-18mg) 
Vacuette® tubes (VWR, UK) from healthy consenting volunteers  in accordance with 
the Faculty of Health and Medical Sciences (FHMS) Ethics Committee guidelines 
(reference number EC2009/45).  
Whole blood and leucocyte cone blood were diluted using warm PBS + 2mM 
EDTA in a 1:1 and 1:13 ratio respectively and gently layered over Histopaque®-1077 
(Sigma-Aldrich, UK), a solution containing polysucrose and diatrizoate. Layered 
blood was centrifuged at 400xg for 30minutes at room temperature in a swinging 
bucket rotor without brakes. This allowed for the rapid sedimentation of 
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erythrocytes and granulocytes at the bottom of the tube with PBMCs at the 
Histopaque®-plasma interface. The PBMC layers were removed into fresh tubes and 
further diluted with PBS + 2mM EDTA (to chelate calcium and prevent clumping of 
cells) before centrifugation at 250xg for 10 minutes at room temperature with the 
break on to remove any remaining Histopaque®. The cell pellet was washed once 
more in PBS + 2mM EDTA and spun at 250xg for 10 minutes at 4°C. Viable cells were 
counted using Trypan Blue (Sigma-Aldrich, UK) and a Bright-Line improved 
Neubauer haemocytometer (Hausser Scientific, USA).  
2.2.2.2 Magnetic bead separation of CD14 positive cells 
CD14+ cells were positively selected from the isolated PBMCs using anti-
human CD14 Microbeads (Miltenyi Biotec Ltd, UK) by resuspending every 107 cells 
with 80µl of CD14+ cell separation buffer and 20µl of anti-human CD14+ beads 
before being incubated at 4°C for 15minutes. The cells were washed with 2ml of 
CD14+ cell separation buffer per 107 cells and centrifuged at 250xg for 10minutes at 
4°C. Prior to magnetic separation the cell pellet was resuspended in 500µl of CD14+ 
cell separation buffer. Separation of CD14+ cells from whole blood PBMCs was 
carried out using an MS Column with a MiniMACS™ separator and separation of 
CD14+ cells from leucocyte cone PBMCs was carried out using an LS Column with a  
MidiMACS™ separator (all from Miltenyi Biotec Ltd, UK). Both the MiniMACS™ and 
MidiMACS™ were mounted onto a MACS®MultiStand (Miltenyi Biotec Ltd, UK) and 
washed through with CD14+ cell separation buffer before the PBMC cell suspension 
was added through a 70µm nylon mesh Pre-Separation Filter (Miltenyi Biotec Ltd, 
UK). Unlabelled cells were eluted by washing the column reservoir with 3 bed 
volumes of CD14+ cell separation buffer. CD14+ cells were flushed out by removing 
the column from the magnetic field of the separator and using the supplied plunger 
with a small volume of CD14+ cell separation buffer.  
2.2.2.3 Differentiation of CD14 positive cells to macrophage and dendritic-like 
cells      
 Following magnetic separation, CD14 positive cells were washed and seeded 
at 3 x 105cells/ml in 8 well plastic chamber slides (Thermo Fischer Scientific) 
(200µl/well) or 6 well plates (2ml/well) in complete Roswell Park Memorial Institute 
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(RPMI) media (containing 100units/ml penicillin, 100ug/ml streptomycin, 2mM L-
glutamine and 10% (v/v) heat inactivated foetal bovine serum (FBS, all Invitrogen, 
UK).  The cells were cultured for 5 days at 37°C + 5% (v/v) carbon dioxide (CO2) with 
a media change at day 3 for differentiation into macrophages whereas 
differentiation into immature DCs was achieved with the addition of 1000units/ml 
granulocyte-macrophage colony-stimulating factor (GM-CSF) and 100units/ml 
human Interleukin 4 (IL-4, both Peprotech, UK) on the day of seeding and on day 3.  
Dendritic cells were used as immature cells on day 5. 
2.2.3 Culture of monocytic cell lines 
 The human monocyte-like cell line Tamm-Horsfall Protein-1 (THP-1) was 
purchased from the European Collection of Cell Culture (ECACC, UK) and was 
maintained in complete RPMI media. For differentiation into macrophage-like cells, 
THP-1s were seeded at 5 x 105cells/ml in 8 well plastic chamber slides (200µl/well) 
with 10nM phorbol myristate acetate (PMA, Sigma-Aldrich, UK) for 72 hours prior to 
use in experiments.  
2.2.4 Purification of human C - reactive protein (CRP)  
97% pure human C-reactive protein (CRP) (The Binding Site Group, UK) was 
further purified by dialysis using cellulose membrane dialysis tubing (Sigma Aldrich, 
UK) for 48 hours in tris buffered saline (TBS) followed by affinity chromatography. 
An affinity purification column was prepared by adding 1mM hydrogen chloride 
(HCl) to 3g of lyophilised CNBr-activated SepharoseTM 4B (GE Healthcare, UK) to 
allow the medium to swell followed by extensive washing with 1mM HCl to remove 
additives. The ligand, immobilised p-aminophenyl phosphoryl choline (Thermo 
Scientific, UK), was dissolved in coupling buffer (0.1M NaHCO3 pH8.3 + 0.5M NaCl), 
added to the SepharoseTM gel and rotated overnight at 4°C. Any excess ligand was 
removed by 4 bed volume washes of 1mM HCl and remaining active groups were 
blocked with 0.1M Tris-HCl pH8.0 for 2 hours. The gel was washed with 3 cycles of 
alternating 0.1M acetic acid (pH4.0 + 0.5M NaCl) followed by 0.1M Tris-HCl (pH8.0 + 
0.5M NaCl) and equilibrated with 10 bed volumes of TBS followed by 10 bed 
volumes of TBS containing 0.5mM CaCl2. Dialysed CRP containing 0.5mM CaCl2 was 
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then incubated with the SepharoseTM gel overnight at 4°C with rotation. 2ml 
fractions were collected using TBS containing 0.5mM CaCl2 until an absorbance of 0 
at 280nm (using a Nanodrop 2000 spectrophotometer, Thermo Scientific, UK) was 
achieved. The bound CRP was eluted with TBS containing 10mM (EDTA) in 1ml 
fractions. The highest concentrations read at 280nm were pooled and using the 
specific extinction coefficient of pure CRP (1.75 for 1mg/ml, Nelson et al. 1991) the 
final concentration was established. Purified CRP was dialysed for 24 hours at a 
time, first with TBS, then two cycles of phosphate buffered saline (PBS).  The purity 
of the CRP was analysed by sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE) and silver staining as described below. 
2.2.5 Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-
PAGE)  
Original CRP and purified CRP samples were prepared using a Protein 
Loading Buffer Pack (Fermentas Life Sciences, UK) containing 20x Reducing Agent 
(final concentration 0.1M dithiothreitol (DTT)) and 5x Protein Loading Buffer (63mM 
Tris HCl, 2% (w/v) SDS, 0.01% (w/v) bromophenol blue and 10% (v/v) glycerol). 
Samples were mixed with the components of the pack, boiled for 5 minutes at 
100°C and left to cool to room temperature before being loaded onto a 12.5% (v/v) 
polyacrylamide resolving gel, cast using a Mini-PROTEAN® Tetra Handcast system 
(Bio-Rad, UK). 1mm glass plates were used and resolving gels were poured to two 
thirds the height of the glass plates followed by layering with water saturated 
butanol to even the gel surface and remove any bubbles. Once complete 
polymerisation had occurred, the butanol was thoroughly washed away with 
distilled water before the 4.5% (v/v) stacking gel was poured and a 10x well comb 
inserted. Following polymerisation of the stacking gel, the comb was removed and 
the wells washed out with distilled water to remove any excess acrylamide. 
Prepared samples were loaded alongside a PageRulerTM Unstained Protein Ladder 
(Fermentas Life Sciences, UK) and any empty wells were loaded with loading buffer 
to ensure each well contained the same concentration of SDS detergent, therefore 
enabling even migration. Gels were run in SDS-PAGE running buffer at 70V before 
being increased to 150V once the bromophenol blue dye front reached the 
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resolving gel. All mini gels were run using a Mini-PROTEAN® Tetra Cell 
electrophoresis system (Bio-Rad, UK).  
2.2.6 Gel visualisation  
Gels were either stained for visualisation of protein bands using PageBlue™ 
Protein Staining Solution (Thermo Scientific, UK) or silver stained using the 
maximum sensitivity staining protocol of a PageSilverTM Staining kit (Fermentas Life 
Sciences, UK) according to the manufacturer’s guidelines. PageBlue™ Protein 
Staining Solution uses the properties of Coomassie G-250 dye but with a more 
efficient staining method; gels were placed in a clean tray and rinsed three times for 
10 minutes with distilled water and gentle agitation. A sufficient volume of 
PageBlue™ Protein Staining Solution was used to immerse the gel and was 
incubated for 60 minutes at room temperature with gentle agitation. The staining 
solution was discarded and the gel rinsed twice with distilled water for 5 minutes 
before being scanned using a Gene Flash gel doc (Syngene Bio Imaging, UK). 
 Silver staining can detect between 0.05-0.60ng of protein per band, making 
it over 100 times more sensitive than traditional Coomassie staining. The kit utilises 
silver nitrate to bind to proteins at a weakly acidic pH, followed by the reduction of 
silver ions to metallic silver by formaldehyde at an alkaline pH. Briefly, the gel was 
fixed using ethanol and acetic acid to bind the proteins in the gel and washed with 
sensitizer to increase the sensitivity and contrast of the stain. Staining solution 
containing silver ions was used to saturate the gel which binds to the protein within 
the gel matrix, followed by the developing solution which reduces the silver ions to 
metallic silver allowing the visualisation of protein bands. Further reduction of the 
silver ions was stopped by the addition of the stop solution. Gels were rinsed using 
distilled water, viewed and scanned using a Gene Flash gel doc (Syngene Bio 
Imaging, UK). 
2.2.7 Cell growth determination  
 A cell growth determination kit (Sigma Aldrich, UK) was used to assess the 
cytotoxic effects of Neisseria meningitidis (Nm) on human phagocytes across a 
range of time points and multiplicity of infections (MOIs). The kit utilises the 
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component 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) 
which is normally yellow in colour. However, in the presence of mitochondrial 
dehydrogenase of viable cells, the MTT tetrazolium ring is cleaved to yield purple 
formazan crystals which are insoluble in aqueous solutions. Using acidified 
isopropanol, the crystals can be dissolved to form a uniform purple colour which 
can be spectrophotometrically measured. An increase in viable cells results in an 
increase in MTT formazan crystals and therefore an increase in absorbance.  
Human monocyte derived macrophages and dendritic cells were cultured as 
described in 2.2.2. On day 5, cells were gently collected using Cell Lifters (Corning, 
USA) and washed twice with warm complete RPMI media without serum at 300xg 
for 10 minutes at room temperature. Viable cells were counted as per section 2.2.2 
and were resuspended at 3x105cells/ml in complete RPMI media without serum and 
seeded into 96-well flat bottomed sterile cell culture plates (Thermo Scientific, UK) 
at 50µl/well. Nm cultured and fixed in 4% PFA as per section 2.2.1 was washed 
twice in PBS at 1500xg for 10 minutes and resuspended in PBS before establishing 
the final OD. Nm was added to both cell types in triplicate at the following MOIs: 
25:1, 50:1, 100:1 and 200:1 for either 2, 24 or 28 hours. Nm was also seeded in 
triplicate at these MOIs alone without cells as microbes can contribute to MTT 
cleavage leading to erroneous results. Each test also contained a triplicate of culture 
medium alone as the blank. To each well, MTT Solution was added in an amount 
equal to 10% of the well volume (in this case, 5µl was added) and all plates were 
incubated for 3 hours at 37°C. Isopropanol was added at 50µl/well to dissolve the 
formazan crystals, with gentle gyration to enhance dissolution. The plates were 
then read within the hour at a wavelength of 570nm with the background 
absorbance measured at 690nm using a Fluo Star Omega plate reader. Data were 
analysed using Mars Software (both BMG Labtech, UK). 
2.2.8 Opsonisation and uptake of meningococci into human phagocytes 
 Macrophages, dendritic cells and differentiated THP-1 cells were prepared 
and adhered to 8 well plastic chamber slides at 3x105cells/ml as described in 
sections 2.2.2-2.2.3 in complete RPMI media. Fixed Nm cultures were washed twice 
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and resuspended in PBS to 2.4x108 colony forming units (CFU) per ml and were 
opsonised for 30 minutes at 37°C with 4 different opsonising conditions; PBS 
containing 0.5mM CaCl2 (mock opsonin), 50µg/ml CRP in PBS containing 0.5mM 
CaCl2, or 50% normal human serum (NHS) at a final density of 1.2 x 10
8CFU/ml. The 
culture media was carefully aspirated from the cells and all wells were washed 
twice with PBS containing 0.5mM CaCl2. 200µl of the bacterial suspension was 
added to the wells in duplicate along with 200µl of PBS containing 0.5mM CaCl2 to 
further dilute Nm two-fold (to 6x107CFU/ml giving a MOI of 200:1) and incubated at 
37°C for 2 hours. All wells were then washed gently 4 times with PBS and fixed for 
30 minutes with 1% PFA. PFA was gently aspirated from the cells and the slides 
were mounted in vectashield soft-set mounting media with propidium iodide 
(Vector Laboratories, UK). A coverslip was applied, excess mounting media was 
removed and the slide was sealed with clear nail polish. Slides were examined on 
the Zeiss LSM5.1 confocal fluorescent microscope (Carl Zeiss Ltd, UK) using at least 
x400 magnification. Both Cy2 and Cy3 channels were set in order to detect both 
green and red fluorescence simultaneously. For each well examined, at least 5 
random field images were taken and all images were later viewed and analysed 
using LSM Image Browser (Carl Zeiss Ltd, UK).  
2.2.9 Cell membrane staining 
The internalisation of bacteria was confirmed by staining of the plasma cell 
membrane using CellMask™ Deep Red Plasma Membrane Stain (Invitrogen, UK). 
CellMask™ stains are amphipathic molecules that are able to load into the cell 
membrane via their lipophilic moiety and remain anchored there via the hydrophilic 
dye, thereby providing more consistent staining than traditional lipophilic dyes that 
are prone to rapid internalisation. Macrophages, dendritic cells and differentiated 
THP-1 cells were prepared and adhered to 8 well plastic chamber slides at 
3x105cells/ml as described in sections 2.2.2-2.2.3 in complete RPMI media. Cells 
were infected with fixed, opsonised Nm as per section 2.2.8 and washed 3 times 
with PBS before being incubated with 2.5µg/ml of CellMask™ (diluted in warm PBS) 
for 5 minutes at 37°C. The staining solution was removed and the cells were fixed 
with 3.75% warm formaldehyde for 10 minutes at 37°C, washed 3 times in warm 
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PBS before being mounted in ProLong® Gold (Invitrogen, UK) anti-fade mounting 
media. A clear coverslip was applied to the slide and sealed with clear nail varnish 
before being imaged immediately using an excitation of 633nm to view the plasma 
membrane stain and 488nm to view GFP labelled Nm. Z stack sections (1.5µm) were 
taken through the cells to confirm the internalisation of Nm.  
2.2.10 Co-localisation of meningococci with Fcγ receptors  
 To qualitatively assess the interaction of Neisseria meningitidis with Fcγ 
receptors I and II with and without opsonisation with CRP or NHS, co-localisation 
assays were carried out. Macrophages and dendritic cells were prepared and 
adhered to 8 well plastic chamber slides as described in section 2.2.2 at 
3x105cells/ml. Nm was prepared, opsonised and incubated with both cell types as 
per section 2.2.1 and 2.2.8 at a final MOI of 200:1. The cells were gently washed 
with warm PBS before being incubated with PBS + 3% PFA at room temperature for 
15 minutes. All wells were washed twice with ice cold PBS and then permeabilised 
with PBS containing 0.1% Triton X-100 (Sigma-Aldrich, UK) for 5 minutes. Triton X-
100 is a non-ionic detergent used to solubilise proteins and therefore makes cell 
surface antigens (that were cross-linked in the fixation step) available to antibody 
binding. Cells were washed 3 times with PBS for 5 minutes and then blocked with 
PBS containing 1% BSA for 30 minutes at room temperature, followed by 3 more 
washing steps with PBS for 5 minutes each. The relevant wells were incubated with 
1µg per test of the following antibodies (all purchased from Invitrogen, USA) diluted 
in PBS containing 1% BSA; mouse IgG1 anti-human FcγRI-PE, mouse IgG1 anti-human 
FcγRII-PE and mouse IgG1 PE isotype control and incubated for 1 hour at 37°C. Cells 
were washed three times with PBS for 5 minutes and subsequently stained for 30 
minutes at 37°C with 5µM of DRAQ5™ (eBioscience, UK), an organic based dye with 
a high affinity for double stranded DNA widely used as a nuclear counterstain in 
fluorescent microscopy. Slides were washed 3 times with PBS for 5 minutes and 
prepared for confocal fluorescent microscopy as per section 2.2.8. The 488nm laser 
was used to excite both GFP expressing Nm and PE conjugated flourochromes. GFP 
emission is around 510nm whereas PE emission occurs at 578nm so they can be 
detected by different band pass filters. The 633nm laser was used to excite 
 
 
29 
 
DRAQ5™ dye molecules which are detected at 683nm. Co localisation was identified 
as yellow fluorescence resulting from the merge of red and green fluorescence from 
PE-labelled Fc gamma receptors and GFP expressing Nm, respectively.  
2.2.11 Immunoglobulin G (IgG) blocking of Fc gamma (γ) receptors 
 Macrophages, dendritic cells and differentiated THP-1 cells were prepared 
and adhered to 8 well plastic chamber slides as described in sections 2.2.2-2.2.3 at 
3x105cells/ml.  
Wells to be blocked with purified human IgG (Sigma-Aldrich, UK) were first 
washed twice with serum free media before being incubated for 30minutes with 0, 
2.5, 5 or 10µg/ml human IgG at 37°C. Fixed Nm was prepared, opsonised and 
incubated with the cells as described in section 2.2.1 and 2.2.8. The slides were 
incubated for 2 hours at 37°C, before being fixed, mounted and examined using the 
confocal fluorescent microscope as described in section 2.2.8. 
2.2.12 Blocking of Fcγ receptors I and II using whole antibodies 
Macrophages, dendritic cells and differentiated THP-1 cells were prepared 
and adhered to 8 well plastic chamber slides as described in sections 2.2.2-2.2.3 at 
3x105cells/ml.  
Wells to be blocked with purified mouse IgG1 anti-human Fcγ receptor I 
(CD64) and mouse IgG2B Fcγ receptor II (CD32, both BD Pharmingen™, UK) were 
gently washed twice with serum free media before 0, 2.5, 5 or 10µg/ml of antibody 
or isotype matched controls (mouse IgG1 and mouse IgG2B, BD Pharmingen™) were 
added and the slides incubated for 1 hour at 37°C. The cells were infected with 
mock opsonised/opsonised Nm and prepared for confocal microscopy as per 
section 2.2.8. 
2.2.13 Generation of human anti-Fcγ receptor I and II F(ab’)2 fragments 
 0.8mg of purified mouse IgG2B anti-human Fcγ receptor (FcγR) II, (BD 
Pharmingen™, UK) was dialysed overnight in citrate buffer pH5.0 at 4°C using 
cellulose membrane dialysis tubing. The buffer was replaced with pH3.5 
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fragmentation buffer (Thermo Scientific, UK) and the antibodies were further 
dialysed for 3 hours at room temperature.  
 To cleave 0.8mg of FcγRII antibody into fragment crystallisable (Fc) regions 
and fragment antigen-binding (F(ab’)2) regions, 33mg of the enzyme pepsin-agarose 
from porcine gastric mucosa (Sigma Aldrich, UK) was reconstituted from a 
lyophilised powder to a packed gel using 300µl of citrate buffer pH3.5. The dialysed 
antibodies were then added to the pepsin and rolled together for 30 minutes at 
room temperature to allow the enzyme to cleave the antibodies below the hinge 
region. A filtration column was set up and washed through several times with 
citrate buffer pH3.5 to equilibrate before the pepsin/antibody combination was 
added. Cleaved antibodies (both Fc and F(ab’)2)  were eluted with citrate buffer 
pH3.5 as 1ml fractions until 2 column bed volumes were collected. The protein 
content of each fraction was measured at 280nm using a Nanodrop2000 
spectrophotometer and the fractions containing the highest protein content were 
pooled and pipetted into prepared dialysis tubing. This was tightly sealed at both 
ends and dialysed overnight at 4°C in acetate buffer pH5.0.  
 To separate the F(ab’)2 regions from the Fc regions, truncated Protein G 
immobilised on cross-linked 4% agarose (Fluka, Switzerland) was used. Truncated 
Protein G prepared from recombinant cell wall Protein G (originally isolated from 
Type G Streptococci) ensures that only Fc binding sites are retained as intact Protein 
G is also able to bind F(ab’)2. 100mg of Protein G lyophilised powder was hydrated 
with 2.5ml distilled water and allowed to swell for 30 minutes to a packed resin. The 
filtration column was set up and washed through with acetate buffer pH5.0 to 
equilibrate before the Protein G resin was added. The resin was washed through 
with 5 bed volumes of acetate buffer pH5.0 before adding the cleaved antibodies to 
the column. The antibody fragments were incubated with the resin for 10 minutes 
at room temperature to allow Fc binding to Protein G. 1ml fractions were collected 
using 10ml of acetate buffer pH5.0 to elute the unbound F(ab’)2 fragments. The 
protein content of each fraction was measured using the Nanodrop2000 
spectrophotometer and the highest were pooled together. Elution buffer was 
added to resin and incubated for 10 minutes at room temperature to dissociate the 
Fc fragments from the Protein G. 1ml fractions were collected and their protein 
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content measured before pooling the highest together. The pH of the pooled 
fractions was determined before neutralising each with either HCl or NaOH as 
appropriate.  
 The enzyme pepsin is commonly used to generate F(ab’)2 fragments from 
IgG as the cleavage site contains a leucine 234 residue which is conserved in most 
species. However, mouse IgG1 lacks this residue, creating a restricted hinge region 
and therefore resists pepsin cleavage. In order to cleave the mouse IgG1 anti-human 
FcγRI antibody a Pierce® Mouse IgG1 Fab and F(ab’)2 Micro Preparation Kit (Thermo 
Scientific, UK) was used. This kit utilises the enzyme Ficin, which, unlike pepsin, is 
able to bind to mouse IgG1 and in the presence of 4mM cysteine, is able to digest it 
into F(ab’)2 and Fc fragments. On the day of fragmentation, the digestion buffer was 
prepared by dissolving 7mg of cysteine-HCl in 10ml of the supplied Mouse IgG1 
Digestion Buffer to create the required 4mM solution. The Immobilised Ficin was 
equilibrated by washing in Digestion Buffer (5000xg for 1minute) and 0.8mg of FcγRI 
antibody was prepared using the supplied Thermo Scientific Zebra Spin Desalting 
Column, which contains a high performance resin that retains over 95% of salts and 
other small molecules.  F(ab’)2 fragments were generated by adding the de-salted 
FcγRI antibodies to the equilibrated Immobilised Ficin and incubating for 24 hours 
at 37°C using a table top rocker to maintain constant mixing of the resin. To 
separate the digest from the Immobilised Ficin, the column was centrifuged for 1 
minute at 5000xg. To remove any remaining fragments, the Immobilised Ficin resin 
was washed through 3 times with Protein A Binding Buffer and all wash fractions 
were combined with the digested antibodies.  
 To assess digestion completion of both FcγRI and FcγRII antibodies, the 
digests were evaluated alongside their whole counterparts via SDS-PAGE.  
F(ab’)2 fragments were purified using a Nab Protein A Column (Thermo 
Scientific, UK), which was first equilibrated with Protein A Binding buffer. The F(ab’)2 
fragments were added to the column and resuspended with the column resin by 
rotary mixing for 10 minutes. The flow through was collected and the column was 
centrifuged for 1 minute and the fraction combined with the previous flow through. 
IgG Elution Buffer was then added to the column and centrifuged for one minute to 
obtain any undigested IgG and Fc fragments which were neutralised with 1M Tris 
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pH8. The protein concentration was estimated by measuring the absorbance at 
280nm (using the Nanodrop Spectrophotometer) and the extinction coefficient of 
1.4.  
2.2.14 Inhibition of N. meningitidis uptake into phagocytic cells using 
human anti-CD64 and human anti-CD32 F(ab’)2 fragments 
Macrophages, dendritic cells and differentiated THP-1 cells were prepared 
and adhered to 8 well plastic chamber slides as described in sections 2.2.2 and 2.2.3 
at 3x105 cells/ml.  
Wells to be blocked with purified mouse anti-human FcγRI and FcγRII F(ab’)2 
fragments were gently washed twice with serum free media before 0, 2.5, 5 or 
10µg/ml of antibody was added and the slides incubated for 1 hour at 37°C. The 
cells were infected with mock opsonised/opsonised Nm and prepared for confocal 
microscopy as per section 2.2.1 and 2.2.8. 
2.2.15 Short interference RNA (siRNA) transfection of myeloid cells 
 Short interfering RNA (otherwise known as small interfering or silencing 
RNA, siRNA) specific for FcγRI and FcγII genes was purchased from Life 
Technologies, UK. Ambion Silencer® Select Pre-designed siRNA was obtained as 
double stranded RNA molecules, each 21 base pairs long. The details of each siRNA 
duplex utilised in all transfection protocols are shown in Table 2.1. 
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Table 2.1 Details of siRNA duplexes used in transfection protocols specific to FcγRI and II 
genes. 
Each siRNA product was purchased as 5nmole lyophilised powder, reconstituted to 50µM in 
nuclease free water. All target genes are located on human chromosome 1.  
 
Target 
gene 
Sense sequence Anti-sense sequence SiRNA 
ID 
FcγR1 GACUCUGGGUUAUACUGGUtt ACCAGUAUAACCCAGAGUCtt s5070 
FcγR2a CUUCAACCAUUGACAGUUUtt AAACUGUCAAUGGUUGAAGca s5072 
FcγR2b CCUAUUCACUUCUCAUGCAtt UGCAUGAGAAGUGAAUAGGtg S5073 
 
2.15.1 Transfection of siRNA into human phagocytic cells using Lipofectamine™ 
RNAiMAX,  INTERFERin® or DharmaFECT 
Macrophages, dendritic cells and differentiated THP-1 cells were prepared 
as described in sections 2.2.2-2.2.3 but were adhered to 6 well plates at 1 x 106 
cells/ml, 2ml per well in complete RPMI. One day before forward transfection, the 
cells were washed and re-plated in 2.5ml of antibiotic free RPMI media. On the day 
of transfection, 50µM stock siRNA duplexes were diluted across a range of 
concentrations using Opti-MEM® Reduced Serum Medium (Invitrogen, UK) and 
mixed gently. Lipofectamine™ RNAiMAX (Invitrogen, UK), INTERFERin® (Polyplus 
transfection™, France) or DharmaFECT (GE Healthcare, UK)  transfection reagents 
were diluted 1 in 50 using Opti-MEM® before being combined with the siRNA 
duplexes and incubated for 20minutes at room temperature.  The siRNA duplex-
transfection reagent complexes were added to each well containing cells which 
were then mixed gently by rocking the plates. The cells were incubated at 37°C over 
a range of time points (with a media change 6 hours post transfection) before being 
analysed for gene knockdown either by reverse transcription polymerase chain 
reaction (RT-PCR) or Western blotting as per sections 2.2.16 and 2.2.17 respectively.  
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2.2.15.2 Transfection of siRNA into human phagocytic cells using 
electroporation 
Macrophages, dendritic cells and differentiated THP-1 cells were prepared 
as described in sections 2.2.2-2.2.3. On the day of transfection, cells were washed 
twice in complete RPMI media without serum and resuspended at 4x106 cells/ml.  
4mm electroporation cuvettes (Sigma-Aldrich, UK) were rinsed out with serum free 
media before the cells were added (500μl per cuvette) along with a range of siRNA 
concentrations. The cuvettes were then incubated at 4°C for 5 minutes before being 
placed into the Shockpod™ cuvette chamber and electroporated using a Gene 
Pulser Xcell™ electroporation system (both Bio-Rad, UK) with the attached 
Capacitance Extender (CE) module. An exponential decay wave pulse of 250V and a 
capacitance of 500µF was used to shock the cells, following the procedure of Jordan 
et al. 2008. The cells were then transferred back to a 6 well plate containing pre-
warmed complete RPMI and incubated for a range of time points at 37°C before 
being analysed for gene knockdown either by reverse transcription polymerase 
chain reaction (RT-PCR) or Western blotting as per sections 2.2.16 and 2.2.17 
respectively.  
2.2.16 Reverse transcription polymerase chain reaction (RT-PCR) 
2.2.16.1 Ribonucleic acid (RNA) extraction from whole cells 
 RNAse/DNAse free tips and plasticware (Gilson, UK) were used in all RNA 
extractions. RNA manipulations were carried out in a PCR dedicated workstation 
which was decontaminated prior to each use with RNAse Away solution (Invitrogen, 
UK). THP-1 monocyte like cells and monocyte derived macrophages and dendritic 
cells were cultured in 6 well plates as detailed in sections 2.2.2-2.2.3. Cell growth 
media was removed and total RNA was extracted from cells using an Ultraspec™-II 
RNA Isolation System (Biotecx Laboratories, USA) containing 14M solutions of 
guanidine salts and urea which act as denaturing agents. Homogenisation of cells 
using 1ml of Ultraspec™-II per 5-10 million cells was carried out directly within plate 
wells and collected into eppendorf tubes. Full dissociation of nucleoproteins was 
achieved by incubating the homogenates at 4°C for 5 minutes followed by 0.2ml of 
chloroform per 1ml of Ultraspec™-II to extract the RNA. Homogenates were 
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vigorously shaken for 15 seconds, incubated on ice for 5 minutes and spun at 
12,000 x g for 15 minutes. Two phases were then formed; the lower organic phase 
containing deoxyribonucleic acid (DNA) and proteins (also at the interphase) and 
the upper aqueous phase containing the RNA. This upper phase was collected into 
fresh tubes and 0.5 of this volume of isopropanol and 0.05 of this volume of 
RNATack™ Resin was added and vortexed together. Extracted RNA and resin was 
spun for 1 minute and the supernatant was discarded. The pellet was washed twice 
with 1ml of 75% ethanol (Fisher Scientific, UK) by vortexing for 30 seconds and 
spinning for 30 seconds. Supernatants were discarded and traces of ethanol were 
removed by brief drying in a 37°C dry incubator. RNA was eluted by resuspending 
the pellet in 1 volume (as that of the resin) of RNAse free water and washed as 
before, retaining the supernatant containing purified RNA. This was transferred to 
fresh tubes prior to quantitation of RNA yield using a Nanodrop2000 (Thermo 
Scientific) and stored at -70°C until further use. 
2.2.16.2 Complimentary deoxyribonucleic acid (cDNA) synthesis 
 Total RNA extracted as detailed in section 2.2.16.1 was used as a template to 
reverse transcribe complimentary deoxyribonucleic acid (cDNA) using a Tetro cDNA 
Synthesis kit (Bioline, UK) containing a Moloney Murine Leukemia Virus (MMLV) 
reverse transcriptase enzyme. 1µg of RNA was mixed with 1µl Oligo deoxythymine 
(dT)18 primer, 1µl 10mM deoxynucleoside triphosphates (dNTP) and made up to 
10µl using diethylpyrocarbonate (DEPC) water. This mixture was incubated at 65°C 
for 10 minutes in a UnoCycler (VWR, UK). The tubes were then placed on ice and 
the following was added to each; 4µl Reverse Transcriptase (RT) buffer, 1µl Ribosafe 
RNAse Inhibitor, 0.25µl Tetro RT and  4.75µl DEPC water. Tubes were incubated for 
1 hour at 37°C and the reaction was terminated by heating for 15 minutes at 70°C 
(both in the UnoCycler). Samples were either stored at -20°C or used immediately in 
polymerase chain reactions (PCR).  
2.2.16.3 Polymerase chain reaction (PCR) 
 Primers specific to human FcγRI (CD64), FcγRIIa and FcγRIIb (CD32) genes 
were designed using the OligoPerfect™ Designer (Invitrogen Life Technologies, UK) 
primer designing tool. The 5 highest ranking primer pairs were synthesised for each 
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gene of interest as sterile lyophilised powder. All primers were reconstituted in 
sterile nuclease free water to a stock concentration of 100µM and stored at -20°C 
until use. All 15 primer pairs were tested using reverse transcribed cDNA from 
untreated cells (monocyte derived macrophages, monocyte derived dendritic cells 
and THP-1 differentiated macrophages) as per sections 2.2.16.2. The sequences and 
product sizes of the 3 most specific primers chosen to use in all subsequent PCR 
assays are detailed in Table 2.2. 
 
Table 2.2 Primer sequences for amplification using cDNA as a template.  
The specific annealing temperatures for each sequence are shown as well as the specific 
section of the gene to which the primers anneal and the expected product size. 
Primer Name Sequence Annealing 
Temperature 
(°C) 
Product 
Region 
Expected 
Length (bp) 
FcγRI 
 Forward 5’-aatggcacctaccattgctc-3’ 59.96 
 
 
537-
647 
 
 
111 FcγRI 
 Reverse 3’-tgtcacagatgcattcagca-5’ 59.99 
FcγRIIa 
Forward 5’-gggcacctactgacgatgat-3’ 59.96 
 
 
934-
1060 
 
 
127 FcγRIIa 
Reverse 3’-ttgtcatccactcagcaagc-5’ 59.99 
FcγRIIb 
Forward 5’-gttggggctgagaacacaat-3’ 59.97 
 
 
927-
1263 
 
 
287 FcγRIIb 
Reverse 3’-aggtgcagtcggttatttgg-5’ 59.99 
 
Each PCR reaction tube contained 10µl of 2x PCR Master Mix (50units/ml 
Taq DNA polymerase, 400µM of each dNTP, 3mM magnesium chloride (MgCl2), 
Promega, UK), 2µl of cDNA and 1µl (final concentration of 20µM) of each respective 
FcγR forward/reverse primers (Table 2.2). The PCR was carried out using the 
Unocycler with the following amplification programme: initiation at 95°C for 5 
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minutes followed by 40 cycles of denaturation at 95°C for 1 minute to convert 
double stranded DNA to single stranded, annealing at 60°C for 30 seconds to allow 
the primers to bind to the gene area of interest and elongation at 72°C for 1 minute, 
which is the optimal temperature for the DNA polymerase enzyme to operate at. 
The reaction was terminated by a final elongation step at 72°C for 5 minutes and 
the PCR products were kept at 4°C until further use.  
2.2.16.4 Agarose gel electrophoresis  
The products were analysed by running on a 1.5% (v/v) TAE agarose gel 
made using molecular grade agarose powder (Fisher Scientific, UK) supplemented 
with 4µl GelRed nucleic acid gel stain (Biotium, USA).  The gels were prepared in a 
gel caster (EmbiTec, USA) and each 20µl sample was mixed with 2µl of Blue Gel 
Loading Dye (New England BioLabs, UK). 10µl of this mixture was loaded into the 
cast gels alongside 5µl of Quick-Load 100bp DNA Ladder (New England BioLabs, UK) 
containing bromophenol blue as a tracking dye. Electrophoresis was carried out at 
100V until the loading bromophenol blue dye front migrated approximately two-
thirds from the top of the gel. The electrophoretic separation was visualised by 
exposing the agarose gel to an ultraviolet (UV) light within the Gene Flash gel doc 
(Syngene Bioimaging, UK). 
2.2.17 Western blotting 
2.2.17.1 Protein extraction 
THP-1 monocyte like cells and monocyte derived macrophages and dendritic 
cells were cultured in 6 well plates as detailed in sections 2.2.2-2.2.3. Prior to 
extraction, cells were collected by gentle scraping and spun down at 2500xg for 5 
minutes and washed twice in ice cold PBS. The cell pellet was then resuspended in 
ice cold radioimmunoprecipitation assay (RIPA) buffer (Thermo Scientific, UK). RIPA 
buffer contains 25mM Tris-HCl pH7.6, 150mM NaCl, 1% (v/v) nonyl 
phenoxypolyethoxylethanol (NP)-40, 1% (v/v) sodium deoxycholate and 0.1% (w/v) 
SDS and enables cytoplasmic, membrane and nuclear protein extraction. 200µl of 
RIPA buffer and 7µl of Protease Inhibitor Cocktail (Thermo Scientific, UK) was added 
per 1x106 cells and resuspended thoroughly before sonicating the pellet at 50% 
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pulse for 30 seconds to increase the yield.  The mixture was shaken gently for 15 
minutes on ice to ensure complete solubilisation of the cell membrane lipids and 
homogenates were centrifuged for 15 minutes at 14,000xg. The supernatants were 
collected containing the extracted protein and were stored at -20°C until further 
use.        
2.2.17.2 Protein quantification 
 Protein concentration of whole cell extracts was determined using a Micro 
BCA™ Protein Assay Kit (Thermo Scientific, UK). This utilises bicinchoninic acid (BCA) 
as the detector of copper Cu +1 which are formed when Cu2+ are reduced by protein 
in the presence of an alkaline environment. When this reduction occurs, one Cu1+ 
chelates to two molecules of BCA forming a purple coloured reaction product that 
exhibits a strong absorbance at 562nm which is linear with increasing protein 
concentrations. The microplate procedure was used where standard and samples 
were loaded in triplicate, 100µl per well into a 96 well flat bottomed plate. The 
standard curve was prepared using the supplied bovine serum albumin (BSA) 
ampules diluted in PBS from 200µg/ml down to 0.5µg/ml using serial 2-fold 
dilutions. The Micro BCA Working Reagent (WR) was prepared and added to the 
standards and samples in a 1:1 ratio. The plate was thoroughly mixed on a plate 
shaker for 30 seconds, sealed and incubated for 2 hours at 37°C. It was then left to 
equilibrate to room temperature before being read on a Wallac plate reader. A 
standard curve of absorbance versus concentration was generated, from which the 
concentration of the unknown samples could be interpolated.   
2.2.17.3 Electrophoretic transfer  
 Once the protein concentration had been determined, samples were 
prepared for SDS-PAGE and run on 12.5% (v/v) acrylamide gels as per section 2.2.5 
alongside an Enhanced Chemiluminescence (ECL) DualVue Western Blotting Marker 
(GE Healthcare, UK). Gels were blotted overnight at 4°C in ice cold 1x Western 
blotting transfer buffer using a Mini Trans-Blot® Electrophoretic Transfer Cell (Bio-
Rad, UK). Amersham Hybond-P polyvinylidene difluoride (PVDF) membrane (GE 
Healthcare, UK) was prepared by cutting to the size of the gel and pre-wetting in 
100% methanol for 10 seconds. It was then rinsed in distilled water for 5 minutes 
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and equilibrated in transfer buffer for at least 10 minutes. Whatman blotting paper 
was cut to size and equilibrated along with transfer fibre pads for at least 15 
minutes in transfer buffer before the gel sandwich was prepared; transfer cassettes 
were placed black side down in transfer buffer, followed by one pre-wetted fibre 
pad, one sheet of blotting paper and then the gel. The equilibrated PVDF membrane 
was carefully placed onto the gel followed by another sheet of blotting paper. At 
this point, the sandwich was carefully rolled over with a glass rod to remove any air 
bubbles to allow for even transfer of proteins. The sandwich was completed by 
placing the final fibre pad on the blotting paper and the cassette firmly closed and 
transferred overnight at 4°C in transfer buffer at a constant voltage of 30V. 
Successful transfer was determined by the presence of the pre-stained ladder and 
washing the PVDF membranes in distilled water and staining with ATX Ponceau S 
red staining solution (Sigma-Aldrich, UK) to visualise total protein. The staining 
solution was removed and the membrane washed with distilled water several 
times.  
For each experiment, two replicate gels were run; one to stain with 
PageBlue™ Protein Staining Solution to confirm equal protein loading and the other 
to use for Western blotting and immunoprobing. 
2.2.17.4 Immunoprobing of transferred proteins 
Transferred protein membranes were subsequently blocked for 1 hour in 
blocking buffer (PBS containing 5% non-fat dried milk) with gentle agitation at room 
temperature to block any non-specific binding sites. Membranes were then 
incubated with primary antibodies (rabbit anti-human CD64, rabbit anti-human 
CD32 or rabbit anti-human beta actin, Abcam, UK) diluted in blocking buffer for 2 
hours at room temperature with gentle agitation. Blots were washed 3 times for 10 
minutes with wash buffer (PBS containing 0.01% (v/v) Tween®20, Sigma Aldrich, UK) 
and then rolled for 1 hour at room temperature with horseradish peroxidase (HRP) 
IgG conjugated secondary antibody (goat anti-rabbit-HRP, Abcam, UK). S-Protein-
HRP (5ng per membrane) was also added along with the secondary antibodies in 
order to bind and view the ECL DualVue Western Blotting Marker during 
developing.  Blots were washed again with 3 changes of wash buffer for 10 minutes 
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and finally with PBS alone. To detect protein bands, membranes were soaked in 
Amersham ECL Prime Western Blotting Detection Reagent (GE Healthcare, UK) 
which was prepared by equilibrating the pack components to room temperature 
before adding Solution A (luminol/enhancers) to Solution B (peroxide) in a 1:1 ratio. 
Enhanced chemiluminescence is a process where the light intensity is greater and 
more prolonged than that of ordinary chemiluminescence due to the presence of 
chemical enhancers and catalysts provided in the detection reagent pack. The 
presence of HRP (conjugated to secondary antibodies) along with peroxide catalyses 
the oxidation of luminol in a multistep reaction to generate light emissions. The 
amount of light emission is proportional to protein quantity. Membranes were 
drained of any excess wash buffer using Whatman blotting paper and incubated 
with detection reagent for 5 minutes. Excess detection reagent was discarded and 
the membranes were placed in photographic cassettes to be exposed and 
developed onto autoradiography film (Hyperfilm ECL, GE Healthcare, UK).  
2.2.18 Analysis of dendritic cell activation markers using flow cytometry 
 Monocyte derived dendritic cells were cultured as described in 2.2.2 for 5 
days in complete RPMI media. On the fifth day, immature DCs were collected and 
washed twice in serum free complete RPMI and re-plated in 6 well plates at 3x105 
cells/ml, 2ml per well.  Nm was grown, cultured and opsonised for 30 minutes with 
PBS, NHS or CRP as described in 2.2.1 and 2.2.8 before being added to DCs 
alongside controls of PBS and 5μg/ml lipopolysaccharide (LPS) for 24 hours.  
 Supernatants were collected from untreated and treated DCs and frozen at -
80°C for analysis of secreted cytokines at a later date. DCs were gently collected 
using Cell Lifters (Corning, USA) and washed twice in azide-free and serum/protein-
free PBS before being resuspended to 1x106 cells/ml in PBS. Cells were stained with 
a Fixable Viability Dye (eBioscience, UK, 1µl/1ml of cells) and vortexed immediately 
prior to incubation for 30 minutes at 2-8°C, protected from light. DCs were washed 
twice more in ice cold FACS buffer before double staining with anti-human CD11c as 
a DC lineage marker, together with a selection of antibodies targeting a range of DC 
maturation and activation markers (Table 2.3). All antibodies were purchased from 
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R&D Systems, UK, except for mouse anti-human CD11c-A647 and the matched 
isotype control, mouse IgG1-A647, which were purchased from AbD Serotec, UK. 
Table 2.3. Amounts of antibody used per test in double staining flow cytometry 
experiments. 
Antibody µg/test Isotype control µg/test 
CD11c-A647 0.25 Mouse IgG1-A647 0.25 
CD40-PE 0.125 Mouse IgG2B-PE 0.125 
CD80-PE 0.125 Mouse IgG1-PE 0.125 
CD86-PE 0.125 Mouse IgG1-PE 0.125 
CD206-PE 0.1 Mouse IgG2a-PE 0.1 
CD209-PE 0.125 Mouse IgG2B-PE 0.125 
HLA-DR-PE 12.5 Mouse IgG1-PE 0.125 
  
Following double antibody labelling, cells were incubated in the dark for one hour 
followed by 2 washes in ice cold FACS buffer. Cells were spun down and 
resuspended in 2% (w/v) PFA for analysis on the FACS Canto flow cytometer. Data 
were analysed using FACSDiva software.  
2.2.19 TNF detection ELISA 
 The levels of tumour necrosis factor (TNF) present in cell culture 
supernatants was determined using a sandwich enzyme-linked immunosorbent 
assay (ELISA). Nunc MaxiSorp® flat-bottom 96 well plates (VWR, uk) were coated 
with mouse anti-human TNFα at 0.25µg/ml diluted in 0.1M disodium hydrogen 
phosphate (Na2HPO4), pH9.0, 50µl per well. The first three wells were coated with 
buffer alone to observe non-specific binding. Antibodies were left to coat the wells 
overnight at 4°C. Plates were washed 4 times the following day with PBS containing 
0.05% (v/v) Tween®20 before subsequent blocking with PBS containing 2% (w/v) 
BSA (200µl/ per well) for 1 hour at room temperature. During this time, a standard 
curve was prepared using a 2nd World Health Organisation (WHO) International 
Standard for human TNF (National Institute for Biological Standards and Control 
(NIBSC), UK) by two-fold serial dilutions from 20ng/ml to 10pg/ml in serum free 
RPMI media.  Prior to loading standards and samples, the plate was thoroughly 
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washed 4 times with PBS containing 0.05% (v/v) Tween®20. All standards and 
samples were loaded in triplicate and if required, samples were diluted in serum 
free RPMI media. The plates were incubated either overnight at 4°C or for 2 hours 
at room temperature.  Standards and samples were washed off with 4 washes of 
PBS + Tween®20 before Biotin mouse anti-human-TNF-α (BD Pharmingen™, UK) was 
added at 1µg/ml, diluted in PBS containing 2% (w/v) BSA and incubated for 1 hour 
at room temperature. Wells were washed 5 times with PBS containing 0.05% (v/v) 
Tween®20 and subsequently incubated for 30 minutes at room temperature with 
Streptavidin-HRP Conjugate (Invitrogen, UK) at 0.5µg/ml, diluted in PBS containing 
2% (w/v) BSA. 3 washes of PBS containing 0.05% (v/v) Tween®20 were carried out, 
followed by 3 PBS washes and 1 citrate phosphate buffer (0.05M, pH5.0, Sigma-
Aldrich, UK) wash. Plates were developed with 50μl/well 3,3’,5,5’–
Tetramethylbenzidine (TMB, Sigma-Aldrich, UK) by dissolving 1 tablet in 10ml of 
0.05M citrate phosphate buffer with the addition of 2µl of hydrogen peroxide. The 
reaction was stopped by the addition of 12.5µl of 2M sulphuric acid to each well. 
Plates were read at 450nm using a Wallac plate reader.  
2.2.20 Quantification of inflammatory cytokines by Cytometric Bead Array 
 A BD biosciences Human Inflammation Cytometric Bead Array kit was used 
as per the manufacturer’s instructions to measure IL-1β, IL-6, IL-8, IL- 12p80, IL-8 
and TNF concentrations from DC cell culture supernatants following incubation with 
unopsonised and opsonised Nm as per section 2.2.18. In principle, the cytometric 
bead array consists of 6 populations of beads with distinct fluorescence intensities 
(of the fluorochrome APC) that are coated with capture antibodies for the 6 
inflammatory cytokines listed. This allows simultaneous quantification of cytokines 
from cell culture supernatants after incubating with test and control samples and a 
PE-conjugated secondary antibody. The in-house TNFα assay results were used to 
choose appropriate dilutions of samples to use in the assay. 
2.2.21 Statistical analyses 
Each experiment was reproduced at least three times, unless otherwise 
stated. Data are expressed as arithmetic means + standard deviation (SD) or 
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standard error of the mean (SE). Analysis of variance was used to measure 
coefficients of variation for 3 or more groups of variables using the 1-way ANOVA, 
correcting with Tukey post-test for multiple comparisons. All data were analysed 
using GraphPad Prism 6 software. For all analyses, P values of less than 0.05 were 
considered statistically significant. 
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CHAPTER 3 
INVESTIGATING C-REACTIVE PROTEIN-
OPSONISED NEISSERIA MENINGITIDIS 
UPTAKE INTO HUMAN PHAGOCYTIC CELLS 
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3.1 Rationale and aims 
 C-Reactive protein (CRP) plasma levels have long been used for clinical 
purposes as a marker of inflammation (for patients suffering either from tissue 
injury or infection) and more recently, links have been noted between minor 
elevated levels of CRP and patients who have intermediate risk of cardiovascular 
disease (Black et al. 2004). The major role, however, for CRP to date has been 
described as an opsonin, with the ability to bind to phosphorylcholine (PC) on a 
variety of pathogens in order to aid their clearance by resident phagocytes. In 
addition to this, CRP can also act as an activator of the classical complement 
cascade via direct interaction with C1q (Mold et al. 1999). It is known that in early 
stages of bacterial infection, CRP levels can increase by up to 10,000 fold, and so far 
no CRP deficiency states have been discovered (Pepys & Hirschfield 2003) indicating 
a significant survival value and importance in aiding clearance of pathogens such as 
Nm.  
 Following a report of PC expression on class I and II pili of Neisseria 
meningitidis (Nm) (Weiser et al. 1998), work in our group established that CRP could 
bind to the Nm C311 pathogenic strain and the requirement for calcium in this 
binding (Casey et al. 2008). It is well known that the meningococcus resides 
commensally in the nasopharynx of 10% of the population and in rare cases is able 
to breach the epithelium (Yazdankhah 2004). Once the meningococci have entered 
the bloodstream they will encounter innate immune cells such as phagocytic 
neutrophils, immature tissue macrophages and also professional antigen presenting 
cells; immature dendritic cells (DCs, Kolb-Mäurer et al. 2001). Indeed, enhanced 
uptake of CRP-opsonised  Nm into neutrophils was previously investigated (Casey et 
al. 2008) as well as monocytes and macrophages. However, this was not 
investigated in DCs. Therefore, the aim of this chapter was to look into the uptake 
of Nm in DCs as well as macrophages with and without CRP opsonisation. Normal 
human serum (NHS) containing antibodies (potentially some specific to Nm), 
complement and possibly CRP acted as a positive control.  
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The first aim of this chapter, therefore, was to establish the ideal time point at 
which to harvest Nm in mid log phase, in order to have bacteria in an actively 
dividing state (mimicking growth during innate inflammation). The second was to 
establish the ideal multiplicity of infection (MOI) of Nm to use to infect human 
phagocytes and to find the maximum length of exposure to the meningococci in 
order to allow for phagocytosis (and limited cell death) to occur. Finally, the third 
aim was to investigate whether opsonisation of Nm with purified CRP enhanced its 
uptake by human DCs in comparison to monocyte derived macrophages and cell 
line-derived macrophages. Internalisation of Nm into these human phagocytic cells 
was also confirmed with the use of plasma membrane dyes alongside uptake 
assays.  
3.2 Results    
3.2.1 Measurement of Neisseria meningitidis growth to determine optimal 
harvesting point for uptake and infection assays 
In order to check that bacterial growth conditions were appropriate for 
harvesting of Nm for use in uptake assays, strain C311 was cultured as described in 
2.2.1 for 4 hours.  Aliquots were sampled every 2 hours for optical density 
measurements at 595nm and dilutions were carried out using Mueller Hinton Broth 
(MHB) to allow for enumeration of bacteria from 20µl drops plated in triplicate onto 
Columbia Blood agar (CBA) plates. 
The mid-log phase of meningococcal growth based on optical density 
measurements occurred at 4 hours of culture (Figure 3.1A).  Interestingly, when 
bacterial growth was assessed via enumeration of colonies at each time point 
(Figure 3.1B) it appeared that the mid-log phase of growth occurred at 6 hours. 
Previous work (Casey et al 2008), however, found that CRP binding to Nm peaked at 
4 hours and that past this time point, rapidly decreased to almost negligible by 8 
hours.  A 4 hour time point, therefore, was chosen for Nm harvesting in order to 
maximise CRP binding to the meningococcus.   
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Figure 3.1 Neisseria meningitidis C311 time course of growth. 
Over 8 hours of bacterial growth, aliquots were taken every 2 hours to measure the optical 
density at 595nm (A). Samples taken at each time point were also serially diluted for plating 
in order to calculate bacterial numbers (B).The mean and standard deviation of 3 replicate 
experiments are shown.  
 
 
A 
B 
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3.2.2 Viability of peripheral blood mononuclear cell (PBMC) derived 
macrophage and dendritic cell (DC) populations following differentiation in 
vitro 
In order to differentiate PBMCs to macrophage and immature DC-like cell 
populations, a minimum of 5 days in culture has been documented (Ylisastigui et al. 
1998 and Zhou & Tedder 1996 respectively). Since additional incubation times were 
required for the investigation of Nm with these cells and that a degree of cell death 
could be expected over this range of incubation times, a time course was therefore 
performed in order to assess the viability of the cells as described in 2.2.7.  
 PBMC derived macrophages and dendritic cells from 4 donors were cultured 
for 5 days and re-seeded into 96 well flat bottomed plates prior to infection with 
Nm at MOIs of 25:1, 50:1, 100:1 and 200:1. Macrophage and DC viability was tested 
after 2, 24 and 48 hours of infection with Nm with the addition of 3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) solution as per 
section 2.2.7.  
 The viability (proportional to absorbance measured at 570nm) of day 5 
human PBMC derived macrophages remained stable after 2 hours incubation with 
increasing MOIs of Nm (Figure 3.2). 2 hours is sufficient time for phagocytosis to 
occur (Jack et al. 2005), therefore the MOI of 200:1 was used for all opsonisation 
and uptake assays to be analysed by fluorescent confocal microscopy.  
In order to observe any changes in cell surface marker expression or 
secreted cytokines however, incubations longer than 2 hours were required 
(Uronen-Hansson, Steeghs, et al. 2004). Figure 3.2 demonstrates that macrophage 
viability decreases marginally following 24 hours incubation with Nm, although this 
was not statistically significantly different. Following 48 hours incubation, however, 
a significant decrease in cell viability was seen when a MOI of 200:1 was used in 
comparison with cells treated with medium alone at that time point (p=<0.0001). 24 
hours was, therefore, selected as the ideal incubation period prior to secreted 
cytokine analysis or antibody staining for flow cytometry analysis.  
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Figure 3.2 Cell growth determination of human PBMC derived macrophages following 
incubation with various Nm MOIs over time.  
PBMC derived macrophages from 4 donors were incubated in triplicate with Nm at MOIs of 
25, 50, 100 and 200:1 for 2, 24 or 48 hours (red dots, blue checks and green stripes 
respectively).  Cell viability was measured using the MTT assay as described in 2.2.7. Data 
are expressed as the mean absorbance of 4 experiments + standard deviation (**** 
denotes a p value <0.0001, NS = not statistically significant).  
 
Similarly, cell viability of monocyte derived DCs (Figure 3.3) was not 
significantly altered after 2 or 24 hours of incubation with various Nm MOIs. After 
48 hours, however, with an MOI of 200:1, a statistically significant reduction was 
observed (p=0.0112). The ideal incubation period of 24 hours was, therefore, 
selected for analysis of secreted cytokines or antibody staining for flow cytometry 
analysis. 
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Figure 3.3 Cell growth determination of human PBMC derived dendritic cells following 
incubation with various Nm MOIs over time. 
PBMC derived dendritic cells from 4 donors were incubated in triplicate with Nm at MOIs of 
25, 50, 100 and 200:1 for 2, 24 or 48 hours (red dots, blue checks and green stripes 
respectively).  Cell viability was measured using the MTT assay as described in 2.2.7. Data 
are expressed as the mean absorbance of 4 experiments + standard deviation (* denotes a 
p value <0.05, NS= not statistically significant).  
 
Analysis of cell viability for the differentiated THP-1 macrophages was not 
carried out, as this is an immortal cell line and the differentiation protocol was only 
for 72 hours.  In addition, THP-1 cells were only used in 2 hour phagocytosis 
experiments.   
3.2.3  Confirmation of C - reactive protein purification 
Human CRP was purchased as a 97% pure preparation from The Binding Site 
company, however, as a serum protein, preparations of CRP may still contain trace 
amounts of antibodies or complement proteins that could affect future assays 
involving CRP-opsonised Neisseria meningitidis. Purchased CRP, therefore, was 
further purified by affinity column chromatography as detailed in section 2.2.4. 
Sodium dodecyl sulphate poly acrylamide gel electrophoresis (SDS-PAGE) followed 
by sensitive silver staining was used to compare the purity of the original 97% pure 
CRP with the phosphorylcholine (PC) affinity column chromatography purified CRP. 
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The presence of a single band at 25KDa (CRP) with no detectable contaminants after 
chromatography down to the limit of the detection of the stain (0.05ng of protein 
per band) was observed in the lanes containing purified CRP (Figure 3.4). 
 
Figure 3.4 PageSilver™ Staining of a SDS-PAGE gel to compare the purity of original and 
affinity column chromatography purified human CRP. 
A maximum sensitivity protocol silver stained 12% SDS-PAGE gel of 1μg original 97% pure 
CRP (B) compared to 1μg (C) and 2μg (D) PC-affinity column chromatography purified CRP 
alongside a molecular weight marker (A). 
 
3.2.4 Association of Neisseria meningitidis into human THP-1 cells, 
macrophages and dendritic cells is enhanced when the bacterium is 
opsonised with either CRP or normal human serum (NHS) 
 Previous work (Casey et al. 2008) showed that uptake of Neisseria 
meningitidis  into human THP-1 macrophages, monocyte derived macrophages and 
neutrophils was enhanced when the bacterium was pre-opsonised with CRP. 
Uptake experiments were, therefore, repeated in THP-1 macrophages and 
monocyte derived macrophages to verify the conditions for enhanced CRP 
mediated uptake in these cells prior to conducting any further experiments on 
dendritic cells or indeed on the specificity of the binding.  
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3.2.4.1 CRP enhanced association of N. meningitidis into human THP-1 derived 
macrophages 
 As a stable model to confirm CRP-enhanced association of Neisseria 
meningitidis with human phagocytic cells, human THP-1 cells were differentiated 
into a more macrophage-like state using phorbol myristate acetate (PMA) following 
the procedure of  Daigneault et al. 2010 as described in 2.2.3. Fixed cultures of GFP-
expressing Nm were prepared as per section 2.2.1 prior to undergoing opsonisation 
with either PBS (negative control), 50% NHS (positive control) or 50µg/ml CRP. 
Unopsonised, NHS and CRP opsonised Neisseria meningitis were incubated with 
THP-1 macrophages for 2 hours to allow phagocytosis to occur.  
For each cell type and treatment, fields were chosen using the 548nm laser 
alone (to detect nuclei of cells stained with propidium iodide) in order to find areas 
based on confluency only. The 488nm laser (to detect GFP expressing Nm) was not 
used in the selection of fields in order to minimise bias and was only utilised during 
image capture. In each case at least 5 images were taken of each treatment. 
Overlays using bright field imaging to view the perimeters of each cell were also 
used to assess bacterial interactions with each cell.  
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Representative fluorescent confocal microscopy images revealed enhanced 
association of Nm with THP-1 macrophages when opsonised with NHS and to a 
greater extent, with CRP (Figure 3.5). 
 
Upon analysis of 4 replicate experiments, the increase in the percentage of 
THP-1 derived macrophages associated with Nm opsonised with NHS and CRP when 
compared to the unopsonised controls was statistically significantly different 
(p=0.0065 and p=0.0290 respectively, figure 3.7A). Interestingly, the percentage of 
THP-1 derived macrophages associated with CRP opsonised Nm was greater than 
that associated with Nm pre-treated with NHS.  This was not, however, statistically 
significantly different. Upon analysis of the number of Nm associated with every 
macrophage (bacteria per THP-1 macrophage, figure 3.6B) it was found that with 
CRP opsonisation, higher numbers of meningococci associated with THP-1 cells in 
Figure 3.5 Enhanced association of NHS 
and CRP-opsonised Nm with human THP-1 
macrophages.  
PMA differentiated THP-1 macrophages 
were incubated with unopsonised, NHS pre-
treated and CRP opsonised, GFP-expressing 
Nm at a MOI of 200:1 for 2 hours followed 
by staining with prodium iodide and 
confocal microscopy analysis of association 
with the meningococci.  Representative 
confocal fields of (A) unopsonised, (B) NHS 
pre-treated and (C) CRP-opsonised Nm are 
shown. Scale bar=20µm.    
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comparison to NHS pre-treatment or unopsonised Nm. This was not however, 
statistically significantly different.  
 
Figure 3.6 The effect of CRP opsonisation and NHS pre-treatment on Neisseria 
meningitidis association with human THP-1 macrophages.   
PMA differentiated THP-1 macrophages were incubated with unopsonised, NHS pre-treated 
and CRP-opsonised GFP-expressing Nm at a MOI of 200:1 for 2 hours followed by confocal 
microscopy analysis of association with the meningococci. The mean + standard deviation 
of 4 replicate experiments are shown for (A) percent of THP-1 macrophages associated with 
bacteria and (B) the number of bacteria per cell (where * denotes p<0.05 and ** denotes 
p<0.01). 
 
3.2.4.2 CRP enhanced association of N. meningitidis with human monocyte 
derived macrophages 
 Having established uptake conditions in the THP-1 macrophage model, 
human PBMC derived macrophages were cultured for 5 days as described in 2.2.2.3. 
Fixed cultures of GFP-expressing Nm were pre incubated as detailed above. 
Unopsonised, NHS and CRP opsonised Neisseria meningitis were incubated with 
monocyte derived macrophages for 2 hours to allow for phagocytosis to occur.  
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Representative fluorescent confocal microscopy images revealed enhanced 
association of Nm with monocyte derived macrophages when opsonised with NHS 
and to a greater extent, with CRP (figure 3.7).  
          
      
Upon analysis of 4 donors, the increase in the percentage of monocyte 
derived macrophages associated with Nm opsonised with CRP when compared to 
the unopsonised controls was significant (p=0.0435, figure 3.8A). Interestingly, the 
percentage of monocyte derived macrophages associated with CRP opsonised Nm 
was greater than that associated with Nm pre-treated with NHS.  This was not, 
however, statistically significantly different. Upon analysis of the number of Nm 
associated with every macrophage it was found that with CRP opsonisation, higher 
numbers of meningococci associated with macrophage cells in comparison to NHS 
pre-treatment or unopsonised Nm. Interestingly, the number of Nm associating 
20μm 20μm
20μm
Figure 3.7 Enhanced association of NHS 
and CRP-opsonised Nm with human 
monocyte derived macrophages.  
Human monocyte derived macrophages 
were incubated with unopsonised, NHS 
pre-treated and CRP opsonised GFP-
expressing Nm at a MOI of 200:1 for 2 
hours followed by staining with prodium 
iodide and confocal microscopy analysis 
of association with the meningococci.  
Representative confocal fields of (A) 
unopsonised, (B) NHS pre-treated and (C) 
CRP-opsonised Nm are shown. Scale 
bar=20µm.  
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with macrophages when pre-treated with NHS was lower than that of unopsonised 
Nm. This was not, however, statistically significantly different.       
 
Figure 3.8 The effect of CRP opsonisation and NHS pre-treatment on Neisseria 
meningitidis association with human monocyte derived macrophages.   
Human monocyte derived macrophages were incubated with unopsonised, NHS pre-
treated and CRP-opsonised GFP-expressing Nm at a MOI of 200:1 for 2 hours followed by 
confocal microscopy analysis of association with the meningococci. The mean + standard 
deviation of 4 replicate experiments are shown for (A) percent of monocyte derived 
macrophages associated with bacteria and (B) the number of bacteria per cell (where * 
denotes p<0.05).  
 
3.2.4.3 CRP enhanced association with human monocyte derived dendritic cells 
Having established the enhanced association of CRP-opsonised Nm with 
human macrophages, human PBMC derived dendritic cells (DCs) were cultured for 5 
days as described in 2.2.2.3. Fixed cultures of GFP-expressing Nm were pre 
incubated as detailed above. Unopsonised, NHS and CRP opsonised Neisseria 
meningitis were incubated with monocyte derived DCs for 2 hours to allow for 
phagocytosis to occur.  
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 Representative fluorescent confocal microscopy images revealed enhanced 
association of Nm with PBMC derived DCs when opsonised with NHS and to a 
greater extent, with CRP (figure 3.9). 
 
 
Upon analysis of 4 donors, the increase in the percentage of monocyte 
derived DCs associated with Nm opsonised with CRP when compared to the 
unopsonised controls was highly significant (p=0.0018, figure 3.10A).  There was 
not, however, a statistically significant difference between the percentage of 
monocyte derived DCs associated with CRP opsonised Nm compared to DCs 
associated with Nm pre-treated with NHS. Upon analysis of the number of Nm 
associated with every dendritic cell (Figure 3.10B), it was found that with either NHS 
pre-treatment or CRP opsonisation, higher numbers of meningococci associated 
Figure 3.9 Enhanced association of NHS 
and CRP-opsonised Nm with human 
monocyte derived dendritic cells (DCs).  
Human monocyte derived DCs were 
incubated with unopsonised, NHS pre-
treated and CRP opsonised GFP-
expressing Nm at a MOI of 200:1 for 2 
hours followed by staining with prodium 
iodide and confocal microscopy analysis 
of association with the meningococci.  
Representative confocal fields of (A) 
unopsonised, (B) NHS pre-treated and 
(C) CRP-opsonised Nm are shown. Scale 
bar=20µm. 
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with DCs in comparison to unopsonised Nm, although this was not statistically 
significantly different.  
 
 
Figure 3.10 The effect of CRP opsonisation and NHS pre-treatment on Neisseria 
meningitidis association with human monocyte derived dendritic cells (DCs).   
Human monocyte derived Dcs were incubated with unopsonised, NHS pre-treated and CRP-
opsonised GFP-expressing Nm for 2 hours at a MOI of 200:1 followed by confocal 
microscopy analysis of association with the meningococci. The mean + standard deviation 
of 4 replicate experiments are shown for (A) percent of monocyte derived DCs associated 
with bacteria and (B) the number of bacteria per cell (where * denotes p<0.05 and ** 
denotes p<0.01). 
 
3.2.5 Confirmation of CRP enhanced Neisseria meningitis internalisation 
by human THP-1 macrophages and monocyte derived macrophages and 
dendritic cells. 
 In order to investigate whether CRP opsonised Nm were internalised by THP-
1 derived macrophages and monocyte derived macrophages and dendritic cells, all 
three cell types were stained using an amphipathic cell membrane stain (CellMask™ 
Deep Red) as described in 2.2.9. Following opsonisation and incubation with GFP 
expressing Nm as described above for all uptake assays. Z-stack images were taken 
through each cell type to confirm the uptake of Nm by these human phagocytes.  
 Representative confocal fluorescent microscope z-stack images confirming 
Nm uptake by THP-1 macrophages (figure 3.11), monocyte derived macrophages 
(figure 3.12) and dendritic cells (figure 3.13) are presented below.  
A B
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Figure 3.11 Internalisation of N. meningitidis by human THP-1 macrophages 
PMA differentiated THP-1 cells were incubated with CRP opsonised GFP-expressing Nm for 
2 hours followed by plasma membrane staining with CellMask™ Deep Red plasma 
membrane stain to visualise internalisation of Nm. 1µm z-stack slices were taken from the 
bottom of the cell (i) through to the top of the cell (vi) using confocal fluorescent 
microscopy.  
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Figure 3.12 Internalisation of N. meningitidis by human monocyte derived macrophages 
PBMC derived macrophages were incubated with CRP opsonised GFP-expressing Nm for 2 
hours followed by plasma membrane staining with CellMask™ Deep Red plasma membrane 
stain to visualise internalisation of Nm. 1µm z-stack slices were taken from the bottom of 
the cell (i) through to the top of the cell (viii) using confocal fluorescent microscopy. 
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Figure 3.13 Internalisation of N. meningitidis by human monocyte derived dendritic cells 
PBMC derived dendritic cells were incubated with CRP opsonised GFP-expressing Nm for 2 
hours followed by plasma membrane staining with CellMask™ Deep Red plasma membrane 
stain to visualise internalisation of Nm. 1µm z-stack slices were taken from the bottom of 
the cell (i) through to the top of the cell (vi) using confocal fluorescent microscopy. 
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3.3 Discussion 
 Since CRP enhanced monocyte, macrophage and neutrophil uptake of Nm 
had been previously demonstrated, it was important to see if the same effect 
occurred in DCs. The first aim of this chapter, therefore, was to confirm an ideal 
time point at which to harvest cultures of strain C311 Group B Neisseria 
meningitidis (Nm) in order for the bacterium to be in an actively dividing state for 
subsequent infection of human phagocytic cells. The second was to establish an 
ideal multiplicity of infection (MOI) of Nm during infection assays to ensure minimal 
phagocytic cell death and the third was to investigate CRP-enhanced uptake into 
macrophages and DCs.  
3.3.1 N. meningitidis logarithmic replication occurs after 4 hours of growth  
Bacterial growth curves of N. meningitidis over the course of 8 hours 
confirmed previous work (Casey et al. 2008) that showed the mid log phase of 
growth of this particular strain occurs at 4 or 6 hours when measured by optical 
density and colony forming units respectively. During the lag phase when the 
meningococcus is dormant within the nasopharynx, it is non-dividing and can 
remain for long periods of time as a commensal. Once it crosses the nasopharyngeal 
mucosal barrier and epithelium to reach the bloodstream, however, it begins to 
replicate, thus causing the symptoms of septicaemia (Echenique-Rivera et al. 2011). 
The log phase is, therefore, the ideal point at which to harvest the bacterium as this 
will best mimic disease within a host when Nm will encounter human macrophages 
and dendritic cells in the bloodstream. Since previous work (Casey et al 2008) found 
that CRP binding to Nm peaked at 4 hours and that past this time point, rapidly 
decreased to almost negligible by 8 hours, a 4 hour time point, therefore, was 
chosen for Nm harvesting in order to maximise CRP binding to the meningococcus.   
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3.3.2 Minimal phagocyte cell death was observed 24 hours post infection 
with N.meningitidis 
 Human monocyte derived macrophages and dendritic cells were cultured for 
5 days as described previously (2.2.2.3) and then required further incubation steps 
with Nm in order to carry out phagocytosis assays, analysis of secreted cytokines 
and changes in cell surface markers (see Chapters 4 and 5). It was, therefore, 
necessary to conduct a time course to evaluate the levels of cell death upon 
exposure to Nm over a range of time points. PBMC derived macrophage viability 
following 5 days of culture was not statistically significantly different after 2 or 24 
hours of infection with Nm at any of the MOIs used when compared with cells in 
complete medium only. After 48 hours, however, significant cell death was 
observed at an MOI of 200:1.  2 hours of infection at an MOI of 200:1 was, 
therefore, used for all phagocytosis assays as this is sufficient time for uptake to 
occur (Jack et al. 2005). 24 hours of infection with an MOI of 200:1 was chosen to 
investigate downstream immune responses, as longer incubations are needed to 
detect changes in cytokine secretion and cell surface marker expression (Uronen-
Hansson, Steeghs, et al. 2004). 48 hours of infection could have been employed 
using a lower MOI, but for comparison sake, similar MOIs across all experiments 
were preferred. In addition to this, uptake experiments were designed to mimic the 
initial stages of Nm infection, where the meningococcus will encounter immature 
macrophages. Following 48 hours incubation, however, PBMC derived macrophages 
would be 7 days old and would begin to mature.  
 Very similar results were seen in monocyte derived dendritic cell viability 
assays; 2 and 24 hour infection time points were thus chosen for uptake and 
downstream immune response assay’s respectively.  
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3.3.4 Affinity chromatography purification reduces levels of contaminants 
found in purchased preparations of C-reactive protein    
 CRP that was to be used in all opsonisation experiments was purchased as a 
97% pure preparation before undergoing further purification by dialysis and affinity 
chromatography as per section 2.2.4. To compare the original preparation with the 
newly purified CRP, SDS-PAGE followed by sensitive silver staining was used as 
described in sections 2.2.5 and 2.2.6 respectively. Upon comparison of 1μg of 
original CRP sample to 1μg of purified sample a large difference in band size was 
observed. This could be attributed to the presence of the light chain of human IgG 
(which is also 25KDa in size) or even bacterial endotoxin/lipopolysaccharide (LPS) 
that can have a molecular weight ranging anything from 4-30KDa (Petsch 2000), 
which is known to be a common contaminant of commercial CRP preparations 
(Dasu et al. 2007). Silver staining detects down to as little as 0.05ng of protein but is 
also capable of detecting LPS (Tsai & Frasch 1982) which is a lipid and 
polysaccharide structure (Caroff & Karibian 2003). In order to load 1μg and 2μg of 
CRP for SDS-PAGE, protein content was measured using the Nanodrop2000 
spectrophotometer as per section 2.2.4 which detects cysteine-cysteine disulphide 
bonds, tryptophan and tyrosine (Desjardins et al. 2009), all of which are found 
within the primary sequence of CRP (Oliveira et al. 1977). Having a predominantly 
lipid structure, however, these amino acids are not present in LPS and will not be 
detected by the spectrophotometer A280 function. This may account for the overly 
large band size present at the 25Kda mark.   
3.3.5 CRP-enhanced association of Neisseria meningitidis with human 
phagocytic cells  
The effect of CRP-opsonisation on the association of Nm with phagocytic 
cells was determined by fluorescent confocal microscopy. Initial association 
experiments of opsonised and unopsonised Nm with phagocytic cells showed that 
in all three cell types, the percent of cells associated with the meningococcus 
significantly increased when Nm was pre-incubated with CRP. Previous work has 
shown that CRP binds Nm in a calcium dependant manner and that CRP-
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opsonisation of Nm increased the uptake into human macrophages and neutrophils 
(Casey et al, 2008). In these experiments, CRP enhanced the association of Nm into 
differentiated THP-1’s (dTHP-1) and DCs as well as macrophages. 
 We cannot attribute all association observed to CRP-opsonisation, as Nm 
was still able to associate with the three cell types in the absence of CRP (Nm pre-
incubated with PBS only). In dTHP-1s this background association was low (3-4% of 
cells), whereas in macrophages and dendritic cells it was variably higher (35% and 
9% respectively). The high association of macrophages with unopsonised Nm is to 
be expected as these cells express large numbers of membrane bound pattern 
recognition receptors (PRRs) which recognise pathogen associated molecular 
patterns (PAMPs) on a variety of microbes; and are, therefore essential for innate 
immunity. The PRR CD14 is primarily expressed on macrophages (Arroyo-Espliguero 
et al. 2004) and to a lesser extent, on dendritic cells (Qu et al. 2014) and THP-1 cells 
(Zughaier et al. 2003). CD14s main ligand is LPS, which is structurally very similar to 
the LOS of Nm so it will therefore recognise meningococci. Other PRRs that 
macrophages express are TLR-4 (signalling co-receptor of CD14), which also targets 
LPS as its ligand and is, therefore, a major PRR for gram negative bacteria such as 
Nm and the Class A scavenger receptor, SR-A, which mediates nonopsonic 
phagocytosis of Nm (Leanne Peiser et al. 2002). Dendritic cell association with Nm 
maybe lower than that of macrophages as these cells express less CD14 and TLR-4 
receptors.  
THP-1 cells treated with PMA were induced to differentiate along the 
monocytic pathway towards a more macrophage-like phenotype, as the phorbol 
esters activate protein kinase C (PKC) which is involved in the regulation of cell 
proliferation and differentiation. The addition of PMA stimulates THP-1 cells to 
become more macrophage-like in morphology, phagocytic activity (Daigneault et al, 
2010) and in the amount of superoxide and TNF-α released. They also express 
similar cell surface markers to maturing monocytes, like CD11b, but it has also been 
found that differentiated THP-1s have very low levels of CD14 (Schwende et al, 
1996). This could account for the low levels of THP-1 association with Nm in the 
absence of opsonin.  
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 Other explanations for “background” Nm association with the cells could be 
the activity of complement, although this is unlikely, as the FCS used was heat 
inactivated, therefore all complement proteins should have been denatured. The 
presence of calf IgG in FCS during cell culture assisting association can be ruled out 
as the stringent filtration process of FCS removes almost all antibody. Even if foetal 
calf IgG were present and able to opsonise Nm, they would have a reduced affinity 
for the human Fc receptors present on the surface of the human phagocytes, as 
compared to CRP. In addition, all cell cultures were washed in PBS prior to 
incubation with Nm. 
 Pre-incubation of Nm with normal human serum (NHS) showed an increase 
in association (when compared to Nm pre-incubated with PBS alone) in all three cell 
types but was only statistically significantly different in dTHP-1 and dendritic cells. 
Pooled NHS from healthy donors was used and any IgG or complement present in 
the serum could have opsonised the meningococci aiding their association with 
THP-1 cells and dendritic cells. Similarly, trace amounts of CRP in the NHS could 
have resulted in association. The presence and effect of other acute phase proteins 
such as mannose binding lectin (MBL) and serum amyloid P (SAP) should also be 
considered as these acute phase proteins have been shown to bind to a range of 
pathogens in similar ways (Ip & Lau 2004 and Shah et al. 2006). 
 Confocal images were also used to assess the effect of opsonisation on the 
number of bacteria per cell. Across all three cell types, no significant differences 
were observed when Nm was pre-incubated with PBS, CRP or NHS. The average 
number of bacteria per cell was usually at an average of around 1 and never rose 
above 2.  
3.3.6 Internalisation of N. meningitidis by human phagocytic cells 
 All opsonisation and uptake assays were analysed using fluorescent confocal 
microscopy utilising the nucleic acid dye, prodium iodide. This was used in 
conjunction with the bright field setting on the confocal microscope in order to view 
the extremities of the cells. This is of course especially important with cells such as 
macrophages and dendritic cells which tend to have large cytoplasmic areas and 
dendrites surrounding the nucleus which can come into contact with the 
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meningococcus. In addition to this, whilst conducting counting, images could be 
viewed from different angles using LSM Image browser software to confirm the 
association of the bacterium with the cells.  This does not, however, confirm the full 
internalisation of N. meningitidis with these human phagocytes, only association 
and therefore, the amphipathic CellMask™ Plasma Membrane stain was used post 
infection to confirm uptake of Nm. Z-stack overlay images of dTHP-1 cells, 
monocyte derived macrophages and dendritic cells (where 1µm slices were taken 
through each cell from the bottom upwards) confirmed internalisation as the GFP 
expressing N. meningitidis could be seen localised within the cell membrane and 
potentially within phagocytic vacuoles. This could be further confirmed by co-
localisation staining for markers of endocytic/vesicular trafficking.  
3.3.7 Conclusions 
 In conclusion, re-establishing the ideal time point at which to harvest Nm 
during logarithmic growth confirmed that 4 hours was the most suitable time point. 
2 hours of infection was found to be the most suitable incubation time in order to 
allow for phagocytosis of Nm into human phagocytes and 24 hours was the ideal 
infection period to assess changes in cytokine secretion and cellular surface 
receptors. Results from these optimisation experiments were then used to develop 
all subsequent assays which led to confirmation of enhanced CRP-mediated 
association of Nm with monocyte derived macrophages. These experiments have 
also shown enhanced CRP-mediated uptake of N. meningitidis in differentiated THP-
1 macrophages and monocyte derived dendritic cells. Full internalisation of the 
meningococcus was also confirmed using plasma membrane stains. These findings 
of CRP enhanced association in all three cell types provide the potential for further 
investigation into the receptors involved in the uptake of CRP opsonised Nm into 
these phagocytic cells, the specificity of this binding and the downstream effects on 
DCs which will be discussed in the following chapters. 
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CHAPTER 4 
INVESTIGATING FC GAMMA RECEPTOR 
INVOLVEMENT IN     C-REACTIVE PROTEIN 
MEDIATED UPTAKE OF NEISSERIA 
MENINGITIDIS INTO HUMAN PHAGOCYTIC 
CELLS 
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4.1 Rationale and aims 
 The interaction between human Fc gamma receptors (FcγRs) and C-Reactive 
Protein (CRP) has long been suggested (Mortensen & Duszkiewicz 1977 and Crowell 
et al. 1991) and in particular, the binding of CRP with the high affinity receptor, 
FcγRI (CD64) (Marnell et al. 1995 and Tron et al. 2008). These findings were further 
validated by surface plasmon resonance work which demonstrated that CRP has a 
higher binding affinity to FcγRI than IgG (Bodman-Smith et al. 2002). This was 
suggested to be due to the CRP binding site on the extra cellular portion of domain 
2 of Fcγ receptors which overlap with that of the human IgG binding site (Lu et al. 
2012). CRP has also been shown to be capable of binding the lower affinity IgG 
receptor, FcγRII (CD32) on endothelial cells, monocytes, neutrophils and 
macrophages (Devaraj et al. 2005, Bharadwaj et al. 1999 and Zwaka et al. 2001).   
 Human monocyte derived macrophages and dendritic cells (DCs) both 
express FcγRI and II (Ravetch & Bolland 2001 and Fanger et al. 1996 respectively) 
which are used to internalise potential antigens for destruction or processing and 
presentation to T cells. The previous chapter of this thesis demonstrated that 
enhanced CRP mediated uptake of Nm occurred in human dendritic cells as well as 
monocytes and macrophages, however, whether or not this uptake occurred via Fcγ 
receptor I and/or II expressed by these phagocytes is not known and is the main 
focus of this chapter. Several approaches were employed to investigate CRP 
mediated enhanced uptake of Nm into human phagocytes including RNA 
interference, antibody blocking and visualisation of co-localisation by confocal 
immunohistochemistry microscopy. 
The first aim of this chapter was to use the highly regulated enzyme-
mediated process known as RNA interference (RNAi) to target and transiently 
suppress the gene expression of FcγRI and/or II by monocyte derived macrophages 
and dendritic cells using short interfering ribonucleic acids (SiRNAs). Once successful 
gene knock down was confirmed in both cell types, any changes in CRP-enhanced 
uptake of Nm into human macrophages and dendritic cells were to be analysed. 
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Fcγ receptors are able to bind to IgG via its fragment, crystallisable (Fc) 
region, specifically at the CH2 and CH3 domains of the IgG heavy chain (Gergely & 
Sarmay 1990). Binding is achieved via one of the extracellular domains, D2, 
expressed by all Fcγ receptors (Schwab & Nimmerjahn 2013) and interestingly, CRP 
has also been shown to bind to this domain (Lu et al. 2008).  Purified human IgG, 
therefore, was an appropriate agent to attempt to block CRP enhanced uptake of 
Nm. Thus, the second aim was to use a range of purified human IgG concentrations 
to block all Fcγ receptor D2 binding sites, before assessing CRP enhanced uptake of 
Nm into human phagocytes.  
The third aim was to investigate which of the FcγRs is involved in CRP 
enhanced uptake of the meningococcus into human phagocytes with the use of 
blocking antibodies shown to be specific for FcγRI and II (Williams et al. 2004 and 
Woolhiser et al. 2004, respectively). These antibodies were pre-incubated with 
human phagocytic cells prior to analysis of any changes in CRP enhanced uptake of 
Nm into these particular cells.  
The final aim of this chapter was to visually confirm the interaction of CRP-
opsonised Nm with either receptor, further supporting the theory of FcγR 
involvement in this particular mode of CRP mediated pathogen clearance.  To this 
end, co-localisation experiments were carried out using fluorescently conjugated 
antibodies targeting FcγRI and II and GFP expressing Nm.  
 
4.2 Results 
4.2.1 The use of transfected siRNA duplexes in human phagocytes to 
investigate the effect of Fcγ receptor knock down on CRP-mediated uptake 
 In order to assess the involvement of Fcγ receptors in CRP mediated uptake 
of N. meningitidis into human phagocytic cells, various methods of transfection of 
short interference ribonucleic acid (siRNA) sequences (targeting the messenger RNA 
coding for the Fcγ receptors) into human phagocytic cells was attempted. The 
expectation was to significantly reduce or even completely eliminate expression of 
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these surface receptors in a highly specific manner. The human THP-1 cell line (PMA 
differentiated into a more macrophage-like state) was used initially to test the 
system of siRNA duplex transfection as primary cells are considered difficult to 
transfect (Jordan et al. 2008). The main goal, however, was to eventually use an 
optimised transfection protocol with primary human monocyte derived 
macrophages and dendritic cells, which would more closely resemble in vivo 
conditions of the innate stages of Nm infection. Once successful knock down of Fcγ 
receptors was established, transfected cells were then to be used in opsonisation 
and uptake experiments (as previously described) to test whether CRP-enhanced 
uptake of Nm is specific to any of these receptors. 
Short interfering RNA duplexes designed to target human FcγRI, FcγRIIa and 
FcγRIIb were used in all RNA interference (RNAi) experiments as detailed in section 
2.2.15.  RNAi experiments using siRNA duplexes targeting FcγRIIc and FcγRIIIb were 
not investigated as these receptors are not expressed by human macrophages or 
dendritic cells (Smith & Clatworthy 2010). The low affinity (for human IgG) 
activatory receptor FcγRIIIa is predominantly expressed by natural killer cells as well 
as macrophages and dendritic cells. The involvement of this receptor, however, 
with CRP mediated uptake of Nm into human phagocytes was not investigated as 
previous work has shown that CRP is either unable to or weakly binds this receptor 
(Tron et al. 2008, Devaraj et al. 2005 and Devaraj et al. 2006). In addition to this, 
FcγRIIIa is primarily involved in antibody-dependant cell-mediated cytotoxicity 
(ADCC) and associates with the zeta (ζ) chain of the  T cell receptor (TCR) CD3 
complex (Lanier et al. 1989) during the adaptive stages of immune infection. As the 
main focus of this thesis is investigating innate immune interactions during 
meningococcal infection, investigations involving this receptor would, therefore, be 
beyond the scope of this thesis. 
All RNAi experiments using siRNA duplexes included a separate negative 
“scrambled” siRNA duplex control; which is a non-targeting sequence and should 
not have any effect on the expression levels of the target mRNA thereby confirming 
the lack of non-specific targeting effects of transfected siRNA.  
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Following incubation with transfection reagents and prior to analysis of gene 
knock down, all cells were routinely checked for transfection toxicity; exposure to 
the following transfection methods never yielded more than 10% cell death as 
determined by cell counts with Trypan blue as per section 2.2.2.1. 
 
4.2.1.1 Transfection of siRNA duplexes into human phagocytic cells using 
Lipofectamine™ RNAiMAX  
 Lipofectamine™ RNAiMAX Transfection Reagent is composed of cationic 
liposomes (positively charged lipids) that are able to bind and encapsulate 
negatively charged siRNA duplexes. This complex with an outer positive charge is 
able to overcome the electrostatic repulsion of negatively charged eukaryotic cell 
membranes and help delivery of the siRNA duplexes into the cell (Dalby et al. 2004) 
with high efficiency and minimal cellular toxicity (Zhao et al. 2008) and was, 
therefore, an ideal choice of transfectant to begin with. In addition to this, an 
optimised protocol utilising this particular transfection reagent had been previously 
established by members of the group for the successful knock down of Fcγ 
receptors I and II in human endothelial cell lines and was, therefore, first attempted 
with the human THP-1 cell line, before moving on to primary human monocyte 
derived macrophages.   
 In order for THP-1 macrophages and monocyte derived macrophages to be 
30-50% confluent at the time of transfection (as advised by the Lipofectamine 
transfection protocol and previously verified in the lab) cells were prepared as per 
section 2.2.2 and 2.2.3 respectively, in 6 well plate formats to ensure easy collection 
of cells for subsequent analysis of gene knock down. To ensure minimum toxicity to 
the cells, a high transfection efficiency and low non-specific knock down effects, a 
range of final siRNA duplex concentrations (1, 10, 25 and 50nM) and Lipofectamine 
volumes (2.5, 5 and 7.5µl) were tested. Following the transfection procedure as per 
section 2.2.15.1 media was replaced after 4 hours with serum containing complete 
media and cells were incubated for a range of time points (24, 36 and 48 hours) 
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prior to assessment of gene knock down by reverse transcription polymerase chain 
reaction (RT-PCR).  
This method of gene knock down analysis was chosen as it can easily detect 
the presence of targeted messenger RNA (mRNA) following siRNA duplex 
transfection and the method had been previously established in the group. 
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as the endogenous 
reference gene in all RT-PCR assays; the mRNA levels of this gene should not alter 
regardless of the treatments applied to the cells, and was, therefore, used to 
normalize the targeted mRNA levels. No template controls (NTC) were used in all 
experiments, whereby all RT-PCR components for the reaction to take place were 
added except the template DNA. A positive result here indicated the presence of 
contaminating nucleic acids or that non-specific amplification had taken place. A 
second negative control, a no-reverse transcriptase (no-RT) control was also used 
where all reaction components are added except the enzyme reverse transcriptase, 
thereby providing a control at the point of RNA reverse transcription into 
complimentary DNA (cDNA). This determined that any amplification that occurred 
was due to synthesised cDNA and not contaminating DNA.   
 
Numerous optimisation experiments using Lipofectamine were carried out 
but a reduction in mRNA expression of FcγRI, FcγRIIa or FcγRIIb failed to be seen in 
any of these attempts. Representative agarose gel images from one such 
experiment (Figure 4.1), where PMA differentiated THP-1 macrophages were 
transfected with 50nM of siRNA targeting each FcγR for 24 hours, show the relative 
levels of the endogenous reference gene (GAPDH) remaining stable throughout 
each treatment (Figure 4.1A) and no changes in mRNA expression of FcγRI, FcγRIIa, 
or FcγRIIb (Figure 4.1B, C and D respectively). Similar results were observed when 
cells were treated with the selected range of siRNA duplex concentrations detailed 
above and incubated for 36 and 48 hours prior to gene knock down analysis (data 
not shown).  
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Figure 4.1 THP-1 macrophage FcγR mRNA detection following Lipofectamine transfection 
of siRNA duplexes. 
Representative agarose gel images of final siRNA duplex concentrations of 50nM targeting 
FcγRI (lane 6), FcγRIIa (lane 7), FcγRIIb (lane 8) and both FcγRIIa and IIb (lane 9) were 
incubated with Lipofectamine prior to transfection of PMA differentiated THP-1 
macrophages for 24 hours. Cells were also incubated with 50nM scrambled negative 
control siRNA (lane 5) or left untreated (lane 2). cDNA synthesised from isolated RNA was 
amplified using specific primers to GAPDH (A), FcγRI (B), FcγRIIa (C) and FcγRIIb (D). All PCR 
products were run on 1.5% TAE agarose gels alongside a 100bp DNA ladder (lane 1), a no 
template control (lane 3) and a no reverse transcriptase control (lane 4).  
 
Replicate protocols were conducted using primary human monocyte derived 
macrophages in an attempt to detect knock down of Fc gamma receptor gene 
expression. Upon analysis of the PCR products of macrophages transfected with 
50nM of each siRNA duplex targeting FcγRI, IIa and IIb for 24 hours, no change in 
the relative mRNA levels of any of the receptors was observed (Figure 4.2B-D).  
Primers targeting GAPDH showed that levels of this endogenous gene remained 
stable in each treatment (Figure 4.2A). Similar results were observed when cells 
were treated with the same selected range of siRNA duplex concentrations (1, 10 
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and 25nM) and incubated for 36 and 48 hours prior to gene knock down analysis 
(data not shown). 
 
 
 
Figure 4.2 Monocyte derived macrophage FcγR mRNA detection following Lipofectamine 
transfection of siRNA duplexes.  
Representative agarose gel images of final siRNA duplex concentrations of 50nM targeting 
FcγRI (lane 6), FcγRIIa (lane 7), FcγRIIb (lane 8) and both FcγRIIa and IIb (lane 9) were 
incubated with Lipofectamine prior to transfection of monocyte derived macrophages for 
24 hours. Cells were also incubated with 50nM scrambled negative control siRNA (lane 5) or 
left untreated (lane 2). cDNA synthesised from isolated RNA was amplified using specific 
primers to GAPDH (A), FcγRI (B), FcγRIIa (C) and FcγRIIb (D). All PCR products were run on 
1.5% TAE agarose gels alongside a 100bp DNA ladder (lane 1), a no template control (lane 
3) and a no reverse transcriptase control (lane 4).  
 
4.2.1.2 Transfection of siRNA duplexes into human phagocytic cells using 
electroporation 
Due to a lack of gene knock down using the transfectant reagent 
Lipofectamine, an alternative approach was adopted. Electroporation is a physical 
method of inducing cellular membranes to become temporarily more permeable by 
the application of external electrical impulses, thereby enhancing the transport of 
material (such as siRNA duplexes) across the membrane (Neumann et al. 1982) and 
has been shown to be more effective than lipofectant based transfection reagents 
(Maurisse et al. 2010 and Van Tendeloo 2001). Furthermore, electroporation has 
B 1        2       3      4         5      6       7      8       9
300bp
200bp
100bp FcγRI (111bp) 
GAPDH (189bp) 
A 1        2       3      4       5       6       7         8       9
300bp
200bp
100bp
C 1        2       3      4         5      6       7      8       9
300bp
200bp
100bp FcγRIIa (127bp) 
D 1         2      3       4         5      6       7      8       9
100bp
200bp
300bp
FcγRIIb (287bp) 
 
 
76 
 
previously been used to successfully transfect mammalian cells with Fcγ receptor 
targeting siRNA (Boonnak et al. 2013) and was therefore the next obvious avenue of 
investigation.  
 PMA differentiated THP-1 macrophages were prepared and transfected with 
a range of siRNA concentrations (1, 10, 25 and 50nM) using electroporation as 
described in section 2.2.15.2 whereby an exponential wave pulse of 250V and 
500µF (capacitance) was applied to the cells following the procedure of Jordan et al. 
2008. Transfected cells were incubated for either 24, 36 or 48 hours prior to 
analysis of gene knock down by RT-PCR as per section 2.2.16. 
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  Upon analysis of the PCR products of THP-1 macrophages transfected with 
50nM of each siRNA duplex targeting FcγRI, IIa and IIb for 24 hours, no change in 
the relative mRNA levels of any of the receptors was observed (Figure 4.3B-D).  
Primers targeting GAPDH showed that levels of this endogenous gene remained 
stable in each treatment (Figure 4.3A). Similar results were observed when cells 
were treated with the selected range of siRNA duplex concentrations detailed 
above and incubated for 36 and 48 hours prior to gene knock down analysis (data 
not shown). 
 
 
Figure 4.3 THP-1 macrophage FcγR mRNA detection following transfection of siRNA 
duplexes by electroporation 
Representative agarose gel images of final siRNA duplex concentrations of 50nM targeting 
FcγRI (lane 6), FcγRIIa (lane 7), FcγRIIb (lane 8) and both FcγRIIa and IIb (lane 9) were 
transfected into PMA differentiated THP-1 macrophages by electroporation and incubated 
for 24 hours. Cells were also electroporated with 50nM scrambled negative control siRNA 
(lane 5) or without any siRNA (lane 2). cDNA synthesised from isolated RNA was amplified 
using specific primers to GAPDH (A), FcγRI (B), FcγRIIa (C) and FcγRIIb (D). All PCR products 
were run on 1.5% TAE agarose gels alongside a 100bp DNA ladder (lane 1), a no template 
control (lane 3) and a no reverse transcriptase control (lane 4).  
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Monocyte derived macrophages were prepared and transfected with the 
same range of siRNA concentrations using electroporation as described in section 
2.2.15.2 whereby an exponential wave pulse of 250V and 500µF (capacitance) was 
applied to the cells. Transfected cells were incubated for either 24, 36 or 48 hours 
prior to analysis of gene knock down by RT-PCR as per sections 2.2.16.  
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
79 
 
 Upon analysis of the PCR products of monocyte derived macrophages 
transfected with 50nM of each siRNA duplex targeting FcγRI, IIa and IIb for 24 
hours, no change in the relative mRNA levels of any of the receptors was observed 
(Figure 4.4B-D).  Primers targeting GAPDH showed some variation in band intensity 
between lanes (Figure 4.4A), however, overall there was no constant pattern 
detected across each replicate gel, thus showing levels of this endogenous gene 
remained comparatively stable in each treatment. Similar results were observed 
when cells were treated with the same selected range of siRNA duplex 
concentrations and incubated for 36 and 48 hours prior to gene knock down 
analysis (data not shown). 
 
Figure 4.4 Monocyte derived macrophage FcγR mRNA detection following transfection of 
siRNA duplexes by electroporation 
Representative agarose gel images of final siRNA duplex concentrations of 50nM targeting 
FcγRI (lane 6), FcγRIIa (lane 7), FcγRIIb (lane 8) and both FcγRIIa and IIb (lane 9) were 
transfected into monocyte derived macrophages by electroporation and incubated for 24 
hours. Cells were also electroporated with 50nM scrambled negative control siRNA (lane 5) 
or without any siRNA (lane 2). cDNA synthesised from isolated RNA was amplified using 
specific primers to GAPDH (A), FcγRI (B), FcγRIIa (C) and FcγRIIb (D). All PCR products were 
run on 1.5% TAE agarose gels alongside a 100bp DNA ladder (lane 1), a no template control 
(lane 3) and a no reverse transcriptase control (lane 4). 
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RT-PCR is a good method of detecting relative changes in mRNA expression, 
but does not give an accurate representation of expected protein levels (Holmes et 
al. 2010a) especially in the case of cell surface receptors. The preferred method of 
detecting gene knock down for these proteins is therefore Western blotting as it 
uses specific antibodies to recognise the targeted gene product (Elbashir et al. 
2002).  This is ultimately the main goal of using siRNA duplexes; to induce a 
decrease in expression of Fc gamma receptors on the surface of human phagocytes 
and therefore, this approach was adapted for subsequent analyses.  
 Following electroporation of siRNA duplexes into the cells, all transfected 
cultures were incubated for a minimum of 24 hours. Some transient effects of RNA 
interference can be detected after 4 hours but maximum down regulation is 
observable between 24-48 hours and can last up to 9 days following transfection, 
although the likelihood of primary cells surviving this long is low (Elbashir et al. 
2002). Previous work has shown protein knock down of Fc receptors at 24 (Kramer 
et al. 2010), 48 (Chan et al. 2011) and 72 hours (Yang et al. 2007) following 
transfection, therefore, reduction in Fcγ receptor expression in human monocyte 
derived macrophages and dendritic cells was analysed at each of these time points 
post transfection by Western blotting.  
 Antibodies recognising FcγRI (mouse anti-human CD64) and FcγRII (mouse 
anti-human CD32) were used to detect the relative protein levels of these receptors 
and were normalised to levels of beta (β)-actin, which should not vary due to 
different treatments. β-actin was, therefore, also used as a loading control to 
ensure equal amounts of protein sample was loaded during SDS-PAGE prior to 
Western blotting. Whilst specific antibodies to FcγRIIa and FcγRIIb are available, a 
single antibody capable of targeting all isoforms of FcγRII (Sandilands et al. 1997) 
was used preliminarily. If protein knock down of this particular receptor was 
observed, repeat experiments were to be performed using the higher specificity 
antibodies.    
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 Monocyte derived macrophages were prepared and transfected with the 
same siRNA concentrations using electroporation as described in section 2.2.15.2 
whereby an exponential wave pulse of 250V and 500µF (capacitance) was applied 
to the cells. Transfected cells were incubated for either 24, 48 or 72 hours prior to 
analysis of gene knock down by Western blotting as per sections 2.2.17. 
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  Upon analysis of whole cell protein lysates taken from monocyte derived 
macrophages transfected with 50nM of each siRNA duplex targeting FcγRI, IIa and 
IIb for 72 hours, no change in the relative protein levels of any of the receptors was 
observed (Figure 4.5 B and D).  Anti-β-actin levels showed that this highly conserved 
protein appeared by eye to be ubiquitously expressed following each treatment and 
that a consistent amount of protein was loaded per lane prior to SDS-PAGE (Figure 
4.5 A and C). Similar results were observed when cells were treated with the same 
selected range of siRNA duplex concentrations and incubated for 24 and 48 hours 
prior to protein knock down analysis (data not shown). 
 
Figure 4.5 Representative immunoblots of monocyte derived macrophage FcγR protein 
level detection following transfection of siRNA duplexes by electroporation 
Final siRNA duplex concentrations of 50nM targeting FcγRI (lane 4), FcγRIIa (lane 5), FcγRIIb 
(lane 6) and both FcγRIIa and IIb (lane 7) were transfected into monocyte derived 
macrophages by electroporation and incubated for 72 hours. Cells were also electroporated 
with 50nM scrambled negative control siRNA (lane 3) or without any siRNA (lane 2). Whole 
cell protein lysates were separated by SDS-PAGE alongside a DualVue Western Blotting 
Marker (lane 1), transferred to PVDF membranes and immunoblotted with antibodies 
targeting β-actin (A and C), FcγRI (B) and FcγRII (D). 
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Monocyte derived dendritic cells were prepared and transfected with the 
same range of siRNA concentrations using electroporation as described in section 
2.2.15.2 whereby an exponential wave pulse of 250V and 500µF (capacitance) was 
applied to the cells. Transfected cells were incubated for either 24, 48 or 72 hours 
prior to analysis of gene knock down by Western blotting as per section 2.2.17. 
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  Upon analysis of whole cell protein lysates taken from monocyte derived 
dendritic cells transfected with 50nM of each siRNA duplex targeting FcγRI, IIa and 
IIb for 72 hours, no change in the relative protein levels of any of the receptors was 
observed (Figure 4.6B and C).  Anti-β actin levels showed that this highly conserved 
protein was ubiquitously expressed following each treatment and that a consistent 
amount of protein was loaded per lane prior to SDS-PAGE (Figure 4.6A). Similar 
results were observed when cells were treated with the same range of siRNA duplex 
concentrations and incubated for 24 and 48 hours prior to protein knock down 
analysis (data not shown). 
 
Figure 4.6 Representative immunoblots of monocyte derived dendritic cell FcγR protein 
level detection following transfection of siRNA duplexes by electroporation 
Final siRNA duplex concentrations of 50nM targeting FcγRI (lane 4), FcγRIIa (lane 5), FcγRIIb 
(lane 6) and both FcγRIIa and IIb (lane 7) were transfected into monocyte derived dendritic 
cells by electroporation and incubated for 72 hours. Cells were also electroporated with 
50nM scrambled negative control siRNA (lane 3) or without any siRNA (lane 2). Whole cell 
protein lysates were separated by SDS-PAGE alongside a DualVue Western Blotting Marker 
(lane 1), transferred to PVDF membranes and immunoblotted with antibodies targeting β-
actin (A), FcγRI (B) and FcγRII (C). 
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4.2.1.3 Transfection of siRNA duplexes into human phagocytic cells using using 
INTERFERin® 
 Another approach documented in the literature for successful knock down 
of protein expression in primary monocyte derived macrophages and dendritic cells 
is achieved with another type of lipid based transfectant, INTERFERin® (Bergamaschi 
et al. 2009 and Liu et al. 2010 respectively) which was selected following the use of 
electroporation.  
Optimisation experiments were carried out where a range of INTERFERin® 
volumes (4, 8 and 12µl) were tested in combination with the same range of siRNA 
concentrations to maximise transfection efficiency and minimise effects on cell 
viability as recommended by the manufacturer. Monocyte derived macrophages 
were prepared and transfected with the siRNA duplexes using INTERFERin® as 
described in 2.2.15.3 and were incubated for either 24, 48 or 72 hours prior to 
analysis of gene knock down by Western blotting as per section 2.2.17. 
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Upon analysis of whole cell protein lysates taken from monocyte derived 
macrophages transfected with 50nM of each siRNA duplex using 12µl of 
INTEREFRin® targeting FcγRI, IIa and IIb for 72 hours, no change in the relative 
protein levels of any of the receptors was observed (Figure 4.7B and C).  Anti-β-actin 
levels showed that this highly conserved protein was consistently expressed 
following each treatment and that the same amount of protein was loaded per lane 
prior to SDS-PAGE (Figure 4.7A). Similar results were observed when cells were 
treated with the selected range of siRNA duplex concentrations detailed above in 
combination with different amount of INTERFERin® and incubated for 24 and 48 
hours prior to protein knock down analysis (data not shown). 
 
 
Figure 4.7 Representative immunoblots of monocyte derived macrophage cell FcγR 
protein level detection following transfection of siRNA duplexes using INTERFERin 
Final siRNA duplex concentrations of 50nM targeting FcγRI (lane 4), FcγRIIa (lane 5), FcγRIIb 
(lane 6) and both FcγRIIa and IIb (lane 7) were transfected into monocyte derived 
macrophage cells using INTERFERin and incubated for 72 hours. Cells were also transfected 
with 50nM scrambled negative control siRNA (lane 3) or without any siRNA (lane 2). Whole 
cell protein lysates were separated by SDS-PAGE alongside a DualVue Western Blotting 
Marker (lane 1), transferred to PVDF membranes and immunoblotted with antibodies 
targeting β-actin (A), FcγRI (B) and FcγRII (C). 
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Monocyte derived dendritic cells were prepared and transfected with the 
siRNA duplexes using a range (4, 8 or 12µl) of INTERFERin® volumes as described 
above. 
 Upon analysis of whole cell protein lysates taken from monocyte derived 
dendritic cells transfected with 50nM of each siRNA duplex using 12µl of 
INTEREFRin® targeting FcγRI, IIa and IIb for 72 hours, no change in the relative 
protein levels of any of the receptors was observed (Figure 4.78B and C).  Anti-β- 
actin levels showed that this highly conserved protein was consistently expressed 
following each treatment and that the same amount of protein was loaded per lane 
prior to SDS-PAGE (Figure 4.8A). Similar results were observed when cells were 
treated with the selected range of siRNA duplex concentrations detailed above in 
combination with different amount of INTERFERin® and incubated for 24 and 48 
hours prior to protein knock down analysis (data not shown). 
 
Figure 4.8 Representative immunoblots of monocyte derived dendritic  cell FcγR protein 
level detection following transfection of siRNA duplexes using INTERFERin 
Final siRNA duplex concentrations of 50nM targeting FcγRI (lane 4), FcγRIIa (lane 5), FcγRIIb 
(lane 6) and both FcγRIIa and IIb (lane 7) were transfected into monocyte derived 
macrophage cells using INTERFERin and incubated for 72 hours. Cells were also transfected 
with 50nM scrambled negative control siRNA (lane 3) or without any siRNA (lane 2). Whole 
cell protein lysates were separated by SDS-PAGE alongside a DualVue Western Blotting 
Marker (lane 1), transferred to PVDF membranes and immunoblotted with antibodies 
targeting β-actin (A), FcγRI (B) and FcγRII (C). 
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4.2.1.4 Transfection of siRNA duplexes into human phagocytic cells using using 
DharmaFECT 
The last and final approach to RNA interference was attempted using the 
lipid-based transfectant reagent, DharmaFECT.  This was recommended due to it 
having been previously used to successfully knock down protein expression in 
human monocyte derived macrophages (Fontaine et al. 2007 and Wang et al. 2009) 
and dendritic cells (Cao et al. 2008). However, due to time constraints, this method 
was only attempted with monocyte derived macrophages. In the event of success, 
this protocol would have been replicated in monocyte derived dendritic cells.  
Optimisation experiments were carried out where a range of DharmaFECT 
volumes (1, 2.5, 5 and 10µl) were tested in combination with the same range of 
siRNA concentrations to maximise transfection efficiency and minimise effects on 
cell viability. Monocyte derived macrophages were prepared and transfected with 
the siRNA duplexes using DharmaFECT as described in 2.2.15.4 and were incubated 
for either 24, 48 or 72 hours prior to analysis of gene knock down by Western 
blotting as per section 2.2.17. 
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  Upon analysis of whole cell protein lysates taken from monocyte derived 
macrophages transfected with 50nM of each siRNA duplex using 10µl of 
DharmaFECT targeting FcγRI, IIa and IIb for 72 hours, no change in the relative 
protein levels of any of the receptors was observed (Figure 4.9B and C).  Anti-β-actin 
levels showed that this highly conserved protein was ubiquitously expressed 
following each treatment and that a consistent amount of protein was loaded per 
lane prior to SDS-PAGE (Figure 4.9A). Similar results were observed when cells were 
treated with the selected range of siRNA duplex concentrations detailed above and 
incubated for 24 and 48 hours prior to protein knock down analysis (data not 
shown). 
 
 
 
Figure 4.9 Representative immunoblots of monocyte derived macrophage cell FcγR 
protein level detection following transfection of siRNA duplexes using DharmaFECT 
Final siRNA duplex concentrations of 50nM targeting FcγRI (lane 4), FcγRIIa (lane 5), FcγRIIb 
(lane 6) and both FcγRIIa and IIb (lane 7) were transfected into monocyte derived 
macrophage cells using DharmaFECT and incubated for 72 hours. Cells were also 
transfected with 50nM scrambled negative control siRNA (lane 3) or without any siRNA 
(lane 2). Whole cell protein lysates were separated by SDS-PAGE alongside a DualVue 
Western Blotting Marker (lane 1), transferred to PVDF membranes and immunoblotted 
with antibodies targeting β-actin (A), FcγRI (B) and FcγRII (C). 
 
A 1        2      3      4       5        6       7
25KDa
35KDa
50KDa
β-Actin (42KDa) 
B 1        2       3       4       5        6       7
75KDa
50KDa
35KDa
FcγRI (72KDa) 
35KDa
C 1       2       3       4       5        6       7
50KDa
75KDa
FcγRII (36KDa) 
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4.2.2 Immunoglobulin G blocking of Fc gamma receptor mediated uptake 
of N. meningitidis into phagocytic cells   
  Following the unsuccessful attempts to knock down gene expression of Fcγ 
receptors in phagocytic cells to investigate their role in CRP-mediated uptake of 
Nm, an alternative approach was used. The combined involvement of all the Fcγ 
receptors was assessed using a range of purified human immunoglobulin G (IgG) 
concentrations to inhibit uptake of Nm into human THP-1 macrophages (as a 
reproducible model), human monocyte derived macrophages and dendritic cells.   
 
4.2.2.1 Immunoglobulin G blocking of Fc gamma receptors in human THP-1 
derived macrophages 
 PMA differentiated human THP-1 cells macrophages were pre-incubated 
with a range of purified human IgG concentrations (0.1, 1 and 10µg/ml). Fixed 
cultures of GFP-expressing Nm were prepared as per section 2.2.1 prior to 
undergoing opsonisation with either PBS (negative control), 50% NHS (positive 
control) or 50µg/ml CRP. Unopsonised, NHS pre-treated and CRP opsonised 
Neisseria meningitis were incubated with THP-1 macrophages for 2 hours to allow 
phagocytosis to occur.  
Upon analysis of 4 replicate experiments, incubation of purified human IgG 
with THP-1 cells prior to incubation with Nm pre-treated with NHS and CRP-
opsonised Nm decreased bacterial association with the cells as the concentration of 
IgG increased (Figure 4.10A). This decrease was significant in cells pre-incubated 
with 10µg/ml of human IgG followed by uptake with NHS pre-treated Nm 
(p=0.0234) and with 10μg/ml and 1μg/ml of human IgG followed by uptake with 
CRP-opsonised Nm (p<0.0001 and p<0.0141 respectively). Although not statistically 
significant, a decrease in association was also observed in cells incubated with Nm 
opsonised with PBS alone when pre-treated with human IgG. No significant 
differences were observed in the number of bacteria per cell with any of the 
treatments (Figure 4.10B). 
 
 
91 
 
 
 
Figure 4.10 The effect of pre-incubation of human THP-1 macrophages with IgG on CRP 
enhanced uptake of Nm  
PMA differentiated THP-1 macrophages were pre-incubated with a range of concentrations 
of purified human IgG (filled bars) followed by incubation with unopsonised, NHS pre-
treated and CRP-opsonised GFP expressing Nm for 2 hours followed by confocal microscopy 
analysis of uptake with the meningococci. The mean + SD of 4 replicate experiments are 
shown for (A) percent of cells associating with bacteria and (B) the number of bacteria 
associating per cell. Where *, ** and **** denote p<0.05, p<0.005 and p<0.0001 upon 
comparison with unblocked uptake (striped bars) respectively.  
 
4.2.2.2 Immunoglobulin G blocking of Fc gamma receptors in human monocyte 
derived macrophages 
 Following establishment of significant blocking in THP-1 derived 
macrophages, human monocyte derived macrophages were pre-incubated with a 
range of purified human IgG concentrations (0.1, 1 and 10µg/ml). Fixed cultures of 
GFP-expressing Nm were pre incubated as detailed above. Unopsonised, NHS pre-
treated and CRP opsonised Neisseria meningitis were incubated with monocyte 
derived macrophages for 2 hours to allow for phagocytosis to occur.  
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 Upon analysis of 4 donors, pre-incubation of monocyte derived 
macrophages with human IgG decreased the percent of cells associating with both 
NHS pre-treated and CRP opsonised Nm as the concentration of IgG increased 
(Figure 4.11A), statistically significantly with 10µg/ml of human IgG (p=0.0165 and 
p=0.0172 respectively). No statistically significant differences in association 
between cells and PBS opsonised Nm were seen following IgG pre-incubation. 
Following analysis of the number of meningococci per macrophage cell, no 
significant differences were observed with any of the treatments (Figure 4.11B). 
 
Figure 4.11 The effect of pre-incubation of human monocyte derived macrophages with 
IgG on CRP enhanced uptake of Nm  
Monocyte derived macrophages were pre-incubated with a range of concentrations of 
purified human IgG (filled bars) followed by incubation with unopsonised, NHS pre-treated 
and CRP-opsonised GFP expressing Nm for 2 hours followed by confocal microscopy 
analysis of uptake with the meningococci. The mean + SD of 4 donors are shown for (A) 
percent of cells associating with bacteria and (B) the number of bacteria associating per 
cell. Where * and ** denote p<0.05 and p<0.005 upon comparison with unblocked uptake 
(striped bars) respectively.  
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4.2.2.3 Immunoglobulin G blocking of Fc gamma receptors in human monocyte 
derived dendritic cells 
 Human monocyte derived dendritic cells (DCs) were pre-incubated with a 
range of purified human IgG concentrations and fixed cultures of GFP-expressing 
Nm were pre-incubated as detailed above. Unopsonised, NHS pre-treated and CRP 
opsonised Neisseria meningitis were incubated with monocyte derived dendritic 
cells for 2 hours to allow for phagocytosis to occur.  
Upon analysis of 4 donors, pre-incubation of DCs with human IgG had a 
significant effect on the percent of DCs associating with meningococci (Figure 
4.12A); as the concentration of IgG increased, association of DCs with NHS pre-
treated Nm significantly decreased, most notably when DCs were pre-incubated 
with 10µg/ml of human IgG (p=0.0317). This effect was most profound in cells 
associating with CRP opsonised Nm, where association was significantly reduced 
upon each IgG concentration (10µg/ml, 1μg/ml and 0.1μg/ml: p<0.0001, p<0.0003 
and p<0.0015 respectively). Interestingly, significant decreases in PBS opsonised Nm 
was observed at 1 and 10µg/ml (p=0.052 and p=0.0015 respectively). No significant 
differences were observed in the number of bacteria per DC with any of the 
treatments (Figure 4.12B). 
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Figure 4.12 The effect of pre-incubation of human monocyte derived dendritic cells with  
IgG on CRP enhanced uptake of Nm  
Monocyte derived dendritic cells were pre-incubated with a range of concentrations of 
purified human IgG (filled bars) followed by incubation with unopsonised, NHS pre-treated 
and CRP-opsonised GFP expressing Nm for 2 hours followed by confocal microscopy 
analysis of uptake with the meningococci. The mean + SD of 4 donors are shown for (A) 
percent of cells associating with bacteria and (B) the number of bacteria associating per 
cell. Where *, **, *** and **** denote p<0.05, p<0.005, p<0.0005 and p<0.0001 upon 
comparison with unblocked uptake (striped bars) respectively.  
 
4.2.3 Anti-Fc gamma receptor I and II antibody blocking of Fc gamma 
receptors in human phagocytic cells and subsequent effects on CRP 
enhanced association with Nm 
Having demonstrated the involvement of Fc gamma (γ) receptors in CRP-
enhanced meningococcal uptake into phagocytic cells, the finer specificity for FcγRs 
was investigated. Specific antibodies to FcγRI (CD64) and FcγRII (CD32) were used to 
bind and block the high and low affinity Fcγ receptors respectively expressed by 
human monocyte derived macrophages and dendritic cells. Isotype matched 
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controls were similarly tested in order to confirm the specificity of each antibody 
and to rule out any non specific Fc binding or other cellular protein interactions. 
In order to further control for any non specific binding of FcγRs by the Fc 
portion of the blocking antibodies, F(ab’)2 fragment preparations of each blocking 
antibody were prepared as described in section 2.2.13 and tested alongside their 
whole counterparts. Successful cleavage was confirmed using SDS-PAGE whereby 
under reducing conditions, the IgG light chain of whole antibodies migrated at 
25kDa and the heavy chain migrated at 50KDa, whereas reduced F(ab’)2 fragments 
migrated at 25KDa. Figure 4.13 demonstrates the successful cleavage of both anti-
human CD64 (FcγRI, Figure 4.13A) and anti-human CD32 (FcγRII, Figure 4.13B).  
 
 
 
Figure 4.13 Reducing SDS-PAGE gel (12.5%) assessing anti-human FcγRI and II antibody 
F(ab’)2 fragmentation. 
2µg of either mouse anti-human FcγRI (A2) or mouse anti-human FcγRII (B2) whole 
antibody was run alongside 1µg (A3 and B3) and 2µg (A4 and B4) of F(ab’)2 digests of each 
antibody. A relative molecular marker (10-200KDa) was loaded in lane 1 to determine band 
sizes. Gels were visualised with PageBlue Coomassie stain.  
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4.2.3.1 The effect of anti-Fc gamma receptor I (high affinity, CD64) antibody 
blocking of human monocyte derived macrophage uptake of meningococci 
 Human monocyte derived macrophages were cultured for 5 days as 
described in 2.2.2 followed by pre-incubation with a range of concentrations of 
either a mouse isotype matched control, a mouse anti-human CD64 or a F(ab’)2 
preparation of the  mouse anti-human CD64. Fixed cultures of GFP-expressing Nm 
were pre incubated as detailed above. Unopsonised, NHS pre-treated and CRP 
opsonised Neisseria meningitis were incubated with monocyte derived 
macrophages for 2 hours to allow for phagocytosis to occur.  
For ease of comparison between macrophages pre-incubated with either the 
isotype control, mouse anti human CD64 or the F(ab’)2 preparation of the mouse 
anti human CD64, the results for unblocked macrophages incubated with 
unopsonised (PBS), NHS pre-treated or CRP-opsonised Nm (black bars) are repeated 
in Figures 4.14, 4.15 and 4.16. 
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To control for non-specific binding of the mouse anti-human CD64 antibody 
the effect of a mouse IgG1 isotype control on CRP enhanced association of Nm with 
human macrophages was investigated. Upon analysis of 3 donors, pre-incubation of 
monocyte derived macrophages with a range of concentrations of the isotype 
matched control to the mouse anti-human CD64 did not significantly change the 
percent of cells associating with either unopsonised, NHS pre-treated or CRP-
opsonised Nm (Figure 4.14A).  
 No significant changes in the number of meningococci per macrophage cell 
were observed with any of the other treatments (Figure 4.14B). 
 
Figure 4.14 The effect of pre-incubation with isotype matched control antibodies (for 
anti-FcγRI) on CRP enhanced uptake of Nm into human monocyte derived macrophages 
Monocyte derived macrophages were either left unblocked (black bars) or pre-incubated 
with a range of concentrations of an isotype matched control (red bars) followed by 
incubation with unopsonised, NHS pre-treated and CRP-opsonised GFP expressing Nm for 2 
hours followed by confocal microscopy analysis of uptake of meningococci. The mean + SD 
of 3 donors are shown for (A) percent of cells associating with bacteria and (B) the number 
of bacteria associating per cell.  
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The effect of adding the blocking antibody mouse anti-human CD64 on CRP 
enhanced association of Nm with human macrophages was investigated. Upon 
analysis of 3 donors, pre-incubation of monocyte derived macrophages with whole 
mouse anti-human CD64 antibodies significantly decreased the percent of 
macrophages associating with CRP-opsonised Nm at 10µg/ml (p=0.0234, Figure 
4.15A). A decrease in cell association with NHS pre-treated Nm was also observed at 
10µg/ml of anti-human CD64, however this decrease was not statistically significant 
when compared to the unblocked association.  
No significant changes in the number of meningococci per macrophage cell 
were observed with any of the other treatments (Figure 4.15B). 
 
Figure 4.15 The effect of pre-incubation with anti-human CD64 antibody on CRP 
enhanced uptake of Nm into human monocyte derived macrophages 
Monocyte derived macrophages were pre-incubated with a range of concentrations of 
mouse anti-human CD64 antibody (red bars) followed by incubation with unopsonised, NHS 
pre-treated and CRP-opsonised GFP expressing Nm for 2 hours followed by confocal 
microscopy analysis of uptake with the meningococci. The mean + SD of 3 donors are 
shown for (A) percent of cells associating with bacteria and (B) the number of bacteria 
associating per cell. Where * denotes p<0.05 upon comparison with unblocked uptake 
(black bars). 
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To further control for specificity of the blocking of CD64 via the Fc portion of 
the mouse anti-human CD64 antibody the effect of a F(ab’)2 preparation of the 
mouse anti-human CD64 antibody on CRP enhanced association of Nm with human 
macrophages was investigated. 
 Pre-incubation of human monocyte derived macrophages with F(ab’)2  
preparations of the mouse anti-human CD64 antibody resulted in a decrease of 
macrophage association with CRP opsonised Nm as the concentration of F(ab’)2 
preparations of anti-human CD64 increased (Figure 4.16A), with a significant 
decrease seen at 10µg/ml (p=0.0394). Pre-incubation of macrophages with F(ab’)2 
preparations of anti-human CD64 had no significant effect on the association of 
these cells with unopsonised or NHS pre-treated meningococci.  
 Pre-incubation of human macrophages with F(ab’)2  preparations of anti-
human CD64 had no significant effect on the number of bacteria per macrophage 
with any of the treatments (Figure 4.16B). 
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Figure 4.16 The effect of pre-incubation with F(ab’)2 preparations of the anti-human CD64 
antibody on CRP enhanced uptake of Nm into human monocyte derived macrophages 
Monocyte derived macrophages were pre-incubated with a range of concentrations of 
F(ab’)2 preparations of mouse anti-human CD64 antibody (red bars) followed by incubation 
with unopsonised, NHS pre-treated and CRP-opsonised GFP expressing Nm for 2 hours 
followed by confocal microscopy analysis of uptake with the meningococci. The mean + SD 
of 3 donors are shown for (A) percent of cells associating with bacteria and (B) the number 
of bacteria associating per cell. Where * denotes p<0.05 upon comparison with unblocked 
uptake (black bars). 
  
4.2.3.2 The effect of anti-Fc gamma receptor II (low affinity, CD32) antibody 
blocking in human monocyte derived macrophages on meningococcal uptake  
 The specificity of CRP enhanced uptake into monocyte derived macrophages 
for the lower affinity Fcγ receptor (FcγRII) was investigated as follows: Human 
monocyte derived macrophages were cultured for 5 days as described in 2.2.2 
followed by pre-incubation with a range of concentrations of either a mouse isotype 
matched control, mouse anti-human CD32 or a F(ab’)2  preparation of the mouse 
anti-human CD32 antibody. Fixed cultures of GFP-expressing Nm were pre 
 
 
101 
 
incubated as detailed above. Unopsonised, NHS pre-treated and CRP opsonised 
Neisseria meningitis were incubated with monocyte derived macrophages for 2 
hours to allow for phagocytosis to occur.  
For ease of comparison between macrophages pre-incubated with either an 
isotype matched control, mouse anti-human CD32 or a  F(ab’)2 preparation of the  
mouse anti-human CD32 antibody, the results for unblocked macrophages 
incubated with unopsonised (PBS), NHS pre-treated or CRP-opsonised Nm (black 
bars) are repeated in Figures 4.17, 4.18 and 4.19.  
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To control for non-specific binding of the Fc portion of anti-CD32 antibody to 
FcγRII the effect of a mouse IgG2B isotype control on CRP enhanced association of 
Nm with human macrophages was investigated. Upon analysis of 3 donors, pre-
incubation of monocyte derived macrophages with a range of concentrations of an 
isotype matched control to mouse anti-human CD32 had no significant effect in the 
percent of macrophages associating with Nm. Although some variability in uptake 
and number of bacteria per cell were observed, when compared to the unblocked 
cells, no significant differences in percentage association or number of bacteria per 
cell were seen (Figure 4.17A and 4.17B respectively). 
 
Figure 4.17 The effect of pre-incubation with isotype matched control antibodies (for anti-
FcγRII) on CRP enhanced uptake of Nm into human monocyte derived macrophages 
Monocyte derived macrophages were either left unblocked (black bars) or pre-incubated 
with a range of concentrations of the mouse IgG2B isotype matched control (red bars) 
followed by incubation with unopsonised, NHS pre-treated and CRP-opsonised GFP 
expressing Nm for 2 hours followed by confocal microscopy analysis of uptake with the 
meningococci. The mean + SD of 3 donors are shown for (A) percent of cells associating 
with bacteria and (B) the number of bacteria associating per cell.  
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The effect of mouse anti-human CD32 on CRP enhanced association of Nm 
with human macrophages was investigated. Pre-incubation of human monocyte 
derived macrophages with whole mouse anti-human CD32 had a significant effect 
on the percentage of macrophages associating with NHS pre-treated Nm at 10µg/ml 
in comparison with unblocked macrophages (p=0.0068, Figure 4.18A). This decrease 
in association was also observed between macrophages and CRP-opsonised Nm, 
significantly when the cells were pre-incubated with 5µg/ml (p<0.0001) and 
10µg/ml (p<0.0001) of α-human CD32.  
 No significant differences were observed in the number of bacteria per 
macrophage cell with any of the treatments (Figure 4.18B). 
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Figure 4.18 The effect of pre-incubation with anti-human CD32 antibody on CRP 
enhanced uptake of Nm into human monocyte derived macrophages 
Monocyte derived macrophages were pre-incubated with a range of concentrations of 
mouse anti-human CD32 (red bars) followed by incubation with unopsonised, NHS pre-
treated and CRP-opsonised GFP expressing Nm for 2 hours followed by confocal microscopy 
analysis of uptake with the meningococci. The mean + SD of 3 donors are shown for (A) 
percent of cells associating with bacteria and (B) the number of bacteria associating per 
cell. Where ** and **** denotes p<0.005 and p<0.0001 upon comparison with unblocked 
uptake (black bars) respectively. 
  
A further control for Fc binding of the blocking antibody to FcγRII was 
performed by investigating the effect of a F(ab’)2 preparation of the mouse anti-
human CD32 antibody on CRP enhanced association of Nm with human 
macrophages. It was observed that pre-incubation of monocyte derived 
macrophages with the F(ab’)2 preparation of the anti-human CD32 antibody 
significantly reduced the percentage of macrophages associating with CRP-
opsonised Nm as the concentration of the F(ab’)2 preparations of the anti-human 
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CD32 antibody increased (Figure 4.19A) significantly with 10µg/ml (p=0.0017). This 
effect was not seen in macrophages associating with unopsonised or NHS pre-
treated Nm.  
 No significant differences in the number of associating bacteria per 
macrophage were seen with any of the treatments (Figure 4.19B). 
 
Figure 4.19 The effect of pre-incubation with F(ab’)2 preparations of the anti-human CD32 
antibody on CRP enhanced uptake of Nm into human monocyte derived macrophages 
Monocyte derived macrophages were pre-incubated with a range of concentrations of 
F(ab’)2 preparations of mouse anti-human CD32 antibody (red bars) followed by incubation 
with unopsonised, NHS pre-treated and CRP-opsonised GFP expressing Nm for 2 hours 
followed by confocal microscopy analysis of uptake with the meningococci. The mean + SD 
of 3 donors are shown for (A) percent of cells associating with bacteria and (B) the number 
of bacteria associating per cell. Where ** denotes p<0.005 upon comparison with 
unblocked uptake (black bars). 
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4.2.3.3 The effect of anti-Fc gamma receptor I, high affinity (CD64) antibody 
blocking in human monocyte derived dendritic cells on meningococcal uptake  
 The specificity of CRP enhanced uptake into monocyte derived dendritic cells 
for the high affinity Fcγ receptor, FcγRI was investigated as follows: Human 
monocyte derived dendritic cells were cultured for 5 days as described in 2.2.2 
followed by pre-incubation with a range of concentrations of either an isotype 
matched control, mouse anti-human CD64 or a F(ab’)2 preparation of the mouse 
anti-human CD64 antibody. Fixed cultures of GFP-expressing Nm were pre 
incubated as detailed above. Unopsonised, NHS pre-treated and CRP opsonised 
Neisseria meningitis were incubated with monocyte derived dendritic cells for 2 
hours to allow for phagocytosis to occur.  
For ease of comparison between dendritic cells pre-incubated with either an 
IgG1 isotype matched control, mouse anti-human CD64 or the F(ab’)2  preparation of 
the mouse anti-human CD64 antibody, the results for unblocked dendritic cells 
incubated with unopsonised (PBS), NHS pre-treated or CRP-opsonised Nm (black 
bars) are repeated in Figures 4.20, 4.21 and 4.22.  
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To control for non-specific Fc binding of the anti-FcγRI antibody to the Fcγ 
receptors, the effect of mouse IgG1 isotype control on CRP enhanced association of 
Nm with human dendritic cells was investigated. Pre-incubation of monocyte 
derived dendritic cells with a range of concentrations of the isotype matched 
control to the mouse anti-human CD64 did not significantly change the percent of 
cells associating with either unopsonised, NHS pre-treated or CRP-opsonised Nm as 
the concentration of the isotype control increased (Figure 4.20A).  
 No significant changes in the number of meningococci per dendritic cell 
were observed with any of the other treatments (Figure 4.20B). 
 
Figure 4.20 The effect of pre-incubation with isotype matched control antibodies (anti-
FcγRI) on CRP enhanced uptake of Nm into human monocyte derived dendritic cells 
Monocyte derived dendritic cells were either left unblocked (black bars) or pre-incubated 
with a range of concentrations of the mouse IgG1 isotype matched control (green bars) 
followed by incubation with unopsonised, NHS pre-treated and CRP-opsonised GFP 
expressing Nm for 2 hours followed by confocal microscopy analysis of uptake with the 
meningococci. The mean + SD of 3 donors are shown for (A) percent of cells associating 
with bacteria and (B) the number of bacteria associating per cell.  
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The effect of mouse anti-human CD64 blocking antibodies on CRP enhanced 
association of Nm with human dendritic cells was investigated. Pre-incubation of 
monocyte derived dendritic cells with whole mouse anti-human CD64 antibodies 
significantly decreased the percent of DCs associating with CRP-opsonised Nm at 
10µg/ml of anti-human CD64 in comparison to unblocked DCs (p=0.0030, Figure 
4.21A). No significant changes in the number of bacteria per cell was observed with 
any of the treatments (Figure 4.21B). 
 
Figure 4.21 The effect of pre-incubation with anti-human CD64 antibody on CRP 
enhanced uptake of Nm into human monocyte derived dendritic cells 
Monocyte derived dendritic cells were pre-incubated with a range of concentrations of 
mouse anti-human CD64 antibody (green bars) followed by incubation with unopsonised, 
NHS pre-treated and CRP-opsonised GFP expressing Nm for 2 hours followed by confocal 
microscopy analysis of uptake with the meningococci. The mean + SD of 3 donors are 
shown for (A) percent of cells associating with bacteria and (B) the number of bacteria 
associating per cell. Where ** denotes p<0.005 upon comparison with unblocked uptake 
(black bars). 
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A second control antibody in the form of a F(ab’)2 preparation of mouse 
anti-human CD64 antibody was tested on the CRP enhanced association of Nm with 
human dendritic cells. Pre-incubation of human monocyte derived DCs with anti-
human F(ab’)2 CD64 fragments reduced the association of DCs with CRP-opsonised 
Nm significantly when 10µg/ml of blocking fragments were used in comparison with 
unblocked DCs (p<0.0001, Figure 4.22A). No differences in the percent of DCs 
associating with unopsonised Nm or NHS pre-treated Nm was observed following 
pre-incubation with any of the anti-human F(ab’)2 CD64 concentrations.  
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 No significant changes in the number of bacteria per cell were observed with 
any of the treatments (Figure 4.22B).  
 
Figure 4.22 The effect of pre-incubation with a F(ab’)2 preparation of anti-human CD64 
antibody on CRP enhanced uptake of Nm into human monocyte derived dendritic cells 
Monocyte derived dendritic cells were pre-incubated with a range of concentrations of 
F(ab’)2 preparations of mouse anti-human CD64 antibody (green bars) followed by 
incubation with unopsonised, NHS pre-treated and CRP-opsonised GFP expressing Nm for 2 
hours followed by confocal microscopy analysis of uptake with the meningococci. The mean 
+ SD of 3 donors are shown for (A) percent of cells associating with bacteria and (B) the 
number of bacteria associating per cell. Where **** denotes p<0.0001 upon comparison 
with unblocked uptake (black bars). 
4.2.3.4 The effect of anti-Fc gamma receptor II, low afinity (CD32) antibody 
blocking in human monocyte derived dendritic cells on meningococcal uptake 
 The specificity of CRP enhanced uptake into monocyte derived dendritic cells 
for the low affinity Fcγ receptor, FcγRII was investigated as follows: Human 
monocyte derived dendritic cells were cultured for 5 days as described in 2.2.2 
followed by pre-incubation with a range of concentrations of either an isotype 
matched control, mouse anti-human CD32 or  a F(ab’)2 preparation of the mouse 
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anti-human CD32. Fixed cultures of GFP-expressing Nm were pre incubated as 
detailed above. Unopsonised, NHS pre-treated and CRP opsonised Neisseria 
meningitis were incubated with monocyte derived dendritic cells for 2 hours to 
allow for phagocytosis to occur.  
For ease of comparison between DCs pre-incubated with either the isotype 
matched control, mouse anti-human CD32 or the F(ab’)2 preparation of the mouse 
anti-human CD32, the results for unblocked dendritic cells incubated with 
unopsonised (PBS), NHS pre-treated or CRP-opsonised Nm (black bars) are repeated 
in Figures 4.23, 4.24 and 4.25.  
To control for non-specific binding of the Fc portion of anti-CD32 antibody to 
FcγRII, the effect of a mouse IgG2B isotype matched control on CRP enhanced 
association of Nm with human dendritic cells was investigated. Pre-incubation of 
monocyte derived dendritic cells with a range of concentrations of an isotype 
matched control to mouse anti-human CD32 had no significant effect on the 
percent of DCs associating with either unopsonised, NHS pre-treated or CRP-
opsonised meningococci as the concentration of the isotype control increased 
(Figure 4.23A). 
 No significant changes in the number of meningococci per macrophage cell 
were observed with any of the other treatments (Figure 4.23B). 
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Figure 4.23 The effect of pre-incubation with an IgG2B isotype matched control antibody 
(for anti-FcγRII) on CRP enhanced uptake of Nm into human monocyte derived dendritic 
cells 
Monocyte derived dendritic cells were either left unblocked (black bars) or pre-incubated 
with a range of concentrations of mouse IgG2B isotype matched control (green bars) 
followed by incubation with unopsonised, NHS pre-treated and CRP-opsonised GFP 
expressing Nm for 2 hours followed by confocal microscopy analysis of uptake with the 
meningococci. The mean + SD of 3 donors are shown for (A) percent of cells associating 
with bacteria and (B) the number of bacteria associating per cell. 
 
 
The effect of adding the blocking antibody mouse anti-human CD32 on CRP 
enhanced association of Nm with human dendritic cells was investigated. It was 
observed that pre-incubation of monocyte derived dendritic cells with the anti-
human CD32 antibody reduced the percentage of monocyte derived DCs associating 
with both NHS pre-treated and CRP-opsonised Nm as the concentration of anti-
human CD32 increased (Figure 4.24A). However, only the decrease in association 
with CRP-opsonised Nm was statistically significantly different when 10µg/ml of 
anti-human CD32 was used   (p=0.0065). No significant changes in percent of 
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association were seen between DCs and unopsonised Nm with any of the blocking 
treatments.  
 No significant differences in the number of associating bacteria per dendritic 
cell were seen with any of the treatments (Figure 4.24B). 
 
Figure 4.24 The effect of pre-incubation with anti-human CD32 antibody on CRP 
enhanced uptake of Nm into human monocyte derived dendritic cells 
Monocyte derived dendritic cells were pre-incubated with a range of concentrations of 
mouse anti-human CD32 (green bars) followed by incubation with unopsonised, NHS pre-
treated and CRP-opsonised GFP expressing Nm for 2 hours followed by confocal microscopy 
analysis of uptake with the meningococci. The mean + SD of 3 donors are shown for (A) 
percent of cells associating with bacteria and (B) the number of bacteria associating per 
cell. Where ** denotes p<0.005 upon comparison with unblocked uptake (black bars). 
 
To further control for the specificity of the blocking of CD32 via the Fc 
portion of the mouse anti-human CD64 antibody, the effect of a F(ab’)2 preparation 
of the mouse anti-human CD32 antibody on CRP enhanced association of Nm with 
human dendritic cells was investigated. Pre-incubation of monocyte derived 
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dendritic cells with F(ab’)2 preparations of anti-human CD32 antibody significantly 
reduced the percentage of DCs associating with CRP-opsonised Nm at 10µg/ml of 
blocking fragments (p=0.0442, Figure 4.25). This effect was not seen in dendritic 
cells associating with unopsonised or NHS pre-treated Nm following pre-incubation 
with any of the blocking treatments.  
 No significant differences in the number of associating bacteria per dendritic 
cell were seen with any of the treatments (Figure 4.25B).  
 
Figure 4.25 The effect of pre-incubation with F(ab’)2 preparations of anti-human CD32 
antibody on CRP enhanced uptake of Nm into human monocyte derived dendritic cells 
Monocyte derived dendritic cells were pre-incubated with a range of concentrations of 
F(ab’)2 preparations of mouse anti-human CD32 (green bars) followed by incubation with 
unopsonised, NHS pre-treated and CRP-opsonised GFP expressing Nm for 2 hours followed 
by confocal microscopy analysis of uptake with the meningococci. The mean + SD of 3 
donors are shown for (A) percent of cells associating with bacteria and (B) the number of 
bacteria associating per cell. Where * denotes p<0.05 upon comparison with unblocked 
uptake (black bars). 
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4.2.4 Co-localisation of Neisseria meningitidis with Fc gamma receptors of 
human phagocytic cells 
Visual confirmation of the involvement of Fcγ receptors I and II with CRP-
mediated uptake of Neisseria meningitides into human monocyte derived 
macrophages and dendritic cells was carried out as a series of co-localisation 
experiments as described in 2.2.10. In these experiments DRAQ5 staining of 
mammalian nuclei to locate cells and phycoerythrin (PE) labelled specific antibodies 
to FcγRI (CD64) and II (CD32) to co-localise with the GFP expression of both 
unopsonised and opsonised meningococci were used. Co-localisation was identified 
as yellow fluorescence on overlay view sections. 
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4.2.4.1 Co-localisation of Neisseria meningitidis with human monocyte derived 
macrophage Fc gamma receptors 
Human monocyte derived macrophages were cultured for 5 days as 
described in 2.2.2 and were incubated with DRAQ5 and the mouse IgG1-PE isotype 
control for both mouse IgG1 anti-human CD64-PE and mouse IgG1 anti-human 
CD32-PE (Figure 4.26). Upon analysis it was observed that limited background 
binding occurred (Figure 4.26C) at the concentration tested (1μg/test). 
Consequently, this concentration of mouse IgG1 anti-human CD64-PE and mouse 
IgG1 anti-human CD32-PE was used in all experiments on similarly derived 
macrophages.  
 
Figure 4.26 Mouse IgG1-PE isotype control staining of human monocyte derived 
macrophages 
Human monocyte derived macrophages were stained with mouse IgG1-PE isotype control 
and confocal microscopy analysis of background binding with the cells was undertaken. 
Representative confocal fields of brightfield imaging to visualise perimeter of cells (A), 
DRAQ5 staining of nuclei (B), isotype matched control staining (C) and are shown separately 
and overlaid together (D).  Scale bar=20µm. 
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Upon investigation of the localisation of unopsonised Nm with FcγRI 
expressed by human monocyte derived macrophages (Figure 4.27), it was observed 
that GFP expressing Nm associated at a low level (routinely 8-15%) confirming data 
from earlier donors. FcγRI staining was mainly cytoplasmic (Figure 4.27C) with 
minimal areas of co-localisation with unopsonised Nm identified as yellow 
fluorescence on overlay. Routinely <5% of cells associating with unopsonised Nm 
co-localised with the meningococci via FcγRI.  
 
Figure 4.27 Localisation of unopsonised GFP expressing N. meningitidis with human 
monocyte derived macrophages stained for FcγRI 
Human monocyte derived macrophages were incubated with unopsonised GFP-expressing 
Nm for 2 hours followed by staining and confocal microscopy analysis of association with 
the meningococci.  Representative confocal fields of bright field images to visualise 
perimeter of cells (A), DRAQ5 staining of nuclei (B), mouse anti-human FcγRI-PE (C) and GFP 
expressing unopsonised Nm (D) are shown separately and overlaid together (E). Scale 
bar=20µm. 
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Analysis of the localisation of unopsonised Nm with FcγRII expressed by 
human monocyte derived macrophages (Figure 4.28) also showed low levels of 
association and that staining of FcγRII was also cytoplasmic. It appeared that 
expression of this receptor was at a lower level compared to FcγRI (Figures 4.27C 
and 4.28C). Routinely <2% of cells associating with unopsonised Nm co-localised 
with the meningococci via FcγRII. 
 
Figure 4.28 Localisation of unopsonised GFP expressing N. meningitidis with human 
monocyte derived macrophages stained for FcγRII  
Human monocyte derived macrophages were incubated with unopsonised GFP-expressing 
Nm for 2 hours followed by staining and confocal microscopy analysis of association with 
the meningococci.  Representative confocal fields of bright field images to visualise 
perimeter of cells (A), DRAQ5 staining of nuclei (B), mouse anti-human FcγRII-PE (C) and 
GFP expressing unopsonised Nm (D) are shown separately and overlaid together (E). Scale 
bar=20µm. 
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Increased association (routinely 25-35%, Figure 4.29D and E) between GFP 
expressing Nm and human macrophages was observed when Nm were pre-treated 
with NHS in comparison to unopsonised Nm confirming data from earlier donors 
and that minimal levels of co-localisation with FcγRI (routinely <2%)  had occurred. 
 
Figure 4.29 Co-localisation of NHS pre-treated GFP expressing N. meningitidis with human 
monocyte derived macrophages stained for FcγRI 
Human monocyte derived macrophages were incubated with NHS pre-treated GFP-
expressing Nm for 2 hours followed by staining and confocal microscopy analysis of 
association with the meningococci.  Representative confocal fields of bright field images to 
visualise perimeter of cells (A), DRAQ5 staining of nuclei (B), mouse anti-human FcγRI-PE (C) 
and GFP expressing NHS pre-treated Nm (D) are shown separately and overlaid together 
(E). Scale bar=20µm. 
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Upon analysis of the localisation of NHS pre-treated Nm with FcγRII 
expressed by human monocyte derived macrophages (Figure 4.30), increased levels 
of association (routinely 25-35%, Figure 4.30D and E) between Nm and human 
macrophages occurred when Nm were pre-treated with NHS in comparison to 
unopsonised Nm. Low levels (routinely <10%) of co-localisation were seen as 
depicted in the overlay of all images, although at a higher level than between 
unopsonised Nm and this receptor.  
 
Figure 4.30 Co-localisation of NHS pre-treated GFP expressing N. meningitidis with human 
monocyte derived macrophages stained for FcγRII 
Human monocyte derived macrophages were incubated with NHS pre-treated GFP-
expressing Nm for 2 hours followed by staining and confocal microscopy analysis of 
association with the meningococci.  Representative confocal fields of bright field images to 
visualise perimeter of cells (A), DRAQ5 staining of nuclei (B), mouse anti-human FcγRII-PE 
(C) and GFP expressing NHS pre-treated Nm (D) are shown separately and overlaid together 
(E). Scale bar=20µm. 
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Investigation of the localisation of CRP-opsonised Nm with FcγRI  expressed 
by human monocyte derived macrophages (Figure 4.31) revealed higher levels of 
CRP-opsonised Nm associated with human macrophages (Figure 4.31D and E, 
routinely 30-45%) when compared to unopsonised and NHS pre-treated Nm, 
confirming  data from earlier donors. Higher levels of co-localisation (routinely 15-
30%) of CRP opsonised Nm with FcγRI in comparison to unopsonised or NHS pre-
treated was observed upon analysis of monocyte derived macrophages identified by 
yellow fluorescence in overlay (Figure 4.31E).  
 
Figure 4.31 Co-localisation of CRP-opsonised GFP expressing N. meningitidis with human 
monocyte derived macrophages stained for FcγRI 
Human monocyte derived macrophages were incubated with CRP-opsonised GFP-
expressing Nm for 2 hours followed by staining and confocal microscopy analysis of 
association with the meningococci.  Representative confocal fields of bright field images to 
visualise perimeter of cells (A), DRAQ5 staining of nuclei (B), mouse anti-human FcγRI-PE (C) 
and GFP expressing CRP-opsonised Nm (D) are shown separately and overlaid together (E). 
Scale bar=20µm. 
 
 
 
 
 
 
 
 
A B
C D E
 
 
122 
 
 Similarly, analysis of the localisation of CRP-opsonised Nm with FcγRII 
expressed by human monocyte derived macrophages (Figure 4.32) showed high 
levels of Nm associating with the cells (Figure 4.32D and E) in comparison to 
unopsonised and NHS pre-treated Nm. Staining of FcγRII was mainly cytoplasmic 
and was seen to co-localise with CRP-opsonised Nm on many of the cells associating 
with Nm (routinely 15-30% of all cells) as identified on overlay (Figure 4.32E) as 
yellow fluorescence.  
 
Figure 4.32 Co-localisation of CRP-opsonised GFP expressing N. meningitidis with human 
monocyte derived macrophages stained for FcγRII 
Human monocyte derived macrophages were incubated with CRP-opsonised GFP-
expressing Nm for 2 hours followed by staining and confocal microscopy analysis of 
association with the meningococci.  Representative confocal fields of bright field images to 
visualise perimeter of cells (A), DRAQ5 staining of nuclei (B), mouse anti-human FcγRII-PE 
(C) and GFP expressing CRP-opsonised Nm (D) are shown separately and overlaid together 
(E). Scale bar=20µm. 
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4.2.4.2 Co-localisation of Neisseria meningitidis with monocyte derived dendritic 
cell Fc gamma receptors 
Human monocyte derived dendritic cells were cultured for 5 days and 
incubated with DRAQ5 and an isotype matched control to both mouse IgG1 anti-
human CD64-PE and mouse IgG1 anti-human CD32 (Figure 4.33). Upon confocal 
analysis it was observed that minimal background binding occurred at the 
concentration tested (1μg per test). Consequently this concentration of mouse IgG1 
anti-human CD64-PE and mouse IgG1 anti-human CD32-PE was used in all 
experiments on similarly derived dendritic cells.  
 
Figure 4.33 Mouse IgG1-PE isotype control staining of human monocyte derived dendritic 
cells 
Human monocyte derived dendritic cells were stained with mouse IgG1-PE isotype control 
and confocal microscopy analysis of background binding with the cells was undertaken. 
Representative confocal fields of brightfield imaging to visualise perimeter of cells (A), 
DRAQ5 staining of nuclei (B), isotype matched control staining (C) and are shown separately 
and overlaid together (D).  Scale bar=20µm. 
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Upon investigation of the localisation of unopsonised Nm with FcγRI 
expressed by human monocyte derived dendritic cells (Figure 4.34), it was observed 
that GFP expressing Nm associated with human DCs at a low level (routinely 10-
15%), confirming previous uptake experiments. FcγRI staining mainly in the 
cytoplasm was observed with no visible areas of co-localisation with the 
unopsonised Nm. 
 
Figure 4.34 Co-localisation of unopsonised GFP expressing N. meningitidis with human 
monocyte derived dendritic cells stained for FcγRI 
Human monocyte derived dendritic cells were incubated with unopsonised GFP-expressing 
Nm for 2 hours followed by staining and confocal microscopy analysis of association with 
the meningococci.  Representative confocal fields of bright field images to visualise 
perimeter of cells (A), DRAQ5 staining of nuclei (B), mouse anti-human FcγRI-PE (C) and GFP 
expressing unopsonised Nm (D) are shown separately and overlaid together (E). Scale 
bar=20µm. 
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Analysis of the localisation of unopsonised Nm with FcγRII  expressed by 
human monocyte derived DCs (Figure 4.35), GFP expressing Nm associated with 
human DCs at a low level (routinely 10-15%). Cytoplasmic FcγRII staining was 
observed in the cells with no co-localisation with unopsonised Nm. 
 
Figure 4.35 Co-localisation of unopsonised GFP expressing N. meningitidis with human 
monocyte derived dendritic cells stained for FcγRII 
Human monocyte derived dendritic cells were incubated with unopsonised GFP-expressing 
Nm for 2 hours followed by staining and confocal microscopy analysis of association with 
the meningococci.  Representative confocal fields of bright field images to visualise 
perimeter of cells (A), DRAQ5 staining of nuclei (B), mouse anti-human FcγRII-PE (C) and 
GFP expressing unopsonised Nm (D) are shown separately and overlaid together (E). Scale 
bar=20µm. 
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Increased levels of association between GFP expressing Nm and human 
macrophages occurred when Nm were pre-treated with NHS (routinely 15-30%) in 
comparison with unopsonised Nm confirming earlier uptake experiments (Figure 
4.36). Cytoplasmic FcγRI staining was observed in the cells with no co-localisation 
with NHS pre-treated Nm.  
 
Figure 4.36 Co-localisation of NHS pre-treated GFP expressing N. meningitidis with human 
monocyte derived dendritic cells stained for FcγRI 
Human monocyte derived dendritic cells were incubated with NHS pre-treated GFP-
expressing Nm for 2 hours followed by staining and confocal microscopy analysis of 
association with the meningococci.  Representative confocal fields of bright field images to 
visualise perimeter of cells (A), DRAQ5 staining of nuclei (B), mouse anti-human FcγRI-PE (C) 
and GFP expressing NHS pre-treated Nm (D) are shown separately and overlaid together 
(E). Scale bar=20µm. 
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 Analysis of the co-localisation of NHS pre-treated Nm with FcγRII expressed 
by human monocyte derived DCs (Figure 4.37) revealed increased levels of 
association between Nm and human DCs occurred when Nm were pre-treated with 
NHS in comparison to unopsonised Nm (routinely 15-30%). Minimal levels (<5%) of 
co-localisation were observed between FcγRII and NHS pre-treated Nm. Expression 
of FcγRII in these cells appeared to be lower than their expression of FcγRI as 
observed in monocyte derived macrophages.  
 
Figure 4.37 Co-localisation of NHS pre-treated GFP expressing N. meningitidis with human 
monocyte derived dendritic cells stained for FcγRII 
Human monocyte derived dendritic cells were incubated with NHS pre-treated GFP-
expressing Nm for 2 hours followed by staining and confocal microscopy analysis of 
association with the meningococci.  Representative confocal fields of bright field images to 
visualise perimeter of cells (A), DRAQ5 staining of nuclei (B), mouse anti-human FcγRII-PE 
(C) and GFP expressing NHS pre-treated Nm (D) are shown separately and overlaid together 
(E). Scale bar=20µm. 
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Upon investigation of the localisation of CRP-opsonised Nm with FcγRI 
expressed by human monocyte derived DCs (Figure 4.38), higher levels of CRP-
opsonised Nm associated with human DCs in comparison to unopsonised and NHS 
pre-treated Nm (routinely 20-40%, confirming earlier uptake experiments). Analysis 
of cells associating with CRP opsonised Nm revealed high levels of co-localisation 
(routinely 30-40%) of CRP opsonised Nm and FcγRI expressed by monocyte derived 
DCs (Figure 4.38E).  
 
Figure 4.38 Co-localisation of CRP opsonised GFP expressing N. meningitidis with human 
monocyte derived dendritic cells stained for FcγRI 
Human monocyte derived dendritic cells were incubated with CRP-opsonised GFP-
expressing Nm for 2 hours followed by staining and confocal microscopy analysis of 
association with the meningococci.  Representative confocal fields of bright field images to 
visualise perimeter of cells (A), DRAQ5 staining of nuclei (B), mouse anti-human FcγRI-PE (C) 
and GFP expressing CRP-opsonised Nm (D) are shown separately and overlaid together (E). 
Scale bar=20µm. 
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Analysis of the localisation of CRP-opsonised Nm with FcγRII expressed by 
human monocyte derived DCs (Figure 4.39) showed high levels of Nm associating 
with the cells in comparison to unopsonised and NHS pre-treated Nm (routinely 20-
40%, confirming earlier uptake experiments). Staining of FcγRII was mainly 
cytoplasmic and was seen to co-localise with CRP-opsonised Nm on many cells 
(routinely 20-25%) where a high degree of association of Nm was observed (Figure 
4.39E).  
 
 
Figure 4.39 Co-localisation of CRP opsonised GFP expressing N. meningitidis with human 
monocyte derived dendritic cells stained for FcγRII 
Human monocyte derived dendritic cells were incubated with CRP-opsonised GFP-
expressing Nm for 2 hours followed by staining and confocal microscopy analysis of 
association with the meningococci.  Representative confocal fields of bright field images to 
visualise perimeter of cells (A), DRAQ5 staining of nuclei (B), mouse anti-human FcγRII-PE 
(C) and GFP expressing CRP-opsonised Nm (D) are shown separately and overlaid together 
(E). Scale bar=20µm. 
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The combined relative association and co-localisation of CRP opsonised Nm 
with FcγRI and II from 3 donors revealed statistically significant differences in 
comparison to the co-localisation of unopsonised and NHS pre-treated Nm with 
these receptors. Levels of co-localisation between Nm and FcγRI expressed by 
monocyte derived macrophages were significantly increased upon CRP opsonisation 
of Neisseria meningitidis in comparison to unopsonised Nm (p=0.0010) and NHS 
pre-treated Nm (p=0.0007, Figure 4.40A). Similar results were observed when 
monocyte derived macrophages were stained for FcγRII where levels of co-
localisation were significantly increased upon CRP opsonisation of Nm in 
comparison to unopsonised Nm (p=0.0009) and NHS pre-treated Nm (p=0.0047, 
Figure 4.40B). No significant difference between CRP opsonised Nm and co-
localisation with either of the two receptors was observed.  
 
 
Figure 4.40 The effect of CRP opsonisation on Nm association with monocyte derived 
macrophage Fcγ receptors I and II 
Human monocyte derived macrophages were incubated with unopsonised, NHS pre-
treated or CRP-opsonised GFP-expressing Nm for 2 hours followed by DRAQ5 staining of 
nuclei and either mouse anti-human FcγRI-PE (A) or mouse anti-human FcγRII-PE (B) 
staining. Association of the cells with the meningococci was analysed using confocal 
microscopy. The mean + SD of 3 donors are shown for percent of cells associated with 
bacteria (filled bars) and the percent of cells co-localised with bacteria (striped bars) where 
** and *** denote p<0.005 and p<0.0005 respectively. 
 
 
131 
 
Similarly, upon analysis of the same 3 donors, levels of co-localisation 
between Nm and FcγRI expressed by monocyte derived dendritic cells were 
significantly increased upon CRP opsonisation of Neisseria meningitidis in 
comparison to unopsonised Nm (p<0.0001) and NHS pre-treated Nm (p<0.0001, 
Figure 4.40A). In addition, levels of co-localisation with FcγRII were significantly 
increased upon CRP opsonisation of Nm in comparison to unopsonised Nm 
(p=0.0001) and NHS pre-treated Nm (p=0.0001, Figure 4.40B). No significant 
difference between CRP opsonised Nm and co-localisation with either of the two 
receptors was observed.  
 
 
 
Figure 4.41 The effect of CRP opsonisation on Nm association with monocyte derived 
dendritic cell Fcγ receptors I and II 
Human monocyte derived dendritic cells were incubated with unopsonised, NHS pre-
treated or CRP-opsonised GFP-expressing Nm for 2 hours followed by DRAQ5 staining of 
nuclei and either mouse anti-human FcγRI-PE or mouse anti-human FcγRII-PE staining. 
Association of the cells with the meningococci was analysed using confocal microscopy. The 
mean + SD of 3 donors are shown for percent of cells associated with bacteria (filled bars) 
and the percent of cells co-localised with bacteria (striped bars) where **** denotes 
p<0.0001. 
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4.3 Discussion   
 Having demonstrated enhanced uptake of Nm into human macrophages and 
dendritic cells following CRP opsonisation, it was important to investigate the 
mechanism by which this occurred. The interaction between Fcγ receptors and CRP 
is now long established and it was, therefore, logical to investigate if the enhanced 
meningococcal uptake occurred by these receptors and, in particular, the 
contribution of either FcγRI, FcγRII or both. The first aim, therefore, was to use RNA 
interference approaches to knock down the expression of human phagocyte Fcγ 
receptors in a highly specific manner to assess if CRP-enhanced uptake by these 
cells could be reduced. The second aim was to use human IgG antibody blocking of 
all Fcγ receptors prior to analysing CRP mediated uptake of Nm into human 
phagocytes. The third aim was to block Fcγ receptors more specifically using whole 
or F(ab’)2 preparations of anti-human FcγRI and anti-human FcγRII antibodies to see 
if a difference in inhibition of CRP mediated uptake could be observed. The final aim 
was to visually confirm the involvement of Fcγ receptors in CRP mediated uptake of 
green fluorescent protein (GFP) expressing Nm using PE conjugated antibodies 
targeting FcγRI and II and fluorescence confocal microscopy. 
 
4.3.1 RNA interference approaches were unable to knock down Fc gamma 
receptor I or II in primary human phagocytic cells 
 It is well known that primary cells and particularly myeloid macrophages are 
amongst those most difficult to transfect (Gresch & Altrogge 2012), however their 
use is preferred over immortalised cell lines as they resemble in vivo conditions 
more closely and are, hence, more physiologically relevant. Transfection of primary 
human macrophages and dendritic cells with Fcγ receptor targeting siRNA was 
attempted using a variety of techniques, but in each case, knock down failed to be 
induced. 
 The lipofectant, Lipofectamine™ was the first to be tested as this had been 
successfully used in our laboratory to knock down the same targets (Fc gamma 
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receptors) in human endothelial cells. However, this success was not reproducible 
in primary myeloid cells. Detection of Fcγ receptor knock down was initially carried 
out using RT-PCR to assess relative levels of Fcγ receptor mRNA. As all the necessary 
RT-PCR controls were carried out (GAPDH endogenous reference gene control, no 
template and no reverse transcriptase control), the chance of false positive results 
was minimal and it was with confidence, therefore, that the lack of mRNA knock 
down was reported. As mRNA knock down was not observed over the time course 
tested (24-48 hours, routinely used in similar experimental set-ups (Liang et al. 2006 
and Wojtal et al. 2012)), protein levels would, therefore, also remain unaffected as 
the mRNA was still intact to be translated into the relevant proteins and so these 
experiments were not repeated for protein level detection by Western blotting.  
Alternatively, detection of mRNA reduction could have been monitored 
quantitatively using reverse transcriptase quantitative PCR (RT-qPCR) which would 
offer a faster and quantitative approach to detecting mRNA knock down. If minimal 
levels of knock down occurred, these may have been detected unlike with 
conventional PCR (Bustin 2000) due to its high sensitivity and quantitative nature. 
 Electroporation of siRNA duplexes into human macrophages and dendritic 
cells was the next approach that was tested. Electroporation has been noted to be 
more effective than lipofectant reagents and has been used to successfully transfect 
mammalian cells with FcγR targeting siRNA (Maurisse et al. 2010 and Boonnak et al. 
2013 respectively), however, knock down of Fc gamma receptors failed to be 
detected at either the mRNA or protein level. Whether or not siRNA duplexes were 
successfully entering the cells is something that could have been investigated using 
GFP tagged siRNA to monitor transfection efficiency using fluorescence microscopy 
(Muratovska & Eccles 2004).  
 Knock down of Fc gamma receptors following transfection of siRNA duplexes 
into human macrophages and dendritic cells using INTERFERin® and DharmaFECT 
was not detectable at the protein level either. As the protein half-life of these 
receptors have not yet been established, the turn over time is unknown and the 
optimal length of time at which to incubate the cells with siRNA duplexes was, 
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therefore, difficult to establish in order to induce maximum knock-down. The mRNA 
half-life of human Fcγ receptors had been determined in U937 cells as 
approximately 3 hours (Comber et al. 1992), however, mRNA half-lives are often 
much shorter than their protein counterparts (Schwanhäusser et al. 2011) and so 
this information was not relevant in assisting with optimisation experiments. 
Establishing the protein turn over time of these receptors would be beneficial to 
optimising future RNAi experiments, and could be done using protein degradation 
assays by which the protein of interest is pulse labelled with radioactive nucleosides 
or amino acids in order to measure protein half-life (Zhou 2004). These receptors 
may have a high turnover rate, in which case, transient knock down using siRNA 
may not be adequate and adenoviral, retroviral or lentiviral vectors could be 
employed to transfect short hairpin RNA (shRNA) into human phagocytes to induce 
more stable knockdown of Fcγ receptors (Moore et al. 2010).  
It has also been found that on occasion, for reasons still not clear, when 
siRNA is introduced into cells and induces cleavage of mRNA, its degradation can be 
blocked and therefore rejection of valid siRNA duplexes can occur (Holmes et al. 
2010b), thereby inhibiting RNA interference. In order to overcome this potential 
problem in future attempts, a variety of siRNA duplexes from a range of suppliers 
would have to be purchased and tested. Some groups have also found that knock 
down can be more successful upon multiple transfections of the same cells, and 
although Elbashir et al found single transfections to be as effective as multiple 
(Elbashir et al. 2001) this is another variable that should be considered in all future 
RNAi experiments.  
 
4.3.2 IgG inhibition of CRP enhanced uptake of Neisseria meningitidis into 
human phagocytes 
To establish the involvement of Fcγ receptors in CRP enhanced association 
of Nm with monocyte derived macrophages and dendritic cells, purified human IgG 
was pre-incubated with the cells at levels shown to be effective in pan-Fcγ receptor 
blocking experiments (McArthur et al. 2009) for 2 hours prior to uptake assays.  
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The effect of IgG blocking on unopsonised Nm association with human phagocytic 
cells 
Background levels of association of unopsonised Nm occurred in 
approximately 7% of THP-1 macrophages and monocyte derived macrophages and 
13% of dendritic cells. This low level of Nm uptake into THP-1 macrophages, 
monocyte derived macrophages and DCs without the aid of opsonisation indicated 
that the bacteria were able to interact directly with surface pattern recognition 
receptors (PRRs) such as the scavenger receptor SR-A, CD14 and its signalling co-
receptor TLR-4 expressed by these cells as previously discussed in Chapter 3. 
Association of unopsonised Nm with DCs in this set of experiments (as compared to 
Chapter 3) was higher in comparison to macrophages. Across all antibody blocking 
experiments, however, unopsonised association of Nm with both monocyte derived 
macrophages and dendritic cells was similar and ranged from 8-15%.  
Pre-incubation of THP-1 macrophages and monocyte derived macrophages 
with purified human IgG had no significant effect on the percent of cells associated 
with unopsonised Nm indicating that the bacteria were still utilising other surface 
PRRs to maintain the background levels of approximately 7% association in the 
event of Fcγ receptor blocking. In dendritic cells, however, a significant decrease in 
unopsonised Nm uptake was observed upon pre-incubation of the cells with IgG. 
This could have been due to non specific blocking of PRRs by the added IgG or direct 
interaction of Nm with Fcγ receptors without the assistance of an opsonin, although 
this has not been demonstrated by any other groups. In addition, this could be due 
to the slightly higher background levels of association of unopsonised Nm in these 
experiments as discussed above.  
 
The effect of IgG blocking on NHS pre-treated Nm association with human 
phagocytic cells 
Enhanced association of NHS pre-treated Nm with THP-1 macrophages and 
monocyte derived macrophages was observed upon comparison with unopsonised 
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Nm association.  This was expected as NHS (acting as the positive control) contains 
acute phase proteins such as CRP, mannose binding lectin (Kuhlman 1989) and 
other opsonins such as C3b and IgG (Hemming et al. 1976) capable of binding and 
opsonising Nm and enhancing uptake into phagocytes. Interestingly, increased 
association of NHS pre-treated Nm with DCs was not observed in this set of IgG 
blocking experiments. This may have been due to donor variability as NHS pre-
treatment significantly increased association of Nm with DCs in all other antibody 
blocking experiments in this chapter and chapter 3.  
In all three cell types, pre-incubation of the cells with IgG induced significant 
decreases in association of NHS pre-treated Nm with the cells as the concentration 
of IgG increased, indicating that blocking of all Fcγ receptors inhibited association of 
meningococci with these cells. Complete inhibition (back to background levels) of 
the NHS enhanced association of Nm with all three cell types was achieved, 
however, this association never reached 0% for the reasons discussed above i.e. 
NHS pre-treated Nm may have been interacting with PRRs aiding uptake by an 
alternative receptor to the Fcγ receptors.  
 
The effect of IgG blocking on CRP opsonised Nm association with human 
phagocytic cells 
CRP enhanced association of Nm was observed in all three cell types, as 
demonstrated in Chapter 3 and upon pre-incubation with IgG, significant inhibition 
of this association with each cell type was observed. This was particularly noticeable 
in DCs. DCs express lower levels of CD14 and TLR-4 than macrophages (Ling et al. 
2014), which could possibly explain why the effect of blocking all Fcγ receptors was 
so pronounced in these cells as they may be playing a more significant role in the 
uptake of this microorganism. The inhibition of CRP enhanced uptake into these 
cells was expected as CRP shares binding site homology with IgG for domain 2 of Fcγ 
receptors (Lu et al. 2012). The decrease in CRP mediated uptake can, therefore, be 
assumed to be due to IgG blocking the Fcγ receptors, confirming the involvement of 
these receptors in CRP-mediated responses. Total inhibition (back to background 
levels) of CRP mediated uptake, however, was not observed in monocyte derived 
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macrophages. This might be due to another uncharacterised receptor expressed by 
these cells that CRP is able to utilise (Zeller et al. 1989).  
 
The effect of IgG blocking on the number of bacteria per cell 
Across all three cell types, pre-incubation with IgG had no effect on the 
number of bacteria per cell following uptake with unopsonised, NHS pre-treated or 
CRP-opsonised Nm. This may be, in part, due to the experimental set up where all 
opsonisation and uptake experiments allowed phagocytosis to occur for 2 hours.  
Whilst this is a routine incubation time (Leidi et al. 2009; Casey et al. 2008; Chen et 
al. 2008) other groups have demonstrated phagocytosis occurring in as fast as 7.5-
30 minutes   of infection (Sjursen et al. 1992; Ross et al. 1987), so it is possible that 
higher numbers of CRP opsonised Nm per cell may have been observed at the 
beginning of incubation. CPR opsonised Nm may have been phagocytosed and 
internalised much faster within that window than unopsonised or NHS pre-treated 
Nm, leaving similar numbers of external associating bacteria to be counted after 2 
hours. It would, therefore, be of interest to look at more (earlier) time points 
perhaps using flow cytometry (alongside association counts) in future opsonisation 
and uptake experiments to accurately determine levels of Nm internalisation in 
addition to associating bacteria. Heyderman et al demonstrated that after 1 hour of 
incubation with Nm, over 60% of neutrophils (which are known to phagocytose 
much faster) with associated Nm had internalised the bacteria (Heyderman et al. 
1999). Counting associating bacteria after 2 hours would not take into account the 
vast numbers of Nm that had been internalised over that time period.  This would 
provide a more accurate representation of the number of bacteria per cell and, 
therefore, accurate phagocytic index values to show how effective CRP mediated 
uptake of Nm into human phagocytes really is.  
 
4.3.3 Specific blocking of FcγRI or FcγRII inhibited CRP enhanced 
association of Neisseria meningitidis with human phagocytes 
 Having demonstrated an involvement of Fcγ receptors in CRP opsonised Nm 
association with monocyte derived macrophages and dendritic cells, it was 
 
 
138 
 
pertinent to try to further characterise which of the 3 Fcγ receptors were important 
in this particular mode of uptake. FcγRIIc and FcγRIIIb were discounted from this 
analysis as they are not expressed by monocyte derived macrophages or dendritic 
cells (Smith & Clatworthy 2010) and FcγRIIIa is unable to or only weakly bind CRP 
(Tron et al. 2008, Devaraj et al. 2005 and Devaraj et al. 2006). FcγRI and FcγRII, 
however, are known to be expressed by these cells (Smith & Clatworthy 2010). 
Blocking of these 2 receptors was investigated by the addition of whole and F(ab’)2 
preparations of anti-CD64 and anti-CD32 alongside matched isotype controls.  
 The pre-incubation of monocyte derived macrophages and dendritic cells 
with identical levels of isotype matched controls to the mouse IgG1 anti-human 
CD64 (FcγRI) and mouse IgG2b anti-human CD32 (FcγRII) antibodies had no 
significant effects on the association of unopsonised, NHS pre-treated or CRP-
opsonised Nm with each cell types as observed by the percent of cells associating 
with Nm or in the number of bacteria per cell. These results confirmed the 
specificity of the chosen blocking antibodies and confirmed that any non specific Fc 
receptor binding by the IgG1 and IgG2b isotypes was not responsible for any 
observed inhibitory effects of the Fcγ receptor antibodies.  
 
The effect of specific blocking of FcγRI or FcγRII on unopsonised Nm association 
with human phagocytic cells 
 The association of unopsonised Nm with monocyte derived macrophages 
was not significantly different upon pre-incubation of macrophages with either 
blocking antibody or F(ab’)2 preparation of either antibody in comparison to un-
blocked cells. This confirmed the results obtained from the IgG blocking 
experiments, where unopsonised association of Nm with macrophages did not 
significantly change upon pre-incubation of the cells with IgG, most likely due to the 
array of PRRs expressed by these cells (such as SR-A, CD14 and TLR-4) contributing 
to background association of the microorganism.  
Interestingly, unopsonised association of Nm with DCs was significantly 
decreased upon IgG pre-incubation of the cells (indicating FcγR involvement in 
unopsonised Nm association with these cells), but not observed upon pre-
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incubation of DCs with either blocking antibody (whole or F(ab’)2 preparation). This 
suggested that in DCs there may have been non specific blocking as there have been 
no reports of Nm interacting directly with Fcγ receptors.  
 
The effect of specific blocking of FcγRI or FcγRII on NHS pre-treated Nm 
association with human phagocytic cells 
 Involvement of Fcγ receptors in NHS pre-treated Nm association with 
monocyte derived macrophages was implied when a significant decrease in 
association of NHS pre-treated Nm with these cells was observed in the IgG blocking 
experiments in comparison to un-blocked cells. Upon pre-incubation of human 
macrophages with whole and F(ab’)2 preparations of anti-human CD64 antibody, 
however, no significant change in NHS pre-treated Nm association with these cells 
was observed, indicating that NHS pre-treated Nm association may have been 
occurring by FcγRII or PRRs expressed by macrophages (as discussed previously) 
when FcγRI was unavailable. 
 Pre-incubation of macrophages with whole anti-human CD32 antibody on 
the other hand significantly reduced the association of NHS pre-treated Nm with 
the cells, indicating a preference for this receptor in NHS mediated uptake of the 
meningococci. Pre-incubation of the cells with the F(ab’)2 preparation of the same 
antibody, however, had no significant effect on NHS pre-treated Nm association 
with these cells. This indicated that whole anti-human CD32 may have non-
specifically bound both FcγRI and FcγRII via its Fc region and therefore, significantly 
inhibited association, as seen in the IgG blocking experiments, where a significant 
decrease in association of NHS pre-treated Nm with these cells was observed when 
all Fcγ receptors were blocked. As association of NHS pre-treated Nm with 
macrophages was not significantly affected in the event of more specific FcγRII 
blocking with F(ab’)2 preparations, this suggested that NHS pre-treated Nm can also 
use FcγRI or other PRRs when FcγRII is unavailable.  
Similar results were observed in DCs, whereby a significant decrease in NHS 
pre-treated Nm association with these cells was observed in the IgG blocking 
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experiments but not upon pre-incubation of DCs with either of the blocking 
antibodies (whole or F(ab’)2 preparations). This suggests that NHS pre-treated Nm is 
able to use both FcγRI and FcγRII expressed by these cells and that in the event of 
blocking of FcγRI, NHS pre-treated Nm can use FcγRII and vice versa.   
 
The effect of specific blocking of FcγRI or FcγRII on CRP opsonised Nm association 
with human phagocytic cells 
 Fcγ receptor involvement in CRP opsonised Nm association with monocyte 
derived macrophages was demonstrated when a significant decrease in association 
of CRP opsonised Nm with IgG pre-blocked macrophages was observed in 
comparison to un-blocked cells.  This was further demonstrated upon pre-
incubation of these cells with either anti-human FcγRI or anti-human FcγRII 
antibodies (whole and F(ab’)2 preparations).  
Pre-incubation of macrophages with whole or F(ab’)2 preparations of anti-
human CD64 both significantly reduced association of CRP-opsonised Nm with 
these cells, showing that in these particular cells, whole CD64 was not blocking non-
specifically via its Fc region. Upon comparison between the two antibodies, anti-
human CD32 seemed to have a more profound effect on inhibition of CRP mediated 
uptake of Nm than blocking with anti-human CD64, which agrees with previous 
work suggesting that the major receptor for CRP is FcγRII (Bharadwaj et al. 1999). 
However, as blocking with both whole and F(ab’)2 preparations of  anti-human CD64 
induced significant decreases in Nm uptake, CRP is still obviously able to utilise this 
receptor as well. Blocking with whole anti-human CD32 had a more significant 
effect on inhibition than F(ab’)2 preparations of anti-human CD32 did, which may be 
attributable to non-specific binding of the anti-human CD32 antibody. 
 CRP-opsonised Nm uptake in monocyte derived dendritic cells was 
significantly reduced upon pre-incubation with either blocking antibody (whole or 
F(ab’)2 preparations). Once again, these results agree with the IgG blocking 
experiments, where pre-blocking DCs with IgG significantly reduced CRP mediated 
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association of Nm with these cells, demonstrating the involvement of Fcγ receptors 
in this mode of uptake. Blocking with either whole anti-human CD64 or whole anti-
human CD32 significantly reduced CRP mediated association of Nm with DCs, 
confirming that CRP opsonised Nm utilises either receptor. Blocking with F(ab’)2 
preparations of anti-CD64, however, had a more significant effect in blocking than 
its whole counterpart, showing that, much like in macrophages, whole anti-human 
CD64 was not blocking FcγRI receptors non-specifically. It is possible, however, that 
the antibody may have bound the other Fcγ receptors expressed by macrophages 
such as FcγRIIIa or FcγRIIb (Smith & Clatworthy 2010) via its Fc region, thereby 
leaving FcγRI and FcγRII available for binding to CRP opsonised Nm. F(ab’)2 
preparations of anti-CD32, however, did not inhibit association of CRP opsonised 
Nm with DCs as significantly as its whole counterpart, implying that (as observed in 
macrophages) whole anti-human CD32 may have been blocking both FcγRII and 
FcγRI non-specifically.  
It is important to keep in mind that the F(ab’)2 preparations may have been 
more successful at blocking than their whole counterparts because there would 
have been a higher concentration of F(ab’)2 epitope binding portions present in 
these preparations in comparison to the whole antibody solutions, which would 
have also contained Fc regions. Any future work comparing whole antibody blocking 
to F(ab’)2 preparation blocking would need to account for the presence of Fc 
portions and adjust the antibody concentrations accordingly.  
Discrepancies may also have arisen due to the use of different donors in 
each experiment, none of which were genotyped. Variation in levels of Nm 
association may have occurred because of polymorphisms in either Fcγ receptor, in 
particular FcγRIIa, which can exist in two forms (R-131 or H-131). These two forms 
are able to bind IgG and CRP with different avidities (Stein et al. 2000) and previous 
work found that variability was not due to levels of expression between donors, but 
more likely due to these polymorphisms (Bodman-Smith et al. 2004). 
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4.3.4 C - reactive protein opsonised Neisseria meningitidis co-localises with 
Fc gamma receptor I and II 
 Following the specific antibody blocking experiments confirming the 
involvement of both FcγRI and FcγRII in the association of CRP opsonised Nm with 
human monocyte derived macrophages and dendritic cells, it was important to 
confirm this interaction using a second approach. Phycoerythrin (PE) conjugated 
antibodies for FcγRI or FcγRII in combination with the GFP expressing Nm were 
analysed by confocal microscopy to assess the relative levels of co-localisation 
between CRP opsonised meningococci and Fcγ receptors.  
Staining of monocyte derived macrophages and dendritic cells with identical 
levels of the isotype matched control to both mouse IgG1-PE anti-human CD64 
(FcγRI) and mouse IgG1-PE anti-human CD32 (FcγRII) antibodies showed that limited 
background binding had occurred. These results confirmed the specificity of the 
chosen staining antibodies at the concentration tested and confirmed that any PE-
fluorescence observed in the co-localisation experiments were attributable to the 
presence of either FcγRI or FcγRII and not as a result of non-specific binding.  
Co-localisation experiments once again demonstrated background levels of 
association occurring between unopsonised Nm and both monocyte derived 
macrophages and dendritic cells. Interestingly, levels of co-localisation between 
unopsonised Nm and FcγRI and FcγRII expressed by both cell types were minimal, 
supporting the fact that unopsonised Nm is using PRRs expressed by these cells (as 
previously discussed) and not either of the Fcγ receptors investigated in this work.  
Similar results were observed upon analysis of the co-localisation between 
NHS pre-treated Nm and monocyte derived macrophages and dendritic cells’ Fcγ 
receptors. Enhanced association of Nm in this pre-treated state with both cell types 
was observed as seen in previous experiments, but levels of co-localisation were 
minimal as seen with unopsonised Nm. This also supports previously discussed 
theories that opsonins present in NHS are able to assist association of Nm with 
these cells via the PRRs expressed by macrophages and dendritic cells. Trace 
amounts of CRP may also have been present in the NHS used in these experiments, 
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possibly explaining why higher levels of co-localisation between NHS pre-treated 
Nm and FcγRII were observed in comparison to unopsonised Nm, although this was 
not significant.  
Enhanced association of CRP opsonised Nm in comparison to both 
unopsonised and NHS pre-treated Nm was observed in both cell types as 
demonstrated in previous uptake experiments.  Upon analysis of the relative levels 
of co-localisation between CRP opsonised Nm and either FcγRI and FcγRII, 
significantly higher levels of co-localisation were observed between CRP opsonised 
Nm and both receptors expressed by both cell types in comparison to unopsonised 
and NHS pre-treated Nm. This visually confirms the theory that CRP opsonised Nm 
is able to associate with these phagocytic cells via both FcγRI and FcγRII. 
Levels of co-localisation were semi quantitatively analysed by counting areas 
of yellow fluorescence produced as a result of the overlap of PE-conjugated 
antibodies to either FcγRI or FcγRII and GFP expressing Nm. A common problem in 
co-localisation experiments is cross talk or “bleed through” of the two chosen 
fluorophores, whereby the detector for PE may also pick up emission of GFP and 
vice versa. Bleed through was minimised in these experiments by choosing 
flourophores (PE and GFP) with emission spectra that are sufficiently distinct from 
one another with limited overlap (Tsien et al. 1995). Additionally, each fluorophore 
was excited and imaged individually using sequential scanning before combining to 
create composite images as this minimises bleed through (Zinchuk et al. 2007). The 
correct band pass filters were also used and adjusted accordingly to collect the 
correct emission from the relevant fluorophores to minimise detection of 
overlapping emission spectra. 
 It would be of interest, in future co-localisation experiments, to 
quantitatively analyse the co-localisation of CRP opsonised Nm with Fcγ receptors 
expressed by monocyte derived macrophages and dendritic cells using co-
localisation algorithms provided with most confocal microscopy analysis software. 
Scatter plots of the individual pixels are created to calculate several coefficients in 
order to quantitatively assess the presence and level of co-localisation such as 
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Pearson’s Correlation Coefficient, Overlap Coefficients K1 and K2 and Colocalization 
Coefficients M1 and M2. Pearson’s Correlation Coefficient describes the extent of 
overlap using the similarities of the shapes, Overlap Coefficients K1 and K2 describe 
differences in intensity of the red and green channels and Colocalization 
Coefficients M1 and M2 describe the contribution of each fluorophore to the co-
localisation area.  
4.3.5 Conclusions 
 RNAi experiments using siRNA duplexes were intended to be used to knock 
down Fc gamma receptors in primary monocyte derived macrophages or dendritic 
cells to assess the role of these receptors in CRP mediated uptake of Neisseria 
meningitidis into these cell types. Numerous optimisation experiments testing a 
variety of transfection protocols (Lipofectamine™ RNAiMAX, electroporation, 
INTERFERin® and DharmaFECT), ranges of siRNA concentrations and incubation 
times were carried out. Knock down of these receptors was assessed using RT-PCR 
and Western blotting to detect mRNA and protein levels of the receptors, 
respectively. Unfortunately, knock down of either receptor in both cell types failed 
to be observed following any of the above protocols. Before considering future 
RNAi experiments, investigations into the half life of Fcγ receptors would need to be 
carried out and transfection set-ups would have to include transfection efficiency 
controls (GFP tagged siRNA). 
  Pre-incubation of human monocyte derived macrophages and dendritic cells 
with purified human IgG significantly reduced the association of CRP opsonised Nm 
with these cells, demonstrating the involvement of Fcγ receptors in this mode of 
meningococcal uptake. Specific Fcγ receptor blocking with whole and F(ab’)2 
preparations of anti-CD64 and anti-CD32 also significantly reduced the association 
of CRP opsonised Nm with both cell types. Meningococci in this opsonised state are 
thus able to associate with these human phagocytes via both FcγRI and FcγRII, 
although in macrophages, FcγRII was the preferred receptor. It would be of interest 
in future opsonisation and uptake experiments to pre-block the cells using both 
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antibodies together to assess the effect on CRP opsonised Nm association with 
human macrophages and dendritic cells.  
 Co-localisation experiments using GFP expressing Nm and PE conjugated 
antibodies to FcγRI and FcγRII revealed significantly higher levels of Nm co-
localisation with macrophage and dendritic Fcγ receptors when Nm was opsonised 
with CRP, in comparison to unopsonised or NHS pre-treated Nm. This supported the 
data from the IgG and specific antibody blocking experiments, which demonstrated 
the involvement of both FcγRI and FcγRII in CRP enhanced association of Nm with 
monocyte derived macrophages and dendritic cells. 
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CHAPTER 5 
INVESTIGATING THE EFFECT OF CRP-
MEDIATED UPTAKE OF NEISSERIA 
MENINGITIDIS ON DENDRITIC CELL 
ACTIVATION  
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5.1 Rationale and aims 
 Enhanced association of CRP opsonised Neisseria meningitidis (Nm) with 
human monocyte derived macrophages and dendritic cells (DCs) was demonstrated 
in Chapter 3. Subsequent antibody blocking experiments described in Chapter 4 
revealed that this enhanced association occurs via Fcγ receptor I (CD64) and Fcγ 
receptor II (CD32) expressed by these cells.  
CRP is known to bind to and activate Fcγ receptors, inducing phagocytosis 
(Lu et al. 2012; Bodman-Smith et al. 2002; Mold et al. 2001), hydrogen peroxide 
formation (Tebo & Mortensen 1990), respiratory burst enhancement (Zeller et al. 
1986), secretion of inflammatory mediators such as interleukin (IL)-1α/β and 
tumour necrosis factor (TNF, Galve-de Rochemonteix et al. 1993; Mold & Du Clos 
2006) and the expression of activation markers such as CD80 and CD40 (Van Vré et 
al. 2008). The effect of CRP enhanced uptake of meningococci on these effector 
functions, however, has not yet been fully investigated and may reveal whether CRP 
enhanced association of Nm with macrophages and DCs is beneficial or detrimental 
to the host during meningococcal infection. 
 Previous work in our laboratory investigating the effect of CRP opsonised 
Nm on macrophage activation revealed that CRP opsonisation had little effect on 
macrophage activation marker expression and inflammatory cytokine secretion in 
comparison to infection with unopsonised meningococci. Whilst macrophages and 
dendritic cells are both phagocytic and able to process and present antigen to T 
cells to stimulate an adaptive immune response, DCs are far more efficient in 
antigen presentation and are distinct from macrophages in that they preserve 
antigen rather than scavenging and destroying upon phagocytosis (Savina & 
Amigorena 2007). DC responses to CRP enhanced Nm association may also be 
distinct from macrophage responses and it was, therefore, of interest to investigate 
the effect of CRP opsonised Nm on DC activation.  
The activation of DCs can be observed by the up-regulation of certain DC 
surface activation markers. Previous studies have shown that co-stimulatory 
receptors (which provide additional stimulation to activate T cells upon antigen 
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presentation by DCs), DC maturation markers (which show functional maturation of 
the cells upon antigen stimulation), pathogen recognition receptors (which 
recognise moieties found on pathogens such as Nm) and major histocompatibility 
complex (MHC) molecules (which are required for antigen presentation to T cells) 
are markedly up-regulated during (unopsonised) Nm infection (Dixon et al. 2001a; 
Kolb-Mäurer et al. 2001b). The effect of CRP opsonisation of Nm on these DC 
activation markers, however, has not been previously investigated.  The first aim of 
this chapter, therefore, was to use flow cytometry to analyse the expression of 
monocyte derived DC activation markers such as MHC molecules, co-stimulatory 
receptors, maturation markers and receptors of phagocytosis following incubation 
of the cells with unopsonised and CRP opsonised Nm for 24 hours.  
The production and secretion of inflammatory cytokines mediates the 
interaction between DCs and other effector cells involved in immune responses. 
Secreted cytokines from DCs can have paracrine and autocrine effects which affect 
downstream immune responses. For example, DCs play a critical role in influencing 
the effector functions of T cells by secreting specific T cell polarising cytokines which 
will determine the balance between different T cell subset development (de Jong et 
al. 2005). Secretion of IL-12 and interferon gamma (IFNγ) will induce Th1 responses 
(which is important for intracellular bacterial infections (Manda et al. 2012)) and 
has been shown to be induced during Nm infection (Aghasadeghi et al. 2011). 
Secretion of IL-6 and transforming growth factor beta (TGF-β) by dendritic cells will 
induce Th17 polarisation which is important during extracellular bacterial infections 
such as meningococcal meningitis (Segura et al. 2013). The effect of CRP 
opsonisation of Nm on DC cytokine secretion, however, has not been investigated. 
The second aim of this chapter, therefore, was to investigate the effect of CRP 
opsonised Nm on DC secreted inflammatory cytokines. Following incubation of DCs 
with unopsonised and CRP opsonised Nm, cell culture supernatants were reserved 
for inflammatory cytokine analysis using cytometric bead arrays measured by flow 
cytometry.  
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5.2 Results  
5.2.1 Flow cytometric analysis of the effect of CRP mediated uptake of 
Neisseria meningitidis on dendritic cell activation markers 
In order to investigate the effect of CRP opsonised Nm on monocyte derived 
dendritic cell activation markers, monocyte derived dendritic cells (DCs) were 
cultured for 5 days as per section 2.2.2. Fixed cultures of GFP-expressing Nm were 
prepared as per section 2.2.1 prior to undergoing opsonisation with either PBS, 50% 
NHS or 50µg/ml CRP. DCs were incubated with PBS, lipopolysaccharide (LPS), 
unopsonised Nm, NHS pre-treated Nm or CRP opsonised Nm for 24 hours as 
described in 2.2.18. LPS was used as a positive control as it is known to activate DCs 
within 24 hours, inducing a more mature phenotype capable of secreting higher 
levels of cytokines and up-regulating cell surface markers such as co-stimulatory 
and MHC class II molecules (Liu et al. 2010; Abdi et al. 2012). 24 hours was chosen 
as the optimal time point at which to collect cells for flow cytometric antibody 
staining as at least 18 hours of incubation with LPS is required in order to generate 
mature DCs (Granucci et al. 1999; Abdi et al. 2012). Additionally, cell viability assays 
performed previously (Chapter 3) revealed marked dendritic cell death following 48 
hours incubation.  
Following incubation of monocyte derived dendritic cells with the controls 
and test treatments, cells were collected and prepared for antibody staining as 
described in section 2.2.18. Prior to incubation with cell surface receptor targeting 
antibodies, cells were incubated with a fixable viability dye, eFluor® 520, or 
“live/dead” stain. Dead or dying cells are irreversibly labelled by the dye and were 
excluded from further analysis. A mouse anti-human CD11c-A647 antibody was 
chosen to select for mature dendritic cells, as used previously by other groups (Liu 
et al. 2010; Cheong et al. 2010; Abdi et al. 2012). Cells positively expressing this 
marker were gated for and used to determine the percentage of cells positive for a 
panel of surface molecules (conjugated to the fluorophore phycoerythrin (PE)) as 
markers of DC maturation, pathogen recognition and antigen presentation (see 
5.2.1.2).  
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 5.2.1.1 Gating strategy 
 Forward scatter (FSC) and side scatter (SSC) dot plots (showing size and 
granularity of cells, respectively) of monocyte derived dendritic cells revealed 
several distinct populations (Figure 5.1A). Contour plots (and subsequent back 
gating using DC maturation markers) were used alongside their respective dot plots 
to exclude dead cells and debris and to gate for either the total population of 
dendritic cells (“DC1”, Figure 5.1B) or for the sub population of larger dendritic cells 
(“DC2”, Figure 5.1C).  
The live/dead stain, eFluor® 520, irreversibly taken up by dead or dying cells, 
was detected by the fluorescein isothiocyanate (FITC) 530/30 band pass filter. 
Unstained DC1 or unstained DC2 populations were used to gate for eFluor® 520 
positive cells (Figure 5.1 D and H, respectively). eFluor® 520 positive cells were 
considered dead or dying and were, therefore, excluded from further analysis 
(Figure 5.1E and I).  
Selected live cells were used to gate for CD11c-A647+ cells using the 
matched isotype control, mouse IgG1-A647, where non-specific Fc receptor binding 
of the isotype control was excluded (Figure 5.1F and J). Live, CD11c-A647+ cells from 
either DC1 or DC2 populations were selected for all further cell surface marker 
expression analysis (Figure 5.1G and K, respectively).  
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Figure 5.1 Gating strategy for the selection of two distinct populations of CD11c+ dendritic cells. 
Representative dot plot and contour images of monocyte derived dendritic cells incubated with PBS for 24 hours are shown where 2 distinct populations 
were selected (DC1(B) or DC2(C)) based on forward (size) and side scatter (granularity, (A)). Unstained selected populations (D and H) were used to select 
for eFluor® 520 -positive cells. Live DC1 (E) or DC2 (I) populations were selected to gate for CD11c+ cells using the matched isotype control, mouse IgG1-
A647 (F and J). Cells fluorescing positive for CD11c-A647 (G-F or K-J to give percentage of cells positive for CD11c) were selected and used to analyse a range 
of cell surface markers detected by PE-conjugated antibodies and their relevant isotype controls. 
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Upon analysis of 7 donors, the percentage of live cells in the DC2 sub 
populations was significantly higher than the percentage of live cells in the DC1 
populations (Figure 5.2A, blue bars and orange bars respectively). This effect was 
observed across all conditions (PBS, LPS, Nm/PBS and Nm/CRP: p=0.0001, p<0.0001, 
p<0.0001 and p<0.0001 respectively) except for dendritic cells incubated with Nm 
pre-treated with NHS. Analysis of the same 7 donors revealed that the DC2 sub 
population had significantly higher percentages of CD11c positive cells (percent of 
cells positive for CD11c – percent of cells positive for matched isotype control) in 
comparison to the DC1 population (Figure 5.2B, blue bars and orange bars, 
respectively).  Again, this effect was observed across all conditions (PBS, LPS, 
Nm/PBS and Nm/CRP: p<0.0001, p=0.0028, p<0.0001 and p<0.0001 respectively) 
apart from dendritic cells incubated with Nm pre-treated with NHS. Following these 
observations, the sub population DC2 was used for all further analysis of cell surface 
markers.  
 
  
 
Figure 5.2 Percent of live cells and CD11c expression levels in two dendritic cell 
populations, DC1 and DC2. 
Monocyte derived dendritic cells were incubated with PBS, LPS, Nm/PBS, Nm/NHS or 
Nm/CRP for 24 hours before staining with a viability dye to exclude dead cells and a 
fluorescent antibody targeting CD11c (percent of cells positive for CD11c – percent of cells 
positive for matched isotype control). The mean and SD of 7 donors are shown for the 
percent of live cells (A) and the percent of cells positive for CD11c (B) where **, *** and 
**** denote p<0.005, p<0.0005 and p<0.0001 upon comparison of the two dendritic cell 
populations, DC1 (orange bars) and DC2 (blue bars) respectively.  
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5.2.1.2 The effect of CRP opsonised Neisseria meningitidis on activation marker 
expression in monocyte derived dendritic cells 
 In order to investigate the effect of CRP opsonised Nm uptake on DC 
activation, monocyte derived macrophages were incubated with PBS, LPS, Nm/PBS, 
Nm/NHS or Nm/CRP before staining with a dead cell exclusion stain and double 
staining with CD11c (as a DC marker) and a range of activation markers, including 
pattern recognition receptors (PRRs), DC maturation markers, antigen presentation 
complexes and co-stimulatory molecules.  
CD206  
The expression of CD206 by dendritic cells is regarded as an immature DC 
phenotype marker, where stimulation of these cells and their subsequent activation 
and maturation induces the down regulation of this receptor (Cochand et al. 1999; 
Wollenberg et al. 2002; Krutzik et al. 2005).  No previous studies have investigated 
the effect of Nm or CRP opsonised Nm on dendritic cell CD206 expression and it was 
of interest, therefore, to investigate if CRP opsonised Nm induced a particular DC 
phenotype.  
In addition to being a maturation marker, CD206 is also known as a C-type 
lectin receptor which is able to bind carbohydrate containing structures of 
pathogens such as Leishmania donovani (Chakraborty et al. 2001) and  
Pneumocystis carinii (O’Riordan et al. 1995) and is involved in their internalisation 
for degradation via the phagocytic pathway (Moll 2003). No previous studies have 
shown that DCs are able to uptake Nm via this receptor, however, Nm has been 
known to bind another acute phase protein, mannose binding lectin (MBL (Jack et 
al. 2005)), which, like CD206, is also a member of the C-type lectin family (Taylor et 
al. 1990) and has similar recognition sites to that of CD206 (Mullin et al. 1997). It 
follows, therefore, that Nm may be able to bind CD206, which may result in uptake 
of the meningococcus. The effect of CRP opsonised Nm on CD206 expression by DCs 
was investigated to further determine the role of CRP on alternative phagocytic 
pathways/PRRs of Nm. 
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Following the gating strategy in Figure 5.1, the cells within the gate staining 
positive for CD11c were used to determine the percent of cells positive for CD206, 
by subtracting the percent of cells positive for the appropriate isotype control. 
Figure 5.3 shows representative histogram overlay plots of the relative expression 
of CD206 by dendritic cells compared to the matched isotype control. The 
histogram plots show the median fluorescence increasing (shifting right) upon DC 
stimulation with LPS (B), Nm/PBS (C), Nm/NHS (D) and Nm/CRP (E) in comparison to 
DCs incubated with PBS alone (A).  
 
Figure 5.3 Representative histograms showing the effect of CRP opsonised N. meningitidis 
on CD206 expression in monocyte derived dendritic cells 
Monocyte derived dendritic cells were incubated with PBS (A), LPS (B), Nm/PBS (C), 
Nm/NHS (D) or Nm/CRP (E) for 24 hours before staining with a viability dye to exclude dead 
cells and fluorescent antibodies targeting CD11c and CD206. Representative overlay 
histogram plots show the relative expression of CD206 (purple) in comparison to the 
matched isotype control (blue).  
 
 Analysis of 7 donors revealed that 78.2 ± 8.2% of unstimulated DCs 
(incubated with PBS) expressed CD206 (Figure 5.4A), with no difference in 
expression observed upon stimulation with LPS. The percent of DCs expressing 
CD206 was not affected upon incubation of the cells with either Nm/PBS or 
Nm/CRP, however, incubation of DCs with Nm/NHS induced a significant increase in 
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percent expression (90 ± 2.5%) by these cells upon comparison to DCs stimulated 
with LPS (p=0.0478). 
 Interestingly, the median fluorescence intensity (MFI) of DC CD206 
expression decreased upon stimulation with LPS, Nm/PBS and Nm/CRP in 
comparison to unstimulated DCs, although this was not statistically significantly 
different (Figure 5.4B).  Incubation of DCs with Nm/NHS had no effect on the MFI of 
CD206 expression by DCs in comparison to unstimulated DCs.  
 
Figure 5.4 The effect of CRP opsonised N. meningitidis on CD206 expression in monocyte 
derived dendritic cells 
Monocyte derived dendritic cells were incubated with PBS, LPS, Nm/PBS, Nm/NHS or 
Nm/CRP for 24 hours before staining with a viability dye to exclude dead cells and 
fluorescent antibodies targeting CD11c and CD206. The mean and SD of 7 donors are 
shown for percent of cells positive for CD206 (A) and the MFI of CD206 expression (B) 
where * denotes p<0.05. 
 
 
CD209 
 Dendritic cell-specific intercellular adhesion molecule-3-grabbing non-
integrin  (DC-SIGN), also known as CD209, is another cell surface receptor that 
decreases upon maturation of DCs (Kato 2000). It is highly expressed in immature 
DCs and following antigen uptake and processing, is involved in the migration of DCs 
to secondary lymphoid organs for antigen presentation. This trafficking is achieved 
with DC-SIGN which assists in binding and rolling the DCs along endothelial cells 
(Geijtenbeek et al. 2000). Much like CD206, it was of interest to investigate the 
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effect of CRP opsonised Nm on the expression of this receptor by DCs and, 
therefore, if CRP opsonised Nm induced a particular DC phenotype.  
CD209 is also a C-type lectin receptor (Figdor et al. 2002) which has been 
shown to be involved in the uptake and phagocytosis of several pathogens such as 
Dengue virus, Escherichia coli and Mycobacterium tuberculosis  (Tassaneetrithep et 
al. 2003; Klena et al. 2005; Tailleux et al. 2002, respectively). As with CD206, 
whether or not DC expressing CD209 is able to bind Group B Nm and mediate 
phagocytosis in the same way has yet to be investigated and the effect of Nm and 
CRP opsonised Nm on this receptor was of interest in order to determine the role of 
CRP on alternative phagocytic pathways/PRRs of Nm. 
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Following the gating strategy in Figure 5.1, the cells within the gate staining 
positive for CD11c were used to determine the percent of cells positive for CD209, 
by subtracting the percent of cells positive for the appropriate isotype control. 
Figure 5.5 shows representative histogram overlay plots of the relative expression 
of CD209 by dendritic cells compared to the matched isotype control. The 
histogram plots show the median fluorescence decreasing (shifting left) upon DC 
stimulation with LPS (B), Nm/PBS (C), Nm/NHS (D) and Nm/CRP (E) in comparison to 
DCs incubated with PBS alone (A).  
 
Figure 5.5 Representative histograms showing the effect of CRP opsonised N. meningitidis 
on CD209 expression in monocyte derived dendritic cells 
Monocyte derived dendritic cells were incubated with PBS (A), LPS (B), Nm/PBS (C), 
Nm/NHS (D) or Nm/CRP (E) for 24 hours before staining with a viability dye to exclude dead 
cells and fluorescent antibodies targeting CD11c and CD209. Representative overlay 
histogram plots show the relative expression of CD209 (purple) in comparison to the 
matched isotype control (blue).  
 
Upon analysis of 7 donors, the percent of DCs expressing CD209 significantly 
decreased when cells were incubated with Nm/NHS in comparison to unstimulated 
cells (PBS) or LPS stimulated cells (p=0.0458 and p=0.0092, respectively (Figure 
5.6A)). No significant differences in CD209 expression by DCs were observed upon 
incubation of the cells with Nm/PBS or Nm/CRP. 
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Interestingly, stimulation of DCs with LPS, Nm/PBS, Nm/NHS and Nm/CRP all 
decreased the MFI of CD209 expression by these cells, although these were not 
statistically different (Figure 5.6B). Upon comparison of Nm/CRP incubated DCs with 
unstimulated cells, however, a significant decrease in MFI of CD209 expression was 
observed (p=0.0046).  
 
Figure 5.6 The effect of CRP opsonised N. meningitidis on CD209 expression in monocyte 
derived dendritic cells 
Monocyte derived dendritic cells were incubated with PBS, LPS, Nm/PBS, Nm/NHS or 
Nm/CRP for 24 hours before staining with a viability dye to exclude dead cells and 
fluorescent antibodies targeting CD11c and CD209. The mean and SD of 7 donors are 
shown for percent of cells positive for CD209 (A) and the MFI of CD209 expression (B) 
where * and ** denotes p<0.05 and p<0.005, respectively. 
 
CD83  
CD83 is a member of the IgG superfamily and is a marker of DC maturation 
(Zhou & Tedder 1996). Increased expression of CD83, along with co-stimulatory 
molecules, is necessary for DCs to induce T cell development, and therefore, 
efficient adaptive immune responses (Prazma et al. 2007). Previous studies have 
shown that upon infection with Group B Nm, DCs maturation is illustrated by the 
increase of several cell surface markers, including CD83 (Dixon et al. 2001b; Mesa et 
al. 2004; Kolb-Mäurer et al. 2001a). The effect of CRP opsonised Nm infection on DC 
CD83 expression, however, has not been investigated and it was, therefore, of 
interest to determine the role of CRP on DC maturation during meningococcal 
infection.  
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Figure 5.7 shows representative histogram overlay plots of the relative 
expression of CD83 by dendritic cells compared to the matched isotype control. The 
histogram plots show the median fluorescence decreasing (shifting left) upon DC 
stimulation with LPS (B), Nm/PBS (C), Nm/NHS (D) and Nm/CRP (E) in comparison to 
DCs incubated with PBS alone (A) and the increase in percentage of cells positive for 
CD83 depicted by the enlargement of the population area in pink.  
 
Figure 5.7 Representative histograms showing the effect of CRP opsonised N. meningitidis 
on CD83 expression in monocyte derived dendritic cells 
Monocyte derived dendritic cells were incubated with PBS (A), LPS (B), Nm/PBS (C), 
Nm/NHS (D) or Nm/CRP (E) for 24 hours before staining with a viability dye to exclude dead 
cells and fluorescent antibodies targeting CD11c and CD209. Representative overlay 
histogram plots show the relative expression of CD209 (purple) in comparison to the 
matched isotype control (blue).  
 
Following the analysis of 7 donors, 24 hours of LPS stimulation induced a 
marked increase in the percent of DCs expressing CD83 in comparison to 
unstimulated cells (p= 0.0012 (Figure 5.7A)). Nm pre-treated with NHS also induced 
an increase in the percent of DCs expressing CD83 in comparison to unstimulated 
cells (p=0.0226), whereas no significant difference was observed in DCs incubated 
with Nm/CRP.  
No significant differences were observed in the MFI of CD83 expression by 
DCs across any of the conditions (Figure 5.7B). 
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Figure 5.8 The effect of CRP opsonised N. meningitidis on CD83 expression in monocyte 
derived dendritic cells 
Monocyte derived dendritic cells were incubated with PBS, LPS, Nm/PBS, Nm/NHS or 
Nm/CRP for 24 hours before staining with a viability dye to exclude dead cells and 
fluorescent antibodies targeting CD11c and CD83. The mean and SD of 7 donors are shown 
for percent of cells positive for CD83 (A) and the MFI of CD83 expression (B) where * and ** 
denotes p<0.05 and p<0.005, respectively. 
 
 
CD40 
 CD40 is a member of the Tumour Necrosis Factor superfamily (TNFSF) and is 
one of several co-stimulatory molecules expressed by resting dendritic cells. Upon 
binding of CD40 to its ligand CD154 on T cells, DCs are activated to become more 
effective antigen presenting cells (APCs) and are thus able to present processed 
antigen to T cells to stimulate effective adaptive immune responses (Dixon et al. 
2001a). Previous studies have demonstrated that upon infection with Group B 
meningococcal outer membrane vesicles, this co-stimulatory molecule is up 
regulated (Al-Bader et al. 2003), signifying that Nm is capable of activating DCs and 
inducing effective T cell responses. The role of CRP during Nm infection has yet to 
be investigated, and the results of which may reveal if this acute phase protein will 
increase or dampen the activation of DCs and therefore affect T cell responses 
accordingly.  
 Figure 5.9 shows representative histogram overlay plots of the relative 
expression of CD40 by dendritic cells compared to the matched isotype control. The 
histogram plots show the median fluorescence increasing (shifting right) upon DC 
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stimulation with LPS (B), Nm/PBS (C) and Nm/CRP (E) in comparison to DCs 
incubated with PBS alone (A) and DCs incubated with Nm/NHS (D). 
 
Figure 5.9 Representative histograms showing the effect of CRP opsonised N. meningitidis 
on CD40 expression in monocyte derived dendritic cells 
Monocyte derived dendritic cells were incubated with PBS (A), LPS (B), Nm/PBS (C), 
Nm/NHS (D) or Nm/CRP (E) for 24 hours before staining with a viability dye to exclude dead 
cells and fluorescent antibodies targeting CD11c and CD40. Representative overlay 
histogram plots show the relative expression of CD40 (purple) in comparison to the 
matched isotype control (blue).  
 
  
 The analysis of 7 donors revealed that percent of DCs expressing CD40 was 
constitutively high and was not affected by any of the conditions (Figure 5.10)  
 Analysis of the MFI of CD40 expression in the same 7 donors, however, did 
reveal differences between each condition (Figure 5.11). LPS stimulation appeared 
to up regulated CD40 expression by DCs (although this was not significantly 
different) and incubation of DCs with Nm/PBS had a similar affect, but to a greater 
extent than LPS (again, not significantly different). Interestingly, pre-treatment of 
Nm with NHS seemed to remove the bacteria’s capacity of inducing CD40 up 
regulation as a significant decrease was observed in MFI of CD40 expression 
between DCs incubated with Nm/PBS and Nm/NHS (p=0.0431). Opsonisation of Nm 
with CRP did not have the same effect as an increase in MFI of CD40 expression was 
seen in DCs incubated with Nm/CRP in comparison to DCs incubated with Nm/NHS 
(p=0.0388).   
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Figure 5.10 The effect of CRP opsonised N. meningitidis on CD40 expression in monocyte 
derived dendritic cells 
Monocyte derived dendritic cells were incubated with PBS, LPS, Nm/PBS, Nm/NHS or 
Nm/CRP for 24 hours before staining with a viability dye to exclude dead cells and 
fluorescent antibodies targeting CD11c and CD40. The mean and SD of 7 donors are shown 
for percent of cells positive for CD40 (A) and the MFI of CD40 expression (B) where * 
denotes p<0.05. 
 
 
B7 Molecules: CD80 and CD86 
 The B7-1 and B7-2 molecules (otherwise known as CD80 and CD86 
respectively) are members of the Ig superfamily and are constitutively expressed by 
dendritic cells. Following antigen uptake and processing for presentation by DCs to 
T cells, the presentation of antigen peptides in the context of MHC molecules to the 
relevant T cell receptor (TCR) is not sufficient enough to fully activate the T cell 
(Harris & Ronchese 1999). A second signal, also known as co-stimulation, is 
necessary to induce this effect and the B7 molecules are the most potent of all co-
stimulatory molecules. The B7 ligands are CD28 and CTLA-4 expressed by T cells, 
binding of which either positively or negatively regulates T cell function, 
respectively (Waterhouse et al. 1996).   
 The expression of the co-stimulatory molecules CD80 and CD86, have been 
shown in previous studies to be moderately up regulated in DCs following infection 
with Nm (Al-Bader et al. 2003; Dixon et al. 2001b) which is typical of a more mature 
DC phenotype, and thus the cells are better primed to stimulate T cell activation 
during Nm infection. The effect of CRP during such infection, however, has not yet 
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been investigated and will be of interest to determine the role of CRP on DC 
activation. 
CD80 
 Figure 5.11 shows representative histogram overlay plots of the relative 
expression of CD80 by dendritic cells compared to the matched isotype control. The 
histogram plots show the median fluorescence increasing (shifting right) upon DC 
stimulation with LPS (B), Nm/PBS (C)  Nm/NHS (D) and Nm/CRP (E) in comparison to 
DCs incubated with PBS alone (A).  
 
Figure 5.11 Representative histograms showing the effect of CRP opsonised N. 
meningitidis on CD80 expression in monocyte derived dendritic cells 
Monocyte derived dendritic cells were incubated with PBS (A), LPS (B), Nm/PBS (C), 
Nm/NHS (D) or Nm/CRP (E) for 24 hours before staining with a viability dye to exclude dead 
cells and fluorescent antibodies targeting CD11c and CD80. Representative overlay 
histogram plots show the relative expression of CD80 (purple) in comparison to the 
matched isotype control (blue).  
 
 Upon analysis of 7 donors, the percent of unstimulated DCs positive for 
CD80 was varied across each donor, however, upon stimulation with LPS and 
Nm/PBS, Nm/NHS and Nm/NHS, CD80 was markedly up regulated and expressed by 
nearly 100% of cells following incubation with each condition, although this was not 
significantly different (Figure 5.12A).  
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 Analysis of changes in MFI of CD80 expression by DCs following incubation 
with each condition showed moderate changes which were statistically significantly 
different as these changes were observed consistently across each donor (Figure 
5.12B). LPS stimulation induced the up regulation of CD80 by DCs in comparison to 
unstimulated cells, although this was not significantly different. Incubation of DCs 
with Nm/PBS also induced up regulation of CD80 expression by DCs in comparison 
to unstimulated cells (not significantly different), levels of which were significantly 
lower than those of LPS stimulated cells (p=0.0146). Interestingly, incubation of DCs 
with NHS pre-treated Nm induced a significantly lower level of CD80 expression by 
DCs in comparison to DCs incubated with LPS, Nm/PBS and Nm/CRP (p=0.0076, 
p=0.0139 and p=0.0264 respectively). Nm/CRP had a similar affect to Nm/PBS and 
was also able to up regulate CD80 expression by DCs in comparison to unstimulated 
cells (not significantly different) and similarly, induce lower levels of CD80 
expression in DCS compared to LPS stimulated cells (p=0.0030).  
 
Figure 5.12 The effect of CRP opsonised N. meningitidis on CD80 expression in monocyte 
derived dendritic cells 
Monocyte derived dendritic cells were incubated with PBS, LPS, Nm/PBS, Nm/NHS or 
Nm/CRP for 24 hours before staining with a viability dye to exclude dead cells and 
fluorescent antibodies targeting CD11c and CD80. The mean and SD of 7 donors are shown 
for percent of cells positive for CD80 (A) and the MFI of CD80 expression (B) where * 
denotes p<0.05. 
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CD86 
Figure 5.13 shows representative histogram overlay plots of the relative 
expression of CD80 by dendritic cells compared to the matched isotype control. The 
histogram plots show the median fluorescence increasing (shifting right) upon DC 
stimulation with LPS (B), Nm/PBS (C)  Nm/NHS (D) and Nm/CRP (E) in comparison to 
DCs incubated with PBS alone (A).  
 
Figure 5.13 Representative histograms showing the effect of CRP opsonised N. 
meningitidis on CD86 expression in monocyte derived dendritic cells 
Monocyte derived dendritic cells were incubated with PBS (A), LPS (B), Nm/PBS (C), 
Nm/NHS (D) or Nm/CRP (E) for 24 hours before staining with a viability dye to exclude dead 
cells and fluorescent antibodies targeting CD11c and CD86. Representative overlay 
histogram plots show the relative expression of CD86 (purple) in comparison to the 
matched isotype control (blue).  
 
 Analysis of 7 donors revealed that CD86 expression profiles were very similar 
to those observed upon analysis of CD80, whereby the percent of unstimulated DCs 
positive for CD86 was varied across each donor, however, upon stimulation with 
LPS and Nm/PBS, Nm/NHS and Nm/NHS, CD86 was markedly up regulated and 
expressed by the majority of cells following incubation with each condition, 
although this was not significantly different (Figure 5.14A).  
 The MFI of CD86 expression of DCs also shared similar expression profiles to 
that of CD80 (Figure 5.14B). LPS stimulation induced the up regulation of CD86 by 
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DCs in comparison to unstimulated cells, although this was not significantly 
different. Incubation of DCs with Nm/PBS also induced up regulation of CD86 
expression by DCs in comparison to unstimulated cells, although this was not 
significantly different. As observed previously, incubation of DCs with NHS pre-
treated Nm induced a significantly lower level of CD86 expression by DCs in 
comparison to DCs incubated with LPS, Nm/PBS and Nm/CRP (p=0.0219, p=0.0083 
and p=0.0172 respectively). Interestingly, Nm/CRP induced significantly lower MFI 
levels of CD86 expression by DCs compared to cells incubated with Nm/PBS 
(p=0.0450).  
 
Figure 5.14 The effect of CRP opsonised N. meningitidis on CD86 expression in monocyte 
derived dendritic cells 
Monocyte derived dendritic cells were incubated with PBS, LPS, Nm/PBS, Nm/NHS or 
Nm/CRP for 24 hours before staining with a viability dye to exclude dead cells and 
fluorescent antibodies targeting CD11c and CD86. The mean and SD of 7 donors are shown 
for percent of cells positive for CD86 (A) and the MFI of CD86 expression (B) where * 
denotes p<0.05. 
 
 
HLA-DR 
Dendritic cells are known to be the most professional of antigen 
presentation cells (APCs) which involves processing of antigen and presentation of 
the peptides to CD4+ T cells using major histocompatibility complex (MHC) class II 
molecules in order to stimulate effective adaptive immune responses. MHC class II 
molecules are only expressed by antigen presenting cells such as DCs and in humans 
are generally referred to as human leukocyte antigens (HLA) as they are encoded by 
the HLA gene on chromosome 6 (Volpi et al. 2000). Within the class II MHC locus, 
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there are 3 genes (HLA-DP, HLA-DQ and HLA-DR), where at least one of each gene 
are inherited from each parent and possibly two of HLA-DR, leading to the 
expression of 6-8 class II molecules by each APC. Thus, fluorescently tagged 
antibodies targeting HLA-DR were chosen as these are the most abundantly 
expressed class II MHC allele (Brooks & Moore 1988).  
MHC Class II expression in DCs is significantly up regulated upon Nm 
infection (Dixon et al. 2001a; Kolb-Mäurer et al. 2001b) however, investigations into 
whether CRP opsonised Nm will induce DC activation in the same way was yet to be 
carried out.  
 Figure 5.15 shows representative histogram overlay plots of the relative 
expression of HLA-DR by dendritic cells compared to the matched isotype control. 
The histogram plots show the median fluorescence increasing (shifting right) upon 
DC stimulation with LPS (B), Nm/PBS (C),  Nm/NHS (D) and Nm/CRP (E) in 
comparison to DCs incubated with PBS alone (A).  
 
Figure 5.15 Representative histograms showing the effect of CRP opsonised N. 
meningitidis on HLA-DR expression in monocyte derived dendritic cells 
Monocyte derived dendritic cells were incubated with PBS (A), LPS (B), Nm/PBS (C), 
Nm/NHS (D) or Nm/CRP (E) for 24 hours before staining with a viability dye to exclude dead 
cells and fluorescent antibodies targeting CD11c and HLA-DR. Representative overlay 
histogram plots show the relative expression of HLA-DR (purple) in comparison to the 
matched isotype control (blue).  
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 Analysis of 7 donors revealed the constitutively high expression of HLA-DR 
by all DCs following all treatments (Figure 5.16A).  
 Interestingly, although the percent of DCs expressing HLA-DR did not vary, 
up regulation of the MFI of HLA-DR expression was observed upon stimulation of 
the cells with LPS, unopsonised Nm, NHS pre-treated Nm and CRP opsonised Nm, 
although these were not statistically significantly different (Figure 5.16B).  
 
Figure 5.16 The effect of CRP opsonised N. meningitidis on HLA-DR expression in 
monocyte derived dendritic cells 
Monocyte derived dendritic cells were incubated with PBS, LPS, Nm/PBS, Nm/NHS or 
Nm/CRP for 24 hours before staining with a viability dye to exclude dead cells and 
fluorescent antibodies targeting CD11c and HLA-DR. The mean and SD of 7 donors are 
shown for percent of cells positive for HLA-DR (A) and the MFI of HLA-DR expression (B). 
 
 
 
5.2.2 The effect of CRP mediated uptake of Neisseria meningitidis on 
cytokine production by dendritic cells 
 Dendritic cells have been implicated as one of the major sources of high 
levels of pro-inflammatory cytokine production during Nm infection (most notably 
IL-1β, IL-6, IL-8 and TNFα), where severity of the disease directly correlates to pro-
inflammatory cytokine production. DCs, therefore, are important contributors to 
the pathology of meningococcal disease (Kolb-Mäurer et al. 2001a; Mazzon et al. 
2007). High levels of the pro-inflammatory cytokine IL-12p70 and the anti-
inflammatory cytokine, IL-10 have also been found to be produced by DCs in 
response to Nm infection (Uronen-Hansson, Steeghs, et al. 2004). The cytokine 
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production in response to CRP mediated uptake of Nm, however, was not yet 
investigated and may reveal if CRP mediated uptake of Nm into DCs is beneficial 
towards the meningococcus or the host in terms of downstream immune 
responses, which may be indicated if CRP opsonisation changes or affects the 
cytokines secreted in culture. 
In order to measure the effect of CRP opsonised Nm uptake on inflammatory 
cytokine production by monocyte derived dendritic cells, supernatants were 
reserved following the protocol described in 2.2.18. In-house TNF-α enzyme linked 
immunosorbant assays (ELISAs) were carried out as per section 2.2.19 (data not 
shown) to screen for any non-responding donors and to determine the dilutions 
required in order to have each cytokine within the detectable ranges of the BD 
Biosciences Human Inflammatory Cytometric Bead Array (CBA2) kit. The kit was 
then used to detect a range of DC secreted inflammatory cytokines (interleukin (IL)-
1β, IL-6, IL-8, IL-10, IL-12p70 and tumour necrosis factor (TNF)) 
IL-1β  
There are two species of the pro-inflammatory cytokine, IL-1: IL-1α and IL-
1β. (Oppenheim et al. 1986). The latter is predominantly expressed and has a higher 
contribution to IL-1 activity than IL-1α. IL-1β has been shown to induce fever via 
increasing the thermostatic set point of the hypothalamus, stimulate hepatic cells 
to produce acute phase proteins and encourage leucocyte-endothelial cell adhesion  
(Kern et al. 1988). It is therefore an important mediator of inducing and maintaining 
inflammatory responses and is recognised as a contributor to the development of 
septic shock during Nm infection (van Deuren et al. 1995).  
Upon analysis of 7 donors, incubation of monocyte derived dendritic cells 
with CRP opsonised Nm resulted in significantly increased levels of IL-1β production 
in comparison to resting cells and DCs incubated with LPS (p=0.0248 and 0.0236 
respectively, Figure 5.17A). Incubation of DCs with unopsonised Nm or NHS pre-
treated Nm also induced increased production of IL-1β compared to resting cells, 
however, this was not statistically significantly different. No significant difference 
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was observed between the effect of unopsonised and CRP opsonised Nm on IL-1β 
production.  
IL-6 
IL-6 has been described as both a pro-inflammatory and an anti-
inflammatory cytokine and it is well established that in healthy individuals little to 
no IL-6 is detected in their serum (Helfgott et al. 1989). Upon infection and during 
inflammatory states, however, marked increases of this protein have been detected 
(Scheller et al. 2011) and high serum levels of IL-6 have also been observed in 
patients suffering from meningococcal sepsis (Helfgott et al. 1989). 
Incubation of monocyte derived DCs with LPS, Nm/PBS, Nm/NHS or Nm/CRP 
significantly increased levels of IL-6 production by these cells in comparison to DCs 
incubated with PBS alone (p=0.0003, 0.0065, 0.0005 and 0.0028 respectively, Figure 
5.17B). Significantly increased levels of IL-6 production were also detected upon 
comparison of Nm/PBS, Nm/NHS and Nm/CRP with LPS (p=0.0321, 0.0019 and 
0.0158 respectively). No significant differences were observed between the effect 
of unopsonised and CRP opsonised Nm on IL-6 production.  
IL-8 
 The pro-inflammatory cytokine IL-8 is known as a potent chemoattractant 
and activator of neutrophils to sites of inflammation. During meningococcal 
meningitis, production of IL-1β and TNFα have been found to initiate inflammatory 
cascades including the release of IL-8 (Waage 1989). This subsequently activates the 
incoming neutrophils inducing respiratory burst activity and secretion of lysosomal 
enzymes which all contribute towards tissue injury typical of bacterial meningitis 
infection (Ehrlich et al. 1998). 
 Resting DCs produced very low levels of IL-8 and significant increases in 
secreted IL-8 was detected upon stimulation of the cells with LPS, Nm/PBS, Nm/NHS 
and Nm/CRP (p=0.0021, 0.0009, 0.0013 and 0.0018 respectively (Figure 5.17C)). DCs 
were also found to secrete significantly higher levels of IL-8 upon incubation with 
Nm/NHS in comparison to cells stimulated with the positive control, LPS (p=0.0022). 
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No significant difference in IL-8 production was found between incubation of DCs 
with unopsonised or CRP opsonised Nm. 
 
Figure 5.17 The effect of CRP opsonised N. meningitidis on inflammatory cytokine 
production by monocyte derived dendritic cells. 
Monocyte derived dendritic cells were incubated with PBS alone (white bars), LPS (green 
bars), Nm/PBS (pink bars), Nm/NHS (purple bars) or Nm/CRP (yellow bars) for 24 hours 
before removing cell culture supernatants to measure IL-1β (A), IL-6 (B), IL-8 (C), IL-10 (D), 
IL-12p70 (E) and TNFα (F) concentrations by  Cytometric Bead Array. The mean and SEM of 
7 replicate experiments are shown where *, ** and *** denote p<0.05, p<0.005 and 
p<0.0005 respectively.    
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IL-10 
IL-10 is an anti-inflammatory cytokine which acts to limit pro-inflammatory 
immune responses, thereby protecting the host from excessive damage. Also 
known as the Cytokine Synthesis inhibiting factor (CSIF (Moore et al. 1990)), IL-10 is 
broadly expressed by various cell types such as T cells, macrophages, neutrophils 
and dendritic cells (Saraiva & O’Garra 2010). IL-10 secretion from DCs acts to limit 
the Th1 response (Dixon et al. 2001b), which is critical during bacterial infections 
such as meningococcal meningitis where the pro-inflammatory response is often 
harmful to the host, and upon infection with Nm, DCs have been shown to secrete 
increased levels of this cytokine (Jones et al. 2007; Steeghs et al. 2006). 
IL-10 secretion was not detected in supernatants from resting DCs and upon 
incubation with LPS, Nm/PBS and Nm/NHS significant increases were detected 
(p=0.0032, 0.0176 and 0.0144 respectively (Figure 5.17D)). Due to the considerable 
amount of IL-10 detected in supernatants from DCs incubated with Nm/NHS, 
significant differences were observed upon comparison to LPS stimulated cells, and 
cells incubated with Nm/PBS and Nm/CRP (p=0.0170, 0.0177 and 0.0250 
respectively). No significant differences were observed between the effect of 
unopsonised and CRP opsonised Nm on IL-10 production. 
IL-12p70 
The pro-inflammatory cytokine IL-12p70 is produced primarily by antigen 
presenting cells and has an important role in CD4+ T cell polarisation to Th1 cells  
(Zhou et al. 2013), which are then stimulated to produce cytokines (IFNγ, IL-2 and 
TNFβ) that induce bactericidal and phagocytic dependant protective responses in 
macrophages. The production of IL-12p70 and, therefore, the Th1 response, is 
particularly important in the clearance of bacterial infections such as meningococcal 
meningitis (Romagnani 1999).  
Resting cells, LPS stimulated DCs and cells incubated with Nm/NHS all 
secreted very low levels of IL-12p70 (Figure 5.17E). DCs incubated with Nm/PBS and 
Nm/CRP, however, induced significantly higher levels of this pro-inflammatory 
 
 
173 
 
cytokine upon comparison to resting cells (p=0.0415 and 0.0360 respectively) and 
LPS (p=0.0426 and 0.0363 respectively). Additionally, a significant increase in IL-
12p70 secretion was detected between Nm/NHS and Nm/CRP incubated cells 
(p=0.0458). No significant differences were observed between the effect of 
unopsonised and CRP opsonised Nm on IL-12p70 production. 
Tumour necrosis factor 
Tumour necrosis factor (TNF) is a soluble cytokine which is able to exert 
cytotoxicity of various tumour cell lines  and cause necrosis and apoptosis of these 
cells (Wajant et al. 2003). It is an endogenous pyrogen that can cause fever and is 
an important contributor to the pathogenesis of meningococcal meningitis and 
septicaemia. It is an early pro-inflammatory cytokine and levels of TNF detected in 
the cerebrospinal fluid of Nm suffering patients correlate with the severity of 
disease (Taha 2000). 
The secretion of high levels of TNF (formally known as TNFα)  by DCs during 
meningococcal meningitis is well established (Steeghs et al. 2008; Al-Bader et al. 
2003; Waage 1989; van Deuren et al. 1995; Unkmeir 2002; Dixon et al. 2001a) and 
levels of TNF secretion from resting DCs were negligible, as expected.  Secretion of 
TNF was significantly increased upon incubation of the cells with Nm/PBS, Nm/NHS 
and Nm/CRP (p=0.0006, 0.0409 and 0.0002 respectively (Figure 5.17F). Significant 
differences were also observed between LPS treated cells and DCs incubated with 
Nm/PBS, Nm/NHS and Nm/CRP (p=0.0073, 0.0464 and 0.0005 respectively). No 
significant differences were observed between the effect of unopsonised and CRP 
opsonised Nm on TNF production. 
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5.3 Discussion 
 Having demonstrated that the enhanced uptake of C - reactive protein (CRP) 
opsonised Neisseria meningitidis (Nm) into human monocyte derived macrophages 
and dendritic cells (DCs) occurred via Fcγ receptor I and II, it was important to 
investigate the possible downstream immune effects this enhanced uptake may 
induce in these cells. The first aim of this chapter was to use flow cytometry to 
analyse the effect of CRP enhanced uptake of Nm on DC activation markers to 
determine if CRP is affecting DC responses during meningococcal infection. The 
second aim was to use reserved supernatants from the flow cytometry experiments 
to analyse a range of inflammatory secreted cytokines using cytometric bead arrays 
to determine the effect of CRP enhanced uptake of Nm on DC immune responses.  
 
5.3.1 The effect of CRP opsonised N. meningitidis uptake on dendritic cell 
activation marker expression 
 Monocyte derived DCs were incubated with PBS, LPS, Nm/PBS, Nm/NHS and 
Nm/CRP for 24 hours prior to double staining with a DC lineage marker  and a range 
of cell surface activation markers for analysis by flow cytometry. 
CD206 expression 
 The immature DC phenotype marker CD206 is markedly down regulated 
upon DC activation (Krutzik et al. 2005) and is also a PRR due to its ability to 
recognise carbohydrate structures of pathogens (Chakraborty et al. 2001). The 
percent of DCs expressing CD206 in these studies remained constitutively high 
(>70%) and no changes were observed following any of the treatments, although 
moderate up regulation of CD206 expression was observed upon incubation of DCs 
with Nm/NHS. This pattern was mirrored in the MFI of CD206 expression where 
incubation of DCs with Nm/NHS had a different effect in comparison to 
unopsonised or CRP opsonised Nm, which induced small decreases in CD206 
expression, although not significantly different. It would be intriguing to theorise 
that as NHS has been found to contain the soluble form of CD206 which maintains 
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its mannose binding abilities (Rødgaard-Hansen et al. 2014), it is possible that 
soluble CD206 may be binding Nm and preventing uptake by cell surface expressed 
CD206, which will not be internalised (maintaining higher MFI levels). In addition to 
binding of Nm by soluble CD206, there are several opsonins present in NHS 
(complement proteins, antibody and CRP) which are able to bind and aid uptake of 
Nm by other cell surface receptors expressed by DCs such as complement receptor 
3 or Fcγ receptors (Kerrigan & Brown 2009).  
 Small decreases (not significantly different) in MFI of CD206 expression were 
observed upon incubation of DCs with LPS, Nm/PBS and Nm/CRP indicating the 
activation of these cells and subsequent internalisation of the receptor, which has 
been shown to occur upon DC activation (Stahl et al. 1980). In addition, CD206 is a 
marker of immature DCs (Figdor et al. 2002) and the down regulation of this 
receptor, therefore, suggests that these treatments are able to induce DC 
maturation. CRP had no effect on the expression of CD206 which suggests that the 
down regulation of CD206 MFI (and subsequent activation) was induced by the 
meningococcus itself and not CRP.   
CD209 expression 
 CD209 (otherwise known as DC-SIGN) is not only a maturation marker which 
decreases upon activation of DCs, it is also an adhesion molecule and a pattern 
recognition receptor (PRR (Kato 2000; García-Vallejo et al. 2008; Gordon 2002)).  
No changes in the percent of DCs expressing this receptor were observed 
upon incubation with LPS, Nm/PBS or Nm/CRP, although a moderate decrease in 
expression was induced by Nm/NHS. As a marker of immaturity, the reduction of 
CD209 indicates DC activation and maturation. The selection of opsonins present in 
normal human serum would have been enhancing Nm uptake into DCs and 
therefore inducing maturation to a greater extent than unopsonised Nm or CRP 
opsonised Nm. 
Although changes in the percent of cells expressing this receptor were 
minimal, stimulation of DCs with LPS, unopsonised Nm, NHS pre-treated Nm and 
CRP opsonised Nm all induced minor down regulation of the MFI of CD209 
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expression indicating DC activation and maturation. As there were no significant 
differences between the effect of unopsonised Nm and CRP opsonised Nm, this 
suggests that Nm alone is able to induce DC activation and maturation. Nm binding 
to DC-SIGN has not been previously shown although DC-SIGN binding to other 
bacterial pathogens expressing LPS has been demonstrated, such as Helicobacter 
pylori and Klebsiella pneumonia (van Kooyk & Geijtenbeek 2003). Down regulation 
of DC-SIGN has also been shown to occur during infection by herpes virus 8 
(Rappocciolo et al. 2006), but this effect has not yet been investigated with Nm. 
Data from these studies suggests that Nm, either directly via CD209 or indirectly via 
other PRRs, is able to activate DCs and induce maturation.    
CD83 expression 
 CD83 is also a marker of DC maturation and this was demonstrated in the 
significant up regulation of this receptor upon stimulation of DCs with LPS which has 
been shown in previous studies (Dixon et al. 2001b; Zhou & Tedder 1996). CD83 has 
been detected as a preformed protein inside of immature DCs, which, upon LPS 
stimulation, is rapidly expressed on the surface of activated DCs (Cao et al. 2005). 
Stimulation of DCs with Nm (unopsonised, NHS pre-treated and CRP 
opsonised) induced up regulation of CD83, although to a lesser extent than LPS. This 
has been shown previously, where Group B meningococci outer membrane proteins 
were shown to be involved in the activation of DCs, demonstrated by CD83 up 
regulation (Al-Bader et al. 2003). As seen previously in the data for CD206 
expression, NHS pre-treatment of Nm induced a unique effect to unopsonised and 
CRP opsonised Nm, whereby CD209 expression was up regulated to a further 
extent. Opsonins present in NHS would have enhanced the uptake of Nm into DCs 
and potentially activated the cells to a greater extent than unopsonised or CRP 
opsonised Nm (as discussed above).  
No differences in the effect of Nm/PBS and Nm/CRP were observed, 
demonstrating that CRP has no additional effect to Nm in DC activation.  
 Across all conditions, no differences were observed in the MFI of CD83 
expression by DCs, showing that the number of molecules per cell does not vary 
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during meningococcal infection, but rather stimulation with LPS or Nm induces 
more dendritic cells to mature and express this receptor. 
CD40, CD80 and CD86 expression 
 The best defined co-stimulation molecules expressed by DCs are CD80, CD86 
and CD40, binding of which to their respective ligands on T cells will induce full 
activation in said T cell and illicit effective adaptive immune responses. Analysis of 
the expression of these three molecules by DCs following incubation with Nm 
revealed similar results and will, therefore, be discussed here together. 
All three types of co-stimulatory molecule were found to be constitutively 
expressed by DCs and no significant changes in the percent of DCs expressing these 
receptors was observed following incubation with any of the conditions, indicating 
that all DCs express this receptor regardless of activation level. The amount of co-
stimulatory molecules per cell, however, did vary depending on activation state as 
demonstrated in the MFI data.  
 LPS stimulation of DCs marginally induced the up regulation of each co-
stimulatory molecule. This has been demonstrated in previous studies using DCs 
whereby LPS activates the DCs inducing the increased expression of co-stimulatory 
molecules per cell (Verhasselt et al. 1997; Dixon et al. 2001b) indicating that 
substances derived from bacteria, like LPS, are able to stimulate maturation of DCs 
in order to become more effective in presentation to T cells to induce adaptive 
responses.  
 Incubation of DCs with Nm/PBS and Nm/CRP had a similar effect in that both 
unopsonised and CRP opsonised Nm induced similar levels of all three receptors’ 
expression and also up regulated the MFI of co-stimulatory molecule expression in 
comparison to resting DCS, which is unsurprising as both LOS and outer membrane 
vesicles produced by Nm have been found to successfully activate DCs in previous 
studies (Dixon et al. 2001b; Al-Bader et al. 2003). Interestingly, both unopsonised 
and CRP opsonised Nm appeared to increase the expression of CD40 to a greater 
extent than stimulation with LPS. This was not observed in CD80 and CD86 
expression and could be explained by the ability of phagocytosed Nm to activate toll 
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like receptors (TLRs) 2 and 4 inside the cells, as opposed to on the cells surface 
(Uronen-Hansson, Allen, et al. 2004): Activation of TLRs induces cross talk with the 
co-stimulatory molecule CD40, which is subsequently up regulated (Chandel et al. 
2014). The effect of unopsonised Nm was similar to that of CRP opsonised Nm 
which suggests that the up regulation of co-stimulatory molecule expression can be 
attributed to Nm alone and demonstrates the ability of Nm to activate DCs.  
 Interestingly, pre-treatment of Nm with NHS appeared to have little effect 
on the activation of DCs, demonstrated by the lack of CD40, CD80 and CD86 up 
regulation in comparison to the effect of unopsonised and CRP opsonised Nm. This 
suggests that some component(s) of NHS were inhibiting the effect of the 
meningococcus on co-stimulatory expression. Nm opsonised by IgG or other acute 
phase proteins found in serum will direct Nm uptake by receptors such as Fcγ 
receptors or complement receptors and will enter phagocytic and degradation 
pathways. The subsequent lack of further maturation signals following phagocytosis 
has been shown to have no effect on activation markers such as CD40, CD80 and 
CD86 (Clayton et al. 2003).   
HLA-DR expression 
 The human leukocyte antigens (HLA) are also known as major 
histocompatibility complex (MHC) molecules and HLA-DR is one of the genes found 
within the MHC Class II locus. This surface protein is expressed by antigen 
presenting cells (APCs) such as DCs and is used to present protein fragments of 
processed antigen to T cells in order to illicit effective adaptive immune responses.  
 HLA-DR was found to be constitutively expressed by all DCs in this study, 
regardless of treatment and activation state, which is in agreement with previous 
work (Dixon et al. 2001b; Franzoso et al. 2008). Minor differences in the MFI of HLA-
DR expression between treatments, however, were noticed.  
 Stimulation of DCs with LPS and Nm (unopsonised, NHS pre-treated and CRP 
opsonised) all induced minor up regulation of HLA-DR expression, indicating DC 
activation. Previous work has shown that incubation of DCs with LPS or Nm 
significantly up regulates the expression of TLR4 which is thought to modulate the 
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activation of DCs characterised by up regulation of MHC Class II molecules (Al-Bader 
et al. 2003). No differences in effect on HLA-DR expression between unopsonised 
and CRP opsonised Nm were observed, indicating that CRP does not play a role in 
the activation of DCs during meningococcal infection. The effect of NHS pre-
treatment of Nm, however, revealed a similar pattern as observed upon analysis of 
each co-stimulatory molecule, whereby NHS appeared to down regulate the effect 
of Nm activation. It seems fitting that similar observations were made across these 
molecules as they are all involved in DC presentation to T cells. It would be of 
interest to further investigate the effect of NHS components on the down 
regulation of DC activation during Nm infection and will be discussed in Chapter 6. 
 
5.3.2 The effect of CRP opsonised N. meningitidis uptake on dendritic cell 
inflammatory cytokine secretion 
 Following dendritic cell activation marker detection using flow cytometry, 
the reserved supernatants were used to investigate the effect of Nm opsonisation 
on downstream immune responses via analysis of DC cytokine secretion using a 
Human Inflammatory Cytometric Bead Array (CBA) kit. 
IL-1β secretion 
 The pro-inflammatory cytokine IL-1β is an important contributor to septic 
shock during meningococcal infection and upon incubation of Nm/CRP with DCs, a 
significant increase in IL-1β secretion in comparison to unstimulated and LPS 
stimulated cells was observed. As there was no significant difference between IL-1β 
production from DCs incubated with unopsonised Nm, this suggests that Nm itself 
was stimulating IL-1β production and secretion. This has been shown in a previous 
study where Nm induced significantly elevated IL-1β production from human 
macrophages in comparison to LPS stimulated cells (Sprong et al. 2003). Another 
species within the Neisseria genus, N. gonorrhoeae, has been shown to activate the 
protease enzyme, cathepsin (in monocytes) which is needed to cleave the inactive 
precursor of IL-1β into its mature bioactive form. N. gonorrhoeae achieves this 
activation by secreting LOS outer membrane blebs which induces the subsequent 
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release of IL-1β as a soluble cytokine (Duncan et al. 2009). A similar situation may 
also be induced by N. meningitides in these studies involving DCs and may explain 
the lack of IL-1β secretion upon DC incubation with NHS pre-treated Nm as 
opsonisation may be inhibiting the extent of outer membrane bleb secretion.  
Additionally, as Nm pre-treated with NHS did not induce the same effect as 
unopsonised and CRP opsonised Nm and as no previous studies have investigated 
these effects in DCs it is, therefore, difficult to identify which component of NHS is 
hindering IL-1β secretion.  A previous study demonstrated that mannose binding 
lectin (MBL) opsonisation of Nm markedly decreased IL-1β secretion by 
macrophages (Jack et al. 2001) and this is a possibility that should also be 
considered, as the NHS used in this study was likely to contain MBL and other 
opsonins.  
IL-8 secretion 
 IL-8 is also a pro-inflammatory cytokine that is a potent inducer of 
neutrophil chemotaxis to sites of inflammation and has been shown to be up 
regulated during meningococcal infection. The significant increase of IL-8 
production upon stimulation of DCs with LPS, Nm/PBS, Nm/NHS and Nm/CRP was 
not unexpected as previous studies have shown marked increases in IL-8 production 
by dendritic cells following stimulation with Group B Nm (Kolb-Mäurer et al. 2001a) 
and recombinant porin proteins which make up the outer membrane of Nm (Al-
Bader et al. 2004). CRP opsonisation appeared to have little effect on IL-8 
production by DCs, as no significant differences were observed between 
unopsonised and CRP opsonised Nm. Interestingly, NHS pre-treatment induced 
significantly higher levels of IL-8 production compared to LPS stimulated cells. No 
previous work has investigated the effect of NHS pre-treated Nm on DC cytokine 
secretion, however, a study using the fungus Malassezia furfur opsonised by NHS 
also found enhanced uptake and enhanced IL-8 production (Suzuki et al. 2000). This 
group hypothesised that this effect was due to complement opsonisation as 
repeated experiments using heat inactivated NHS did not produce the same effect. 
It can be suggested, therefore, that as the NHS used in these studies was not heat 
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inactivated, complement proteins would have been present and active to opsonise 
Nm.    
IL-12p70 secretion 
IL-12p70 is an important mediator of T cell polarisation of Th1 helper cells 
following antigen uptake, processing and presentation by DCs. It was, therefore, 
expected that resting DCs were found to produce minimal levels of IL-12p70, as 
demonstrated in a previous study (Zughaier et al. 2006) and interestingly, LPS 
stimulation had no effect on IL-12p70 production either. Purified LPS is unable to 
stimulate IL-12 production when not expressed as part of intact bacteria (Dixon et 
al. 2001b) and this was demonstrated by the significant increase in IL-12p70 
production upon DC incubation with unopsonised Nm and CRP opsonised Nm. The 
ability of Nm to stimulate IL-12 production has been shown to be dependent on Nm 
LOS binding to TLR4 expressed by DCs (Steeghs et al. 2008) and this may explain the 
lack of IL-12p70 production by DCs incubated with Nm/NHS. As no previous studies 
have investigated the effect of normal human serum pre-treatment on IL-12p70 
production, it can be theorised that unopsonised and CRP opsonised Nm are both 
able to bind TLR4 (CRP binds Nm pili and TLR4 recognises LOS on outer membrane 
of Nm) whereas NHS pre-treatment will expose the meningococci to a much larger 
variety of opsonins (IgG, MBL and complement). This in turn, may prevent binding 
of Nm to TLR4 receptors and aid uptake into DCs via alternative receptors, and, 
therefore hinder IL-12p70 production.  
TNF secretion 
 The secretion of high levels of the pro-inflammatory cytokine TNF (formally 
known as TNFα)  by DCs during meningococcal meningitis is well established 
(Steeghs et al. 2008; Al-Bader et al. 2003; Waage 1989; van Deuren et al. 1995; 
Unkmeir 2002; Dixon et al. 2001a) and, therefore, the significant increase in TNF 
production following incubation of DCs with Nm (unopsonised, NHS pre-treated and 
CRP opsonised) was expected. Resting DCs produced minimal levels of TNF, which is 
in agreement with previous work as it is well documented that up regulation of pro 
inflammatory cytokines such as TNF only occurs following antigen uptake and 
processing for presentation to T cells in secondary lymphoid organs (Abdi et al. 
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2012). LPS stimulation induced minor increases in TNF secretion by DCs in 
comparison to resting DCs, which has been demonstrated previously as isolated LPS 
is not as potent a stimulus as intact bacteria (Dixon et al. 2001b). 
Interestingly, unopsonised, NHS pre-treated and CRP opsonised Nm all 
induced similar levels of TNF up regulation, indicating that Nm is able to stimulate 
TNF production regardless of opsonisation status. Indeed, the presence of TNF in 
the cerebrospinal fluid of patients with meningitis is one of the hallmarks of 
bacterial meningitis as viral meningitis does not induce TNF production at all (Nadal 
et al. 1989). This indicates that some component of Nm (most likely the LOS 
structure) is inducing this up regulation of TNF production, and that opsonisation of 
the bacteria does not affect this production.   
TNF production by DCs during Nm infection is induced by the recognition of 
bacterial components (such as peptidoglycan and LOS) by PRRs such as nucleotide-
binding oligomerisation domain (NOD)-like receptors (NLRs) 1/2 and TLR4 
respectively (Girardin et al. 2003, van Beelen et al. 2007 and Duncan et al. 2009). 
Binding of PRRs to their respective ligands will generate signalling cascades 
throughout the cell, leading to activation of the transcription factor NF-kB which will 
induce production of TNF (Gauglitz et al. 2012). Unopsonised Nm will be detected 
by TLR4 and will induce TNF production via this pathway, however, NHS pre-treated 
Nm and CRP opsonised Nm (which are likely to not be recognised by TLR4 of NOD 
receptors) were also able to stimulate similar levels of TNF production. This may be 
explained by the presence of MBL in NHS which can opsonise Nm and potentially 
direct phagocytosis via mannose receptors expressed by DCs. Although the precise 
signalling cascade following binding of mannose receptors has not been fully 
elucidated, it has been documented that mannose receptors are also capable of NF-
kB activation and production of TNF (Gauglitz et al. 2012). CRP opsonised Nm may 
be inducing TNF production via the uptake of Nm by Fc gamma receptors which 
initiates calcium signalling leading to the production of pro-inflammatory cytokines 
such as TNF (May & Machesky 2001). 
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IL-6 secretion 
The significant increase in IL-6 production induced by Nm infection has been 
demonstrated in DCs previously (Unkmeir 2002), therefore, the significant increase 
observed in these studies by DCs stimulated with LPS and all Nm treatments, was 
not unexpected. Unopsonised, NHS pre-treated and CRP opsonised Nm all induced 
significantly higher levels of IL-6 production upon comparison with the positive 
control (LPS stimulation), which is in agreement with Dixon et al who demonstrated 
that the LOS of Nm was a much more potent stimulator of IL-6 production than 
purified LPS (Dixon et al. 2001b).  
 Unopsonised, NHS pre-treated and CRP opsonised Nm did not have any 
differential effect on the production of IL-6 by DCs, suggesting that Nm alone is 
capable of inducing these pro-inflammatory effects. Interestingly, CRP opsonisation 
of another meningitis inducing pathogen, Streptococcus pneumonia, enhances the 
production of IL-6, which aids the hosts defence in reducing bacterial load and 
increases survival of the host (Mold & Du Clos 2006). These studies involving CRP 
opsonisation of Nm, however, do not mimic this effect.  In the case of 
meningococcal pathogenesis, this may be beneficial towards the host as additional 
enhancement of the pro-inflammatory response to Nm LOS by CRP will further 
contribute to tissue damage and organ failure, which is the major cause of mortality 
during meningococcal infection.  
IL-10 secretion 
IL-10 is an anti-inflammatory cytokine which is produced in a negative 
feedback mechanism to limit pro-inflammatory immune responses, thereby 
protecting the host from excessive damage. Detection of LPS by macrophages (one 
of the major sources of IL-10) activates TLR4 and generates a signalling pathway 
with the induction of type I interferon’s (IFN’s) leading to the production and 
secretion of IL-10 (Iyer et al. 2010). It is possible that a similar mechanism occurs in 
DCs, which also express TLR4 and, in this study, showed significant up regulation of 
IL-10 upon stimulation with LPS.  
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Similarly, incubation of DCs with unopsonised Nm and CRP opsonised Nm up 
regulated the secretion of IL-10 in comparison to resting DCs, although there was no 
difference between the effect of unopsonised or CRP opsonised Nm, suggesting 
that CRP does not have an effect on the production of this cytokine in the context of 
Nm opsonisation. Detection of unopsonised Nm via TLR4 on macrophages  has been 
shown to enhance production of IL-10 (L. Peiser et al. 2002), which may explain the 
up regulation of IL-10 by DCs incubated with unopsonised Nm in these studies.  
Conversely, a previous study demonstrated the ability of CRP to down 
regulate the production of IL-10 in monocyte derived macrophages (Singh et al. 
2006). A similar protocol was used in that CRP was incubated with the cells for 24 
hours, however, half as much CRP was used by Singh and colleagues. This suggests 
that the high bacterial load used in these DC studies may have been masking the 
pro-inflammatory effect of CRP. It will be of interest, therefore, to repeat these 
investigations using a range of Nm MOIs to determine if CRP is having an effect on 
downstream immune responses during meningococcal infection.   
Interestingly, NHS pre-treated Nm had a considerable effect on the up 
regulation of IL-10 in comparison to unopsonised or CRP opsonised Nm, 
demonstrating that some component of NHS is inducing this effect. The presence of 
IgG in NHS may the reason for this substantial up regulation as Kurosaka and 
colleagues demonstrated that the incubation of normal human serum with 
macrophages significantly up regulated the production of IL-10. They investigated 
different components of NHS and found that the presence of IgG which binds FcγRI 
led to the production of anti-inflammatory cytokines such as IL-10 (Kurosaka et al. 
2002).  
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5.3.3 Conclusions 
 The downstream immune effects of CRP opsonised Nm on human monocyte 
derived dendritic cells was investigated using flow cytometry and a cytometric bead 
array (CBA) kit to analyse cells surface activation marker expression and levels of 
secreted cytokines, respectively.  
 In agreement with current literature, unopsonised Nm was able to activate 
DCs as demonstrated by the down regulation of CD206 and CD209 which are known 
to be down regulated upon DC activation. Additionally, Nm up regulated the 
expression of CD83 (which is a marker of DC maturation), all three co-stimulatory 
molecules (CD40, CD80 and CD86) and MHC Class II, which are hallmarks of DC 
activation and maturation. The ability of unopsonised meningococci to activate DCs 
was further confirmed by the up regulation of the production of pro-inflammatory 
cytokine TNF, IL-1β, IL-8, IL-6 and IL-12p70. Moderate increases in the anti-
inflammatory cytokine, IL-10 were also observed.  
  CRP opsonised Nm had very similar effects as unopsonised Nm on DC 
surface marker expression and cytokine production, suggesting that CRP does not 
have any significant effect on DC activation in the context of meningococcal 
infection.  As previous chapters have demonstrated that CRP enhanced the uptake 
of Nm into DCs, it would seem fitting that DC activation should also be enhanced as 
a higher number of bacteria would be phagocytosed by the cells. Additionally, CRP 
is known to induce the production of pro-inflammatory cytokines through its 
interaction with Fc gamma receptors (Clos 2009). As enhanced activation was not 
observed, however, it may be interesting to theorise that even in the event of 
enhanced uptake of Nm, CRP is down regulating the effect of Nm on DC activation. 
This would need to be further investigated where bacterial loading would be 
normalised to ensure any responses are due to the effect of CRP and not higher 
levels of bacterial uptake.  
 NHS pre-treatment of Nm was not able to induce DC maturation and 
activation as well as unopsonised Nm or CRP opsonised Nm as demonstrated by the 
lack of CD206 down regulation and no effect observed in co-stimulatory molecule 
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expression. In addition to this, NHS pre-treatment generally induced an anti-
inflammatory response by marked up regulation of IL-10 production and a lack of IL-
1β and IL-12p70. As previously demonstrated in Chapter 3, NHS is also able to 
enhance uptake of Nm into DCs (although to a lesser extent than CRP), however, 
increased Nm uptake does not appear to be enhancing DC activation, rather the 
opposite. It would be of interest to carry out further work to determine which 
component of NHS may be inducing these anti-inflammatory effects.   
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CHAPTER 6 
FINAL DISCUSSION & CONCLUSIONS 
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6.1 General Discussion 
 Group B meningococcal meningitis is more commonly found as a commensal 
coloniser of the nasopharynx but in rare cases can disseminate into the 
bloodstream to cause bacteraemia, septicaemia and/or invasive meningococcal 
meningitis with devastating effects. For many years, there has been a struggle to 
produce an effective vaccine against this particular pathogenic strain, and only last 
year, Novartis launched a potential candidate; Bexsero®, which is proving successful 
and was approved for worldwide use in January 2015.  Whilst an effective vaccine is 
of course paramount to the prevention of this disease, further investigation into the 
pathogenesis of this organism is required to fully elucidate the reasons why, in rare 
cases, Nm is able to breach innate immune barriers to cause infection. One 
important innate immune defence mechanism is the production of acute phase 
proteins such as CRP, which is known to opsonise pathogens such as N. meningitidis 
and enhance its uptake into human phagocytic cells.  The main aims of this thesis 
were to verify this enhanced uptake in human macrophages and dendritic cells, 
which, aside from endothelial and neutrophil cells, are the first innate immune cells 
Nm will encounter following dissemination. Following on from this, investigations 
into the involvement of Fc gamma receptors in this mode of CRP enhanced uptake 
were carried out and the final aim was to explore the effects of CRP opsonised 
uptake of Nm on downstream immune responses of human phagocytic cells. 
Together, these findings should indicate if CRP enhanced uptake of Nm is indeed 
beneficial or harmful towards the host. This final discussion chapter summarises 
these findings and the limitations to the study as well as possible future avenues of 
investigation.  
 
6.1.1 CRP opsonised Neisseria meningitidis uptake via Fc gamma receptors 
and the effect on downstream immune responses in phagocytic cells 
Initial work carried out to confirm the enhanced uptake of CRP opsonised 
Nm into human macrophages and dendritic cells involved establishing the ideal 
time point at which to harvest Nm during logarithmic growth which confirmed that 
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4 hours was the most suitable point. 2 hours of infection was found to be the most 
suitable incubation time in order to allow for phagocytosis of paraformaldehyde 
fixed Nm into human phagocytes and 24 hours was the ideal infection period to 
assess changes in cytokine secretion and cellular surface receptors. Results from 
these optimisation experiments were then used to develop all subsequent assays 
which led to confirmation of enhanced CRP-mediated association of Nm with 
monocyte derived macrophages. These experiments have also shown enhanced 
CRP-mediated uptake of N. meningitidis in differentiated THP-1 macrophages and 
monocyte derived dendritic cells. Full internalisation of the meningococcus was also 
confirmed using plasma membrane stains in all three cell types, showing that CRP is 
able to facilitate the uptake of Nm into innate immune cells during infection. 
Additionally, certain cytokines have been shown to increase the expression of Fc 
gamma receptors such as IFNγ and TNFα, which, when added to endothelial cells, 
stimulated the up regulation of FcγRII expression in these cells (Pan et al. 1998). 
INFγ has also been shown to increase the expression of Fcγ receptors in dendritic 
cells (Fanger et al. 1997) and macrophages (Sivo et al. 1993). It is well known that 
both macrophages and dendritic cells produce TNFα upon infection with Nm 
(Pridmore et al. 2001 and Kolb-Mäurer et al. 2001 respectively) and is, therefore, 
possible that upon infection of these cells with  CRP opsonised Nm and the 
subsequent production of these inflammatory cytokines, that their expression of 
FcγRs will increase and will enhance their phagocytic activity. Whether or not this 
enhanced uptake led to increased phagocytic killing was beyond the scope of this 
thesis but is a topic for further work which will be discussed later.  
 RNAi experiments using siRNA duplexes were intended to be used to knock 
down Fc gamma receptors in primary monocyte derived macrophages or dendritic 
cells to assess the role of these receptors in CRP mediated uptake of Neisseria 
meningitidis into these cell types. Numerous optimisation experiments testing a 
variety of transfection protocols (Lipofectamine™ RNAiMAX, electroporation, 
INTERFERin® and DharmaFECT), ranges of siRNA concentrations and incubation 
times were carried out. Knock down of these receptors was assessed using RT-PCR 
and Western blotting to detect mRNA and protein levels of the receptors, 
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respectively. Unfortunately, knock down of either receptor in both cell types failed 
to be observed following any of the above protocols.  
 Pre-incubation of human monocyte derived macrophages and dendritic cells 
with purified human IgG significantly reduced the association of CRP opsonised Nm 
with these cells, demonstrating the involvement of Fcγ receptors in this mode of 
meningococcal uptake. Specific Fcγ receptor blocking with whole and F(ab’)2 
preparations of anti-CD64 and anti-CD32 also significantly reduced the association 
of CRP opsonised Nm with both cell types. Meningococci in this opsonised state are 
thus able to associate with these human phagocytes via both FcγRI and FcγRII, 
although in macrophages, FcγRII was the preferred receptor. It would be of interest 
in future opsonisation and uptake experiments to pre-block the cells using both 
antibodies together to assess the effect on CRP opsonised Nm association with 
human macrophages and dendritic cells.  
 Co-localisation experiments using GFP expressing Nm and PE conjugated 
antibodies to FcγRI and FcγRII revealed significantly higher levels of Nm co-
localisation with macrophage and dendritic Fcγ receptors when Nm was opsonised 
with CRP, in comparison to unopsonised or NHS pre-treated Nm. This supported the 
data from the IgG and specific antibody blocking experiments, which demonstrated 
the involvement of both FcγRI and FcγRII in CRP enhanced association of Nm with 
monocyte derived macrophages and dendritic cells. 
The downstream immune effects of CRP opsonised Nm on human monocyte 
derived dendritic cells was investigated using flow cytometry and a cytometric bead 
array (CBA) kit to analyse cells surface activation marker expression and levels of 
secreted cytokines, respectively. In agreement with current literature, unopsonised 
Nm was able to activate DCs as demonstrated by the down regulation of CD206 and 
CD209 which are known to be down regulated upon DC activation. Additionally, Nm 
up regulated the expression of CD83 (which is a marker of DC maturation), all three 
co-stimulatory molecules (CD40, CD80 and CD86) and MHC Class II, which are 
hallmarks of DC activation and maturation. The ability of unopsonised meningococci 
to activate DCs was further confirmed by the up regulation of the production of pro-
 
 
191 
 
inflammatory cytokine TNF, IL-1β, IL-8, IL-6 and IL-12p70. Moderate increases in the 
anti-inflammatory cytokine, IL-10 were also observed. CRP opsonised Nm had very 
similar effects as unopsonised Nm on DC surface marker expression and cytokine 
production, suggesting that CRP does not have any significant effect on DC 
activation in the context of meningococcal infection.  As previous chapters have 
demonstrated that CRP enhanced the uptake of Nm into DCs, it would seem fitting 
that DC activation should also be enhanced as a higher number of bacteria would be 
phagocytosed by the cells. Additionally, CRP is known to induce the production of 
pro-inflammatory cytokines through its interaction with Fc gamma receptors (Clos 
2009). As enhanced activation was not observed, however, it may be interesting to 
theorise that even in the event of enhanced uptake of Nm, CRP is down regulating 
the effect of Nm on DC activation. NHS pre-treatment of Nm was not able to induce 
DC maturation and activation as well as unopsonised Nm or CRP opsonised Nm as 
demonstrated by the lack of CD206 down regulation and no effect observed in co-
stimulatory molecule expression. In addition to this, NHS pre-treatment generally 
induced an anti-inflammatory response by marked up regulation of IL-10 production 
and a lack of IL-1β and IL-12p70. As previously demonstrated in Chapter 3, NHS is 
also able to enhance uptake of Nm into DCs, although to a lesser extent than CRP. 
Increased NHS pre-treated Nm uptake, however, did not appear to enhance DC 
activation, rather the opposite. It would be of interest to carry out further work to 
determine which component of NHS may be inducing these anti-inflammatory 
effects.   
The findings from this study are summarised in Figure 6.1, which also 
proposes a model of the potential interaction of CRP opsonised Nm with 
macrophages and DCs in the bloodstream. The model includes what is currently 
known about unopsonised uptake of Nm by these cells’ pattern recognition 
receptors (scavenger receptors, toll-like receptors, CD14, mannose receptors and 
complement receptor 3) and depicts the effects of both unopsonised and CRP 
opsonised Nm uptake on downstream immune responses: Previous work in the 
group demonstrated that uptake of both unopsonised and CRP opsonised Nm 
induced down regulation of macrophage activation markers CD11b and CD64 and 
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up regulating the secretion of inflammatory cytokines, which suggests that in these 
particular cells Nm is capable of modulating the innate immune response. The 
response in DCs, however, was different in that both unopsonised and CRP 
opsonised Nm were able to activate DCs and stimulate the up regulation of co-
stimulatory and antigen presentation molecules, which is of significant importance 
in order to present processed Nm antigens to T cells and mount effective adaptive 
immune responses. Additionally, unopsonised Nm and CRP opsonised Nm were 
equally capable of up regulating the secretion of inflammatory cytokines from DCs. 
This demonstrates that CRP enhanced uptake of Nm by these cells may be 
beneficial towards the host as the pro-inflammatory response is not up regulated 
further despite the increased levels of Nm taken up for phagocytosis by CRP 
opsonisation. These investigations also demonstrated that CRP opsonised Nm is 
taken up by these phagocytic cells via both FcγRI and II, although the preferred 
receptors were FcγRI expressed by DCs and FcγRII expressed by macrophages. 
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Figure 6.1 Proposed model of the interactions of unopsonised and CRP opsonised Nm 
with human macrophages and dendritic cells in the bloodstream. 
Unopsonised Nm (A) that has disseminated through the mucosal epithelium into the 
bloodstream will be phagocytosed by macrophages and dendritic cells via a range of 
pattern recognition receptors ((B) CD14, scavenger receptors, mannose receptors, toll-like 
receptors (TLRs) and complement receptor 3 (CR3)). Unopsonised Nm may also be 
opsonised by serum CRP via phosphorylcholine expressed on the bacterial pili (C), which 
will enhance phagocytosis by Fcγ receptors I and II on both cell types (D). This enhanced 
CRP mediated uptake occurs preferentially by FcγRI on DCs and FcγRII on macrophages and 
may potentially enhance phagocytic killing of Nm. Both unopsonised and CRP opsonised 
Nm induce the up regulation of inflammatory cytokine secretion from both cell types (E) 
and the up regulation of surface activation markers in DCs (F). Activation marker expression 
in macrophages however, has been shown to be down regulated during infection with both 
unopsonised and CRP opsonised Nm (G).  
 
6.2 Limitations to the study and future work 
Protocols used throughout this study involved paraformaldehyde fixed 
Neisseria meningitidis. It may be argued that usage of inert Nm does not truly 
reflect the immune responses in vivo, however, as most surface receptors and LOS 
of Nm are still present and capable of inducing immune responses (Pridmore et al. 
2001; Devoe 1973), it is still considered physiologically relevant to use fixed 
meningococci. Indeed, several studies utilise fixed Nm (Steeghs et al. 2006; Steeghs 
et al. 2008; Jones et al. 2007; Jack et al. 2001; Casey et al. 2008) as it is often 
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necessary in order to comply with health and safety regulations, as was the case 
with many of the protocols in this study; usage of live bacteria would have limited 
the number of protocols possible outside of containment level 2 facilities, such as 
confocal microscopy and flow cytometry. Previous preliminary work in our 
laboratory investigating live Nm infection of macrophages revealed that CRP 
opsonisation of live Nm still occurred but the uptake into cells was not as enhanced 
as with fixed Nm (data unpublished). Additionally, Jones et al also demonstrated 
that live Nm was not able to stimulate DC maturation as well as killed meningococci 
(Jones et al. 2007) and it would, therefore, be of interest to repeat these 
experiments in both macrophages and in dendritic cells to fully investigate the 
response of live and dead CRP opsonised Nm to human phagocytic cells.  
 The majority of aims in this thesis involved the use of the acute phase 
protein, CRP, which was purchased as a purified protein and further purified using 
chromatography and stored as aliquots for several months as the working 
concentration was as low as 50µg/ml. It was therefore of importance to consider 
the possibility of CRP degradation during the analysis of these results. The stability 
of CRP was never tested, however, previous investigators have demonstrated that 
CRP is stable following multiple freeze thaw cycles and that long term storage of up 
to 34 months was permitted at 4°C (Brindle et al. 2010). Additionally, constant 
examination of CRP aliquots were recommended, as any turbidity, precipitation or 
discolouration would indicate CRP deterioration (Aziz et al. 2003). It was on this 
basis, therefore, that CRP aliquots were routinely checked and new CRP was 
purchased on a yearly basis and kept at 4°C. Future investigations, however, should 
involve carrying out regular non reducing SDS-PAGE and ELISAs to fully verify CRP 
stability.  
 Opsonisation and uptake assays constituted the majority of the data of 
Chapter 3 and 4 and demonstrated that the enhanced uptake of CRP opsonised Nm 
into human macrophages and dendritic cells occurred via FcγRI and FcγRII 
expressed by these cells. This data was collected using 2-dimensional confocal 
microscopy images and due to the volume of images required to carry out statistical 
validation, it was not possible to take z-stack 3-D images of all cell/bacterial 
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interactions to verify full bacterial association/internalisation. Future investigations 
would need to involve either z-stack images of all fields and flow cytometric analysis 
of GFP-expressing Nm uptake into these cells to support the opsonisation/uptake 
and antibody blocking results gathered in these studies. Additionally, gentamicin 
exclusion assays could be carried out alongside these experiments, which allow for 
the enumeration of both adherent Nm on the surface of the cells and internalised 
Nm.  
In order to investigate the involvement of Fcγ receptors in the uptake of CRP 
opsonised Nm into human phagocytes, RNA interference (RNAi) was initially used in 
the hope of knocking down these receptors individually prior to opsonisation and 
uptake assays. Unfortunately, none of the transfection methods employed were 
able to induce significant knock down of either receptors. Although the IgG and 
specific antibody blocking studies revealed that CRP opsonised Nm is able to utilise 
both FcγRI and FcγRII, it would still be of interest to attempt gene knock down of 
these receptors in future experiments to complement the antibody blocking 
studies. There are several strategies that could be used to improve the 
experimental designs used in these RNAi experiments such as using reverse 
transcriptase quantitative PCR (RT-qPCR) to quantitatively detect mRNA level 
changes which would offer a faster approach to detecting mRNA knock down. If 
minimal levels of knock down occurred, these may have been detected unlike with 
conventional PCR (Bustin 2000) due to its high sensitivity and quantitative nature. 
Additionally, the successful transfection of siRNA duplexes into the cells should 
have been verified with GFP tagged siRNA to monitor transfection efficiency 
analysed using fluorescence microscopy (Muratovska & Eccles 2004) and multiple 
transfections should also be considered. Establishing the protein turn over time of 
these receptors would also be beneficial to optimising future RNAi experiments, 
and could be done using protein degradation assays by which the protein of interest 
is pulse labelled with radioactive nucleosides or amino acids in order to measure 
protein half-life (Zhou 2004). These receptors may have a high turnover rate, in 
which case, transient knock down using siRNA may not be adequate and adenoviral, 
retroviral or lentiviral vectors could be employed to transfect short hairpin RNA 
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(shRNA) into human phagocytes to induce more stable knockdown of Fcγ receptors 
(Moore et al. 2010). It has also been reported that in some cases, the unused 
lipofectant-transfected siRNAs can interfere with the observed effects of the used 
siRNA duplexes, in which case, shRNAs are the preferred method (Barreau et al. 
2006). Viral vectors would need to be used with caution, however, as they have the 
potential to activate the transfected cells. This would make downstream immune 
response analysis difficult following opsonisation and uptake of Nm, as the effects 
of the vector and Nm would need to be distinguished.  An alternative approach to 
detecting knock down would be the use of Fcγ receptor specific antibodies 
following siRNA/shRNA transfection and flow cytometry to analyse the surface 
expression of these receptors instead of PCR or Western blotting to detect mRNA or 
protein levels, respectively. Also, rather than targeting the gene to induce knock 
down, signalling of the receptors could be repressed with the use of antibodies 
targeting Fcγ receptors whilst simultaneously using a cytoplasmic protein tyrosine 
kinase (syk) inhibitor called piceatannol that has been shown to block Fcγ receptor 
signalling and inhibit cytokine secretion (Lu et al. 2008). 
Following the unsuccessful attempts at Fcγ receptor knock down, blocking 
antibodies and F(ab’)2 preparations were used to assess the involvement of FcγRI 
and FcγRII in CRP mediated uptake of Nm into human macrophages and dendritic 
cells. It is important to keep in mind, however, that the F(ab’)2 preparations may 
have been more successful at blocking than their whole counterparts because there 
would have been a higher concentration of F(ab’)2 binding portions present in these 
preparations in comparison to the whole antibody solutions which would have also 
contained Fc regions. Any future work comparing whole antibody blocking to F(ab’)2 
preparation blocking would need to account for the presence of Fc portions and 
adjust the antibody concentrations accordingly. Additionally, it would also be of 
interest to assess the effect of using both F(ab’)2 preparations specific to FcγRI and 
FcγRII simultaneously to observe if CRP mediated uptake of Nm can be further 
prevented.  
It would be of interest, in future co-localisation experiments, to 
quantitatively analyse the co-localisation of CRP opsonised Nm with Fcγ receptors 
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expressed by monocyte derived macrophages and dendritic cells using co-
localisation algorithms provided with most confocal microscopy analysis software. 
Scatter plots of the individual pixels are created to calculate several coefficients in 
order to quantitatively assess the presence and level of co-localisation such as 
Pearson’s Correlation Coefficient, Overlap Coefficients K1 and K2 and Co-localisation 
Coefficients M1 and M2. Pearson’s Correlation Coefficient describes the extent of 
overlap using the similarities of the shapes, Overlap Coefficients K1 and K2 describe 
differences in intensity of the red and green channels and Co-localisation 
Coefficients M1 and M2 describe the contribution of each fluorophore to the co-
localisation area.  
Investigations into the effect of CRP enhanced uptake of Nm on dendritic 
cell (DC) downstream immune responses revealed that unopsonised Nm and CRP 
opsonised Nm had very similar effects on DC activation surface marker expression 
and inflammatory cytokine secretion. It would be of interest in future experiments 
to investigate a range of Nm MOI’s as the high level of bacteria per cell (200 Nm per 
dendritic cell) may have been masking the modulatory effects of CRP. Indeed, CRP 
opsonisation of Streptococcus pneumoniae enhanced the pro-inflammatory 
response of PBMCs by up regulating the secretion of TNFα and IL-1β when high 
bacterial loads were used and interestingly, up regulation of IL-10 and IL-6 was also 
observed when lower bacterial concentrations were used (Mold & Du Clos 2006). 
CRP concentrations used in this study have reflected levels observed during acute 
inflammation. Alternatively, it would be of interest to investigate in future works 
the effect of a range of CRP concentrations as it has been shown that the down 
regulation of TNFα production by macrophages stimulated with LPS occurred when 
CRP was used at much higher concentrations (Casals et al. 2003). It is also important 
to keep in mind that Nm/NHS preparations are closer to in vivo situations than 
either Nm/PBS or Nm/CRP. Ideally, serum taken from patients suffering from 
meningococcal infection would have been the model control to use or normal 
human serum spiked with inflammatory levels of CRP to see if the effects of NHS 
alone could be inhibited.  
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Discrepancies may also have arisen due to the use of different donors in 
each experiment, none of which were genotyped. Variation in levels of Nm 
association may have occurred because of polymorphisms in either Fcγ receptor, in 
particular FcγRIIa, which can exist in two allelic forms (R-131 or H-131). These two 
forms are able to bind IgG and CRP with different avidities and previous work found 
that variability was not due to levels of FcγRII expression between donors, but more 
likely due to these polymorphisms (Stein et al. 2000). Any further studies involving 
human phagocytic cells from donor peripheral blood should ideally be genotyped to 
investigate the effect of CRP opsonised Nm binding to the different allelic forms of 
this receptor.  
 In conclusion, results from these studies have confirmed that opsonisation 
of paraformaldehyde fixed Neisseria meningitidis with human C-Reactive Protein 
significantly enhances the uptake of Nm into human monocyte derived 
macrophages and dendritic cells. This enhanced uptake was shown to occur via 
both Fc gamma receptors I and II expressed by macrophages and DCs although the 
preferred receptors were FcγRI expressed by DCs and FcγRII expressed by 
macrophages. Both unopsonised and CRP opsonised Nm, however, had extremely 
similar effects on DC downstream immune responses demonstrated by the up 
regulation of co-stimulatory and antigen presentation molecules, as well as inducing 
the up regulation of a range of inflammatory cytokines. This suggests that CRP 
enhanced uptake of Nm by these phagocytic cells may be beneficial towards the 
host as despite the increased uptake of Nm by both cell types (potentially for 
phagocytic clearance), the pro-inflammatory cytokine response by DCs is not further 
exacerbated, thereby limiting inflammatory damage, which is known to the be the 
major contributor to the pathogenesis of meningococcal meningitis. The response 
of DCs to CRP enhanced uptake of Nm is of particular importance given the role 
these cells play in linking the innate and adaptive immune systems through their 
interactions with T cells and inducing rapid and effective adaptive immune 
responses. Previous work has shown that CRP opsonised Streptococcus pneumoniae 
can also enhance uptake of this pathogen into DCs, and resulted in higher 
secondary and memory IgG responses to different components of Nm. This study 
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also demonstrated that if mice were immunised with DCs that had taken up CRP 
opsonised S. Pneumoniae, their resistance to infection by virulent S. pneumoniae 
was significantly increased (Thomas-Rudolph et al. 2007). This further verifies the 
protective nature of CRP and, together with the results from this study, provides 
scope for further investigations into the effects of CRP on stimulating protective 
adaptive immunity during meningococcal meningitis.  
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